BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Green RC, Berg JS, Grody WW, Kalia SS, Korf BR, Martin CL, McGuire AL, Nussbaum RL, O'Daniel JM, Ormond KE, Rehm HL, Watson MS, Williams MS, Biesecker LG; American College of Medical Genetics and Genomics. ACMG recommendations for reporting of incidental findings in clinical exome and genome sequencing. Genet Med 2013;15:565-74. [PMID: 23788249 DOI: 10.1038/gim.2013.73] [Cited by in Crossref: 1575] [Cited by in F6Publishing: 1391] [Article Influence: 175.0] [Reference Citation Analysis]
Number Citing Articles
1 Plöthner M, Schmidt K, Schips C, Damm K. Which attributes of whole genome sequencing tests are most important to the general population? Results from a German preference study. Pharmgenomics Pers Med 2018;11:7-21. [PMID: 29497326 DOI: 10.2147/PGPM.S149803] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
2 Innes AM, Boycott KM. Next Generation Diagnostics for Rare Neurological Diseases: The Future is Here. Can J Neurol Sci 2014;41:299-300. [PMID: 24718813 DOI: 10.1017/s0317167100017224] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
3 Puckelwartz MJ, McNally EM. Genetic profiling for risk reduction in human cardiovascular disease. Genes (Basel) 2014;5:214-34. [PMID: 24705294 DOI: 10.3390/genes5010214] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 1.5] [Reference Citation Analysis]
4 Hitch K, Joseph G, Guiltinan J, Kianmahd J, Youngblom J, Blanco A. Lynch syndrome patients' views of and preferences for return of results following whole exome sequencing. J Genet Couns 2014;23:539-51. [PMID: 24449059 DOI: 10.1007/s10897-014-9687-6] [Cited by in Crossref: 50] [Cited by in F6Publishing: 43] [Article Influence: 6.3] [Reference Citation Analysis]
5 Middha S, Lindor NM, McDonnell SK, Olson JE, Johnson KJ, Wieben ED, Farrugia G, Cerhan JR, Thibodeau SN. How well do whole exome sequencing results correlate with medical findings? A study of 89 Mayo Clinic Biobank samples. Front Genet 2015;6:244. [PMID: 26257771 DOI: 10.3389/fgene.2015.00244] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
6 Balobaid A, Qari A, Al-Zaidan H. Genetic counselors' scope of practice and challenges in genetic counseling services in Saudi Arabia. Int J Pediatr Adolesc Med 2016;3:1-6. [PMID: 30805460 DOI: 10.1016/j.ijpam.2015.12.002] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
7 Romasko EJ, Devkota B, Biswas S, Jayaraman V, Rajagopalan R, Dulik MC, Thom CS, Choi J, Jairam S, Scarano MI, Krantz ID, Spinner NB, Conlin LK, Lambert MP. Utility and limitations of exome sequencing in the molecular diagnosis of pediatric inherited platelet disorders. Am J Hematol 2018;93:8-16. [PMID: 28960434 DOI: 10.1002/ajh.24917] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 3.0] [Reference Citation Analysis]
8 Vassy JL, Davis JK, Kirby C, Richardson IJ, Green RC, McGuire AL, Ubel PA. How Primary Care Providers Talk to Patients about Genome Sequencing Results: Risk, Rationale, and Recommendation. J Gen Intern Med 2018;33:877-85. [PMID: 29374360 DOI: 10.1007/s11606-017-4295-4] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
9 Cheng DT, Prasad M, Chekaluk Y, Benayed R, Sadowska J, Zehir A, Syed A, Wang YE, Somar J, Li Y, Yelskaya Z, Wong D, Robson ME, Offit K, Berger MF, Nafa K, Ladanyi M, Zhang L. Comprehensive detection of germline variants by MSK-IMPACT, a clinical diagnostic platform for solid tumor molecular oncology and concurrent cancer predisposition testing. BMC Med Genomics 2017;10:33. [PMID: 28526081 DOI: 10.1186/s12920-017-0271-4] [Cited by in Crossref: 57] [Cited by in F6Publishing: 51] [Article Influence: 11.4] [Reference Citation Analysis]
10 Callier SL, Toma I, McCaffrey T, Harralson AF, O'Brien TJ. Engaging the next generation of healthcare professionals in genomics: planning for the future. Per Med 2014;11:89-98. [PMID: 29751387 DOI: 10.2217/pme.13.99] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
11 Warman Chardon J, Beaulieu C, Hartley T, Boycott KM, Dyment DA. Axons to Exons: the Molecular Diagnosis of Rare Neurological Diseases by Next-Generation Sequencing. Curr Neurol Neurosci Rep 2015;15:64. [PMID: 26289954 DOI: 10.1007/s11910-015-0584-7] [Cited by in Crossref: 22] [Cited by in F6Publishing: 17] [Article Influence: 3.7] [Reference Citation Analysis]
12 You YN, Borras E, Chang K, Price BA, Mork M, Chang GJ, Rodriguez-Bigas MA, Bednarski BK, Meric-Bernstam F, Vilar E. Detection of Pathogenic Germline Variants Among Patients With Advanced Colorectal Cancer Undergoing Tumor Genomic Profiling for Precision Medicine. Dis Colon Rectum 2019;62:429-37. [PMID: 30730459 DOI: 10.1097/DCR.0000000000001322] [Cited by in Crossref: 11] [Cited by in F6Publishing: 5] [Article Influence: 3.7] [Reference Citation Analysis]
13 Korvigo I, Afanasyev A, Romashchenko N, Skoblov M. Generalising better: Applying deep learning to integrate deleteriousness prediction scores for whole-exome SNV studies. PLoS One 2018;13:e0192829. [PMID: 29538399 DOI: 10.1371/journal.pone.0192829] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
14 Facio FM, Lee K, O'Daniel JM. A genetic counselor's guide to using next-generation sequencing in clinical practice. J Genet Couns 2014;23:455-62. [PMID: 24151055 DOI: 10.1007/s10897-013-9662-7] [Cited by in Crossref: 24] [Cited by in F6Publishing: 20] [Article Influence: 2.7] [Reference Citation Analysis]
15 Thavaneswaran S, Sebastian L, Ballinger M, Best M, Hess D, Lee CK, Sjoquist KM, Hague WE, Butow PN, Simes RJ, Thomas D. Cancer Molecular Screening and Therapeutics (MoST): a framework for multiple, parallel signal‐seeking studies of targeted therapies for rare and neglected cancers. Medical Journal of Australia 2018;209:354-5. [DOI: 10.5694/mja18.00227] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 3.8] [Reference Citation Analysis]
16 Peeters S, Declerck K, Thomas M, Boudin E, Beckers D, Chivu O, Heinrichs C, Devriendt K, de Zegher F, Van Hul W, Vanden Berghe W, De Schepper J, Rooman R, Mortier G; WES-BESPEED Study Group. DNA Methylation Profiling and Genomic Analysis in 20 Children with Short Stature Who Were Born Small for Gestational Age. J Clin Endocrinol Metab 2020;105:dgaa465. [PMID: 32685970 DOI: 10.1210/clinem/dgaa465] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
17 Cornelis C, Bolt I, Van Summeren M. Contextualizing Genetic Testing and Sequencing Results for Patients and Parents: The Need for Empirical-Ethical Research. The American Journal of Bioethics 2014;14:10-2. [DOI: 10.1080/15265161.2013.879957] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
18 Porntaveetus T, Srichomthong C, Suphapeetiporn K, Shotelersuk V. A novel PCCB mutation in a Thai patient with propionic acidemia identified by exome sequencing. Hum Genome Var 2015;2:15033. [PMID: 27081542 DOI: 10.1038/hgv.2015.33] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
19 Paulo P, Pinto P, Peixoto A, Santos C, Pinto C, Rocha P, Veiga I, Soares G, Machado C, Ramos F, Teixeira MR. Validation of a Next-Generation Sequencing Pipeline for the Molecular Diagnosis of Multiple Inherited Cancer Predisposing Syndromes. J Mol Diagn 2017;19:502-13. [PMID: 28529006 DOI: 10.1016/j.jmoldx.2017.05.001] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
20 Aas M, Blokland GA, Chawner SJ, Choi SW, Estrada J, Forsingdal A, Friedrich M, Ganesham S, Hall L, Haslinger D, Huckins L, Loken E, Malan-Müller S, Martin J, Misiewicz Z, Pagliaroli L, Pardiñas AF, Pisanu C, Quadri G, Santoro ML, Shaw AD, Ranlund S, Song J, Tesli M, Tropeano M, van der Voet M, Wolfe K, Cormack FK, DeLisi L. Summaries of plenary, symposia, and oral sessions at the XXII World Congress of Psychiatric Genetics, Copenhagen, Denmark, 12-16 October 2014. Psychiatr Genet 2016;26:1-47. [PMID: 26565519 DOI: 10.1097/YPG.0000000000000112] [Reference Citation Analysis]
21 Gunaratnam NT, Akce M, Al Natour R, Bartley AN, Fioritto AF, Hanson K, Ladabaum U. Screening for Cancer Genetic Syndromes With a Simple Risk-Assessment Tool in a Community-Based Open-Access Colonoscopy Practice. Am J Gastroenterol. 2016;111:589-593. [PMID: 27021195 DOI: 10.1038/ajg.2016.84] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
22 Zhao JQ, Haga SB. Promoting the participant–researcher partnership. Genet Med 2014;16:228-30. [DOI: 10.1038/gim.2013.118] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
23 Blout Zawatsky CL, Shah N, Machini K, Perez E, Christensen KD, Zouk H, Steeves M, Koch C, Uveges M, Shea J, Gold N, Krier J, Boutin N, Mahanta L, Rehm HL, Weiss ST, Karlson EW, Smoller JW, Lebo MS, Green RC. Returning actionable genomic results in a research biobank: Analytic validity, clinical implementation, and resource utilization. Am J Hum Genet 2021;108:2224-37. [PMID: 34752750 DOI: 10.1016/j.ajhg.2021.10.005] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
24 Christenhusz GM, Devriendt K, Van Esch H, Dierickx K. Ethical signposts for clinical geneticists in secondary variant and incidental finding disclosure discussions. Med Health Care Philos 2015;18:361-70. [PMID: 25407129 DOI: 10.1007/s11019-014-9611-8] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
25 Joseph L, Cankovic M, Caughron S, Chandra P, Emmadi R, Hagenkord J, Hallam S, Jewell KE, Klein RD, Pratt VM, Rothberg PG, Temple-Smolkin RL, Lyon E. The Spectrum of Clinical Utilities in Molecular Pathology Testing Procedures for Inherited Conditions and Cancer: A Report of the Association for Molecular Pathology. J Mol Diagn 2016;18:605-19. [PMID: 27542512 DOI: 10.1016/j.jmoldx.2016.05.007] [Cited by in Crossref: 31] [Cited by in F6Publishing: 31] [Article Influence: 5.2] [Reference Citation Analysis]
26 Vayena E, Tasioulas J. Genetic incidental findings: autonomy regained? Genet Med 2013;15:868-70. [PMID: 23907644 DOI: 10.1038/gim.2013.104] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 2.0] [Reference Citation Analysis]
27 Hood L, Lovejoy JC, Price ND. Integrating big data and actionable health coaching to optimize wellness. BMC Med 2015;13:4. [PMID: 25575752 DOI: 10.1186/s12916-014-0238-7] [Cited by in Crossref: 50] [Cited by in F6Publishing: 42] [Article Influence: 7.1] [Reference Citation Analysis]
28 ACMG Board of Directors. Clinical utility of genetic and genomic services: a position statement of the American College of Medical Genetics and Genomics. Genet Med 2015;17:505-7. [DOI: 10.1038/gim.2015.41] [Cited by in Crossref: 96] [Cited by in F6Publishing: 78] [Article Influence: 13.7] [Reference Citation Analysis]
29 West KM, Blacksher E, Cavanaugh KL, Fullerton SM, Umeukeje EM, Young BA, Burke W. At the Research-Clinical Interface: Returning Individual Genetic Results to Research Participants. Clin J Am Soc Nephrol 2020;15:1181-9. [PMID: 32041801 DOI: 10.2215/CJN.09670819] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
30 Lazo PA, García JL, Gómez-Puertas P, Marcos-Alcalde Í, Arjona C, Villarroel A, González-Sarmiento R, Fons C. Novel Dominant KCNQ2 Exon 7 Partial In-Frame Duplication in a Complex Epileptic and Neurodevelopmental Delay Syndrome. Int J Mol Sci 2020;21:E4447. [PMID: 32585800 DOI: 10.3390/ijms21124447] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
31 Wang X, Teer JK, Tousignant RN, Levin AM, Boulware D, Chitale DA, Shaw BM, Chen Z, Zhang Y, Blakeley JO, Acosta MT, Messiaen LM, Korf BR, Tainsky MA. Breast cancer risk and germline genomic profiling of women with neurofibromatosis type 1 who developed breast cancer. Genes Chromosomes Cancer 2018;57:19-27. [PMID: 28891274 DOI: 10.1002/gcc.22503] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 2.2] [Reference Citation Analysis]
32 Molina-Ramírez LP, Kyle C, Ellingford JM, Wright R, Taylor A, Bhaskar SS, Campbell C, Jackson H, Fairclough A, Rousseau A, Burghel GJ, Dutton L, Banka S, Briggs TA, Clayton-Smith J, Douzgou S, Jones EA, Kingston HM, Kerr B, Ealing J, Somarathi S, Chandler KE, Stuart HM, Burkitt-Wright EM, Newman WG, Bruce IA, Black GC, Gokhale D. Personalised virtual gene panels reduce interpretation workload and maintain diagnostic rates of proband-only clinical exome sequencing for rare disorders. J Med Genet 2021:jmedgenet-2020-107303. [PMID: 33879512 DOI: 10.1136/jmedgenet-2020-107303] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
33 Sirisena N, Biswas K, Sullivan T, Stauffer S, Cleveland L, Southon E, Dissanayake VHW, Sharan SK. Functional evaluation of five BRCA2 unclassified variants identified in a Sri Lankan cohort with inherited cancer syndromes using a mouse embryonic stem cell-based assay. Breast Cancer Res 2020;22:43. [PMID: 32393398 DOI: 10.1186/s13058-020-01272-z] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
34 Gliwa C, Yurkiewicz IR, Lehmann LS, Hull SC, Jones N, Berkman BE. Institutional review board perspectives on obligations to disclose genetic incidental findings to research participants. Genet Med 2016;18:705-11. [PMID: 26583685 DOI: 10.1038/gim.2015.149] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 2.3] [Reference Citation Analysis]
35 Cronin RM, Halvorson AE, Springer C, Feng X, Sulieman L, Loperena-Cortes R, Mayo K, Carroll RJ, Chen Q, Ahmedani BK, Karnes J, Korf B, O'Donnell CJ, Qian J, Ramirez AH. Comparison of family health history in surveys vs electronic health record data mapped to the observational medical outcomes partnership data model in the All of Us Research Program. J Am Med Inform Assoc 2021;28:695-703. [PMID: 33404595 DOI: 10.1093/jamia/ocaa315] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
36 Cook CE, Bergman MT, Finn RD, Cochrane G, Birney E, Apweiler R. The European Bioinformatics Institute in 2016: Data growth and integration. Nucleic Acids Res 2016;44:D20-6. [PMID: 26673705 DOI: 10.1093/nar/gkv1352] [Cited by in Crossref: 83] [Cited by in F6Publishing: 58] [Article Influence: 11.9] [Reference Citation Analysis]
37 Hofmann B. Incidental findings of uncertain significance: To know or not to know--that is not the question. BMC Med Ethics 2016;17:13. [PMID: 26873084 DOI: 10.1186/s12910-016-0096-2] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 3.5] [Reference Citation Analysis]
38 Amendola LM, Lautenbach D, Scollon S, Bernhardt B, Biswas S, East K, Everett J, Gilmore MJ, Himes P, Raymond VM, Wynn J, Hart R, Jarvik GP; CSER Genetic Counseling Working Group. Illustrative case studies in the return of exome and genome sequencing results. Per Med 2015;12:283-95. [PMID: 26478737 DOI: 10.2217/pme.14.89] [Cited by in Crossref: 31] [Cited by in F6Publishing: 29] [Article Influence: 4.4] [Reference Citation Analysis]
39 Nishimura AA, Tarczy-Hornoch P, Shirts BH. Pragmatic and Ethical Challenges of Incorporating the Genome into the Electronic Medical Record. Curr Genet Med Rep 2014;2:201-11. [PMID: 26146597 DOI: 10.1007/s40142-014-0051-9] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
40 Nishimura AA, Shirts BH, Dorschner MO, Amendola LM, Smith JW, Jarvik GP, Tarczy-Hornoch P. Development of clinical decision support alerts for pharmacogenomic incidental findings from exome sequencing. Genet Med 2015;17:939-42. [PMID: 25741865 DOI: 10.1038/gim.2015.5] [Cited by in Crossref: 18] [Cited by in F6Publishing: 12] [Article Influence: 2.6] [Reference Citation Analysis]
41 Botkin JR, Belmont JW, Berg JS, Berkman BE, Bombard Y, Holm IA, Levy HP, Ormond KE, Saal HM, Spinner NB, Wilfond BS, McInerney JD. Points to Consider: Ethical, Legal, and Psychosocial Implications of Genetic Testing in Children and Adolescents. Am J Hum Genet 2015;97:6-21. [PMID: 26140447 DOI: 10.1016/j.ajhg.2015.05.022] [Cited by in Crossref: 255] [Cited by in F6Publishing: 196] [Article Influence: 36.4] [Reference Citation Analysis]
42 Darnell AJ, Austin H, Bluemke DA, Cannon RO 3rd, Fischbeck K, Gahl W, Goldman D, Grady C, Greene MH, Holland SM, Hull SC, Porter FD, Resnik D, Rubinstein WS, Biesecker LG. A Clinical Service to Support the Return of Secondary Genomic Findings in Human Research. Am J Hum Genet 2016;98:435-41. [PMID: 26942283 DOI: 10.1016/j.ajhg.2016.01.010] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 3.0] [Reference Citation Analysis]
43 Johns AL, McKay SH, Humphris JL, Pinese M, Chantrill LA, Mead RS, Tucker K, Andrews L, Goodwin A, Leonard C, High HA, Nones K, Patch AM, Merrett ND, Pavlakis N, Kassahn KS, Samra JS, Miller DK, Chang DK, Pajic M, Pearson JV, Grimmond SM, Waddell N, Zeps N, Gill AJ, Biankin AV; Australian Pancreatic Cancer Genome Initiative. Lost in translation: returning germline genetic results in genome-scale cancer research. Genome Med 2017;9:41. [PMID: 28454591 DOI: 10.1186/s13073-017-0430-4] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 4.0] [Reference Citation Analysis]
44 Esteban I, Lopez-Fernandez A, Balmaña J. A narrative overview of the patients' outcomes after multigene cancer panel testing, and a thorough evaluation of its implications for genetic counselling. Eur J Med Genet 2019;62:342-9. [PMID: 30476626 DOI: 10.1016/j.ejmg.2018.11.027] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
45 [DOI: 10.1101/578674] [Cited by in Crossref: 38] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
46 Yuen T, Carter MT, Szatmari P, Ungar WJ. Cost-effectiveness of Genome and Exome Sequencing in Children Diagnosed with Autism Spectrum Disorder. Appl Health Econ Health Policy 2018;16:481-93. [PMID: 29651777 DOI: 10.1007/s40258-018-0390-x] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
47 Punj S, Akkari Y, Huang J, Yang F, Creason A, Pak C, Potter A, Dorschner MO, Nickerson DA, Robertson PD, Jarvik GP, Amendola LM, Schleit J, Simpson DK, Rope AF, Reiss J, Kauffman T, Gilmore MJ, Himes P, Wilfond B, Goddard KAB, Richards CS. Preconception Carrier Screening by Genome Sequencing: Results from the Clinical Laboratory. Am J Hum Genet 2018;102:1078-89. [PMID: 29754767 DOI: 10.1016/j.ajhg.2018.04.004] [Cited by in Crossref: 20] [Cited by in F6Publishing: 13] [Article Influence: 5.0] [Reference Citation Analysis]
48 Dondorp W, Bolt I, Tibben A, De Wert G, Van Summeren M. 'We Should View Him as an Individual': The Role of the Child's Future Autonomy in Shared Decision-Making About Unsolicited Findings in Pediatric Exome Sequencing. Health Care Anal 2021;29:249-61. [PMID: 33389383 DOI: 10.1007/s10728-020-00425-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
49 Chen W, Li W, Ma Y, Zhang Y, Han B, Liu X, Zhao K, Zhang M, Mi J, Fu Y, Zhou Z. Secondary findings in 421 whole exome-sequenced Chinese children. Hum Genomics 2018;12:42. [PMID: 30217213 DOI: 10.1186/s40246-018-0174-2] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.8] [Reference Citation Analysis]
50 Deverka PA, Dreyfus JC. Clinical integration of next generation sequencing: coverage and reimbursement challenges. J Law Med Ethics 2014;42 Suppl 1:22-41. [PMID: 25298289 DOI: 10.1111/jlme.12160] [Cited by in Crossref: 42] [Cited by in F6Publishing: 33] [Article Influence: 7.0] [Reference Citation Analysis]
51 Reinstein E. Challenges of using next generation sequencing in newborn screening. Genet Res (Camb) 2015;97:e21. [PMID: 26521961 DOI: 10.1017/S0016672315000178] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 1.4] [Reference Citation Analysis]
52 Gasperini M, Starita L, Shendure J. The power of multiplexed functional analysis of genetic variants. Nat Protoc 2016;11:1782-7. [PMID: 27583640 DOI: 10.1038/nprot.2016.135] [Cited by in Crossref: 73] [Cited by in F6Publishing: 46] [Article Influence: 12.2] [Reference Citation Analysis]
53 Elias B, Hanlon-Dearman A, Head B, Hicks GG. Translating to the Community (T2C): a protocol paper describing the development of Canada's first social epigenetic FASD biobank. Biochem Cell Biol 2018;96:275-87. [PMID: 29544064 DOI: 10.1139/bcb-2017-0278] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
54 Chennagiri N, White EJ, Frieden A, Lopez E, Lieber DS, Nikiforov A, Ross T, Batorsky R, Hansen S, Lip V, Luquette LJ, Mauceli E, Margulies D, Milos PM, Napolitano N, Nizzari MM, Yu T, Thompson JF. Orthogonal NGS for High Throughput Clinical Diagnostics. Sci Rep 2016;6:24650. [PMID: 27090146 DOI: 10.1038/srep24650] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
55 Fayer S, Horton C, Dines JN, Rubin AF, Richardson ME, McGoldrick K, Hernandez F, Pesaran T, Karam R, Shirts BH, Fowler DM, Starita LM. Closing the gap: Systematic integration of multiplexed functional data resolves variants of uncertain significance in BRCA1, TP53, and PTEN. Am J Hum Genet 2021;108:2248-58. [PMID: 34793697 DOI: 10.1016/j.ajhg.2021.11.001] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
56 Hirsch S, Dikow N, Pfister SM, Pajtler KW. Cancer predisposition in pediatric neuro-oncology-practical approaches and ethical considerations. Neurooncol Pract 2021;8:526-38. [PMID: 34594567 DOI: 10.1093/nop/npab031] [Reference Citation Analysis]
57 Schaafsma GCP, Vihinen M. Large differences in proportions of harmful and benign amino acid substitutions between proteins and diseases: SCHAAFSMA and VIHINEN. Human Mutation 2017;38:839-48. [DOI: 10.1002/humu.23236] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 2.6] [Reference Citation Analysis]
58 Gray SW, Park ER, Najita J, Martins Y, Traeger L, Bair E, Gagne J, Garber J, Jänne PA, Lindeman N, Lowenstein C, Oliver N, Sholl L, Van Allen EM, Wagle N, Wood S, Garraway L, Joffe S. Oncologists' and cancer patients' views on whole-exome sequencing and incidental findings: results from the CanSeq study. Genet Med 2016;18:1011-9. [PMID: 26866579 DOI: 10.1038/gim.2015.207] [Cited by in Crossref: 78] [Cited by in F6Publishing: 67] [Article Influence: 13.0] [Reference Citation Analysis]
59 Touma M, Reemtsen B, Halnon N, Alejos J, Finn JP, Nelson SF, Wang Y. A Path to Implement Precision Child Health Cardiovascular Medicine. Front Cardiovasc Med 2017;4:36. [PMID: 28620608 DOI: 10.3389/fcvm.2017.00036] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
60 Edwards KL, Goodman D, Johnson CO, Wenzel L, Condit C, Bowen D. Controversies among Cancer Registry Participants, Genomic Researchers, and Institutional Review Boards about Returning Participants' Genomic Results. Public Health Genomics 2018;21:18-26. [PMID: 30227419 DOI: 10.1159/000490235] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
61 Normand EA, Braxton A, Nassef S, Ward PA, Vetrini F, He W, Patel V, Qu C, Westerfield LE, Stover S, Dharmadhikari AV, Muzny DM, Gibbs RA, Dai H, Meng L, Wang X, Xiao R, Liu P, Bi W, Xia F, Walkiewicz M, Van den Veyver IB, Eng CM, Yang Y. Clinical exome sequencing for fetuses with ultrasound abnormalities and a suspected Mendelian disorder. Genome Med 2018;10:74. [PMID: 30266093 DOI: 10.1186/s13073-018-0582-x] [Cited by in Crossref: 50] [Cited by in F6Publishing: 42] [Article Influence: 12.5] [Reference Citation Analysis]
62 Luthra R, Chen H, Roy-Chowdhuri S, Singh RR. Next-Generation Sequencing in Clinical Molecular Diagnostics of Cancer: Advantages and Challenges. Cancers (Basel) 2015;7:2023-36. [PMID: 26473927 DOI: 10.3390/cancers7040874] [Cited by in Crossref: 76] [Cited by in F6Publishing: 69] [Article Influence: 10.9] [Reference Citation Analysis]
63 Pennington JW, Karavite DJ, Krause EM, Miller J, Bernhardt BA, Grundmeier RW. Genomic decision support needs in pediatric primary care. J Am Med Inform Assoc 2017;24:851-6. [PMID: 28339689 DOI: 10.1093/jamia/ocw184] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
64 Gupta A, Cafazzo JA, IJzerman MJ, Swart JF, Vastert S, Wulffraat NM, Benseler S, Marshall D, Yeung R, Twilt M. Genomic Health Literacy Interventions in Pediatrics: Scoping Review. J Med Internet Res 2021;23:e26684. [PMID: 34951592 DOI: 10.2196/26684] [Reference Citation Analysis]
65 Schellevis RL, Breukink MB, Gilissen C, Boon CJF, Hoyng CB, de Jong EK, den Hollander AI. Exome sequencing in patients with chronic central serous chorioretinopathy. Sci Rep 2019;9:6598. [PMID: 31036833 DOI: 10.1038/s41598-019-43152-3] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
66 Swanson K, Sparks TN, Lianoglou BR, Chen F, Downum S, Patel S, Rego S, Yip T, Van Ziffle J, Koenig BA, Slavotinek AM, Norton ME. Preference for secondary findings in prenatal and pediatric exome sequencing. Prenat Diagn 2021. [PMID: 34057224 DOI: 10.1002/pd.5973] [Reference Citation Analysis]
67 Goldfeder RL, Priest JR, Zook JM, Grove ME, Waggott D, Wheeler MT, Salit M, Ashley EA. Medical implications of technical accuracy in genome sequencing. Genome Med 2016;8:24. [PMID: 26932475 DOI: 10.1186/s13073-016-0269-0] [Cited by in Crossref: 86] [Cited by in F6Publishing: 63] [Article Influence: 14.3] [Reference Citation Analysis]
68 Lynch JA, Goldenberg AJ, Garrison NA, Brothers KB. Analogies in Genomics Policymaking: Debates and Drawbacks. Am J Hum Genet 2020;107:797-801. [PMID: 33157006 DOI: 10.1016/j.ajhg.2020.08.024] [Reference Citation Analysis]
69 Tallapaka K, Aggarwal S, Bhattacherjee A, Das Bhowmik A, Dalal A. Co-Occurrence of Leber Congenital Amaurosis and Meckel Syndrome Type 1 in a Fetus: Is There a Lesson to Be Learned? Mol Syndromol 2019;10:177-82. [PMID: 31191208 DOI: 10.1159/000496280] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
70 Stallmeyer B, Dittmann S, Schulze-bahr E. Genetische Diagnostik zur Vermeidung des plötzlichen Herztods. Internist 2018;59:776-89. [DOI: 10.1007/s00108-018-0462-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
71 Brothers KB, East KM, Kelley WV, Wright MF, Westbrook MJ, Rich CA, Bowling KM, Lose EJ, Bebin EM, Simmons S, Myers JA, Barsh G, Myers RM, Cooper GM, Pulley JM, Rothstein MA, Clayton EW. Eliciting preferences on secondary findings: the Preferences Instrument for Genomic Secondary Results. Genet Med 2017;19:337-44. [PMID: 27561086 DOI: 10.1038/gim.2016.110] [Cited by in Crossref: 28] [Cited by in F6Publishing: 24] [Article Influence: 4.7] [Reference Citation Analysis]
72 Christensen KD, Bell M, Zawatsky CLB, Galbraith LN, Green RC, Hutchinson AM, Jamal L, LeBlanc JL, Leonhard JR, Moore M, Mullineaux L, Petry N, Platt DM, Shaaban S, Schultz A, Tucker BD, Van Heukelom J, Wheeler E, Zoltick ES, Hajek C; Imagenetics Metrics Team. Precision Population Medicine in Primary Care: The Sanford Chip Experience. Front Genet 2021;12:626845. [PMID: 33777099 DOI: 10.3389/fgene.2021.626845] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
73 Pervola J, Myers MF, McGowan ML, Prows CA. Giving adolescents a voice: the types of genetic information adolescents choose to learn and why. Genet Med 2019;21:965-71. [PMID: 30369597 DOI: 10.1038/s41436-018-0320-1] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 2.8] [Reference Citation Analysis]
74 Minikel EV, Vallabh SM, Orseth MC, Brandel JP, Haïk S, Laplanche JL, Zerr I, Parchi P, Capellari S, Safar J, Kenny J, Fong JC, Takada LT, Ponto C, Hermann P, Knipper T, Stehmann C, Kitamoto T, Ae R, Hamaguchi T, Sanjo N, Tsukamoto T, Mizusawa H, Collins SJ, Chiesa R, Roiter I, de Pedro-Cuesta J, Calero M, Geschwind MD, Yamada M, Nakamura Y, Mead S. Age at onset in genetic prion disease and the design of preventive clinical trials. Neurology 2019;93:e125-34. [PMID: 31171647 DOI: 10.1212/WNL.0000000000007745] [Cited by in Crossref: 33] [Cited by in F6Publishing: 13] [Article Influence: 11.0] [Reference Citation Analysis]
75 Westerfield LE, Braxton AA, Walkiewicz M. Prenatal Diagnostic Exome Sequencing: a Review. Curr Genet Med Rep 2017;5:75-83. [DOI: 10.1007/s40142-017-0120-y] [Cited by in Crossref: 3] [Article Influence: 0.6] [Reference Citation Analysis]
76 Stergachis AB, Weiss ST, Green RC. Biobanks could identify medically actionable findings relevant for COVID-19 clinical care. Nat Med 2020;26:991. [PMID: 32541961 DOI: 10.1038/s41591-020-0953-x] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
77 Van Allen EM, Robinson D, Morrissey C, Pritchard C, Imamovic A, Carter S, Rosenberg M, McKenna A, Wu YM, Cao X, Chinnaiyan A, Garraway L, Nelson PS. A comparative assessment of clinical whole exome and transcriptome profiling across sequencing centers: implications for precision cancer medicine. Oncotarget 2016;7:52888-99. [PMID: 27167109 DOI: 10.18632/oncotarget.9184] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 3.5] [Reference Citation Analysis]
78 Berkman BE, Hull SC, Eckstein L. The unintended implications of blurring the line between research and clinical care in a genomic age. Per Med 2014;11:285-95. [PMID: 25506378 DOI: 10.2217/pme.14.3] [Cited by in Crossref: 26] [Cited by in F6Publishing: 23] [Article Influence: 3.3] [Reference Citation Analysis]
79 Akdis D, Brunckhorst C, Duru F, Saguner AM. Arrhythmogenic Cardiomyopathy: Electrical and Structural Phenotypes. Arrhythm Electrophysiol Rev. 2016;5:90-101. [PMID: 27617087 DOI: 10.15420/aer.2016.4.3] [Cited by in Crossref: 36] [Cited by in F6Publishing: 21] [Article Influence: 6.0] [Reference Citation Analysis]
80 Buchanan AH, Manickam K, Meyer MN, Wagner JK, Hallquist MLG, Williams JL, Rahm AK, Williams MS, Chen ZE, Shah CK, Garg TK, Lazzeri AL, Schwartz MLB, Lindbuchler DM, Fan AL, Leeming R, Servano PO 3rd, Smith AL, Vogel VG, Abul-Husn NS, Dewey FE, Lebo MS, Mason-Suares HM, Ritchie MD, Davis FD, Carey DJ, Feinberg DT, Faucett WA, Ledbetter DH, Murray MF. Early cancer diagnoses through BRCA1/2 screening of unselected adult biobank participants. Genet Med 2018;20:554-8. [PMID: 29261187 DOI: 10.1038/gim.2017.145] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
81 Landstrom AP, Dailey-Schwartz AL, Rosenfeld JA, Yang Y, McLean MJ, Miyake CY, Valdes SO, Fan Y, Allen HD, Penny DJ, Kim JJ. Interpreting Incidentally Identified Variants in Genes Associated With Catecholaminergic Polymorphic Ventricular Tachycardia in a Large Cohort of Clinical Whole-Exome Genetic Test Referrals. Circ Arrhythm Electrophysiol 2017;10:e004742. [PMID: 28404607 DOI: 10.1161/CIRCEP.116.004742] [Reference Citation Analysis]
82 Rahimzadeh V, Avard D, Sénécal K, Knoppers BM, Sinnett D. To disclose, or not to disclose? Context matters. Eur J Hum Genet 2015;23:279-84. [PMID: 24916647 DOI: 10.1038/ejhg.2014.108] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 1.5] [Reference Citation Analysis]
83 Godley LA. Inherited predisposition to acute myeloid leukemia. Semin Hematol 2014;51:306-21. [PMID: 25311743 DOI: 10.1053/j.seminhematol.2014.08.001] [Cited by in Crossref: 56] [Cited by in F6Publishing: 41] [Article Influence: 7.0] [Reference Citation Analysis]
84 Biancalana V, Laporte J. Diagnostic use of Massively Parallel Sequencing in Neuromuscular Diseases: Towards an Integrated Diagnosis. J Neuromuscul Dis 2015;2:193-203. [PMID: 27858740 DOI: 10.3233/JND-150092] [Cited by in Crossref: 14] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
85 Foley AR, Donkervoort S, Bönnemann CG. Next-generation sequencing still needs our generation's clinicians. Neurol Genet 2015;1:e13. [PMID: 27066550 DOI: 10.1212/NXG.0000000000000019] [Cited by in Crossref: 21] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
86 Mahler EA, Johannsen J, Tsiakas K, Kloth K, Lüttgen S, Mühlhausen C, Alhaddad B, Haack TB, Strom TM, Kortüm F, Meitinger T, Muntau AC, Santer R, Kubisch C, Lessel D, Denecke J, Hempel M. Exome Sequencing in Children. Dtsch Arztebl Int 2019;116:197-204. [PMID: 31056085 DOI: 10.3238/arztebl.2019.0197] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
87 Lee EM, Xu K, Mosbrook E, Links A, Guzman J, Adams DR, Flynn E, Valkanas E, Toro C, Tifft CJ, Boerkoel CF, Gahl WA, Sincan M. Pharmacogenomic incidental findings in 308 families: The NIH Undiagnosed Diseases Program experience. Genet Med 2016;18:1303-7. [PMID: 27253732 DOI: 10.1038/gim.2016.47] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.7] [Reference Citation Analysis]
88 Pillar N, Isakov O, Shomron N. Sequencing your genome: your future is here, but are you sure you want to know it? Genet Res (Camb) 2014;96:e006. [PMID: 25023198 DOI: 10.1017/S0016672314000093] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
89 Wagner H, Kenk M, Fraser M, Berlin A, Fleshner N. Biorepositories and Databanks for the Development of Novel Biomarkers for Genitourinary Cancer Prevention and Management. Eur Urol Focus 2021;7:513-21. [PMID: 34167926 DOI: 10.1016/j.euf.2021.06.002] [Reference Citation Analysis]
90 Murdock DR, Donovan FX, Chandrasekharappa SC, Banks N, Bondy C, Muenke M, Kruszka P. Whole-Exome Sequencing for Diagnosis of Turner Syndrome: Toward Next-Generation Sequencing and Newborn Screening. J Clin Endocrinol Metab 2017;102:1529-37. [PMID: 28324009 DOI: 10.1210/jc.2016-3414] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 3.6] [Reference Citation Analysis]
91 Wolf SM, Branum R, Koenig BA, Petersen GM, Berry SA, Beskow LM, Daly MB, Fernandez CV, Green RC, LeRoy BS, Lindor NM, O'Rourke PP, Breitkopf CR, Rothstein MA, Van Ness B, Wilfond BS. Returning a Research Participant's Genomic Results to Relatives: Analysis and Recommendations. J Law Med Ethics 2015;43:440-63. [PMID: 26479555 DOI: 10.1111/jlme.12288] [Cited by in Crossref: 18] [Cited by in F6Publishing: 39] [Article Influence: 3.6] [Reference Citation Analysis]
92 Schwarze K, Buchanan J, Fermont JM, Dreau H, Tilley MW, Taylor JM, Antoniou P, Knight SJL, Camps C, Pentony MM, Kvikstad EM, Harris S, Popitsch N, Pagnamenta AT, Schuh A, Taylor JC, Wordsworth S. The complete costs of genome sequencing: a microcosting study in cancer and rare diseases from a single center in the United Kingdom. Genet Med 2020;22:85-94. [PMID: 31358947 DOI: 10.1038/s41436-019-0618-7] [Cited by in Crossref: 42] [Cited by in F6Publishing: 39] [Article Influence: 14.0] [Reference Citation Analysis]
93 Hickey KT, Sciacca RR, Biviano AB, Whang W, Dizon JM, Garan H, Chung WK. The effect of cardiac genetic testing on psychological well-being and illness perceptions. Heart Lung 2014;43:127-32. [PMID: 24594249 DOI: 10.1016/j.hrtlng.2014.01.006] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
94 Vears DF, Borry P, Savulescu J, Koplin JJ. Old Challenges or New Issues? Genetic Health Professionals' Experiences Obtaining Informed Consent in Diagnostic Genomic Sequencing. AJOB Empir Bioeth 2021;12:12-23. [PMID: 33017265 DOI: 10.1080/23294515.2020.1823906] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
95 Caminsky N, Mucaki EJ, Rogan PK. Interpretation of mRNA splicing mutations in genetic disease: review of the literature and guidelines for information-theoretical analysis. F1000Res 2014;3:282. [PMID: 25717368 DOI: 10.12688/f1000research.5654.1] [Cited by in Crossref: 53] [Cited by in F6Publishing: 51] [Article Influence: 6.6] [Reference Citation Analysis]
96 Marshall DA, MacDonald KV, Robinson JO, Barcellos LF, Gianfrancesco M, Helm M, McGuire A, Green RC, Douglas MP, Goldman MA, Phillips KA. The price of whole-genome sequencing may be decreasing, but who will be sequenced? Per Med 2017;14:203-11. [PMID: 28993792 DOI: 10.2217/pme-2016-0075] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
97 Knoppers BM. INTRODUCTION: From the Right to Know to the Right Not to Know. J Law Med Ethics 2014;42:6-10. [PMID: 26767471 DOI: 10.1111/jlme.12113] [Cited by in Crossref: 18] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
98 Hamm JA, Mikhail FM, Hollenbeck D, Farmer M, Robin NH. Incidental Detection of Cancer Predisposition Gene Copy Number Variations by Array Comparative Genomic Hybridization. The Journal of Pediatrics 2014;165:1057-1059.e4. [DOI: 10.1016/j.jpeds.2014.07.042] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.9] [Reference Citation Analysis]
99 Patel JN. Lessons in practicing cancer genomics and precision medicine. Expert Review of Precision Medicine and Drug Development 2018;3:287-98. [DOI: 10.1080/23808993.2018.1526081] [Reference Citation Analysis]
100 Gecz J, Corbett M. Developmental disorders: deciphering exomes on a grand scale. Lancet 2015;385:1266-7. [PMID: 25529583 DOI: 10.1016/S0140-6736(14)62122-X] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
101 Borad MJ, Lorusso PM. Twenty-First Century Precision Medicine in Oncology: Genomic Profiling in Patients With Cancer. Mayo Clinic Proceedings 2017;92:1583-91. [DOI: 10.1016/j.mayocp.2017.08.002] [Cited by in Crossref: 18] [Cited by in F6Publishing: 13] [Article Influence: 3.6] [Reference Citation Analysis]
102 Fukami M, Miyado M. Next generation sequencing and array-based comparative genomic hybridization for molecular diagnosis of pediatric endocrine disorders. Ann Pediatr Endocrinol Metab 2017;22:90-4. [PMID: 28690986 DOI: 10.6065/apem.2017.22.2.90] [Cited by in Crossref: 3] [Article Influence: 0.6] [Reference Citation Analysis]
103 Smoller JW, Karlson EW, Green RC, Kathiresan S, MacArthur DG, Talkowski ME, Murphy SN, Weiss ST. An eMERGE Clinical Center at Partners Personalized Medicine. J Pers Med 2016;6:E5. [PMID: 26805891 DOI: 10.3390/jpm6010005] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 2.8] [Reference Citation Analysis]
104 Kost RG, Poppel SM, Coller BS. Informed consent for next-generation nucleotide sequencing studies: Aiding communication between participants and investigators. J Clin Transl Sci 2017;1:115-20. [PMID: 28649453 DOI: 10.1017/cts.2016.21] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
105 Kou T, Kanai M, Matsumoto S, Okuno Y, Muto M. The possibility of clinical sequencing in the management of cancer. Jpn J Clin Oncol 2016;46:399-406. [PMID: 26917600 DOI: 10.1093/jjco/hyw018] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 3.3] [Reference Citation Analysis]
106 Hertz DL, McLeod HL. Integrated patient and tumor genetic testing for individualized cancer therapy. Clin Pharmacol Ther 2016;99:143-6. [PMID: 26537014 DOI: 10.1002/cpt.294] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 1.7] [Reference Citation Analysis]
107 Yehia L, Ni Y, Sesock K, Niazi F, Fletcher B, Chen HJL, LaFramboise T, Eng C. Unexpected cancer-predisposition gene variants in Cowden syndrome and Bannayan-Riley-Ruvalcaba syndrome patients without underlying germline PTEN mutations. PLoS Genet 2018;14:e1007352. [PMID: 29684080 DOI: 10.1371/journal.pgen.1007352] [Cited by in Crossref: 18] [Cited by in F6Publishing: 13] [Article Influence: 4.5] [Reference Citation Analysis]
108 Demougeot L, Houdayer F, Pélissier A, Mohrez F, Thevenon J, Duffourd Y, Nambot S, Gautier E, Binquet C, Rossi M, Sanlaville D, Béjean S, Peyron C, Thauvin-Robinet C, Faivre L. [Changes in clinical practice related to the arrival of next-generation sequencing in the genetic diagnosis of developmental diseases]. Arch Pediatr 2018;25:77-83. [PMID: 29395884 DOI: 10.1016/j.arcped.2017.12.006] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
109 Rost C, Dent KM, Botkin J, Rothwell E. Experiences and lessons learned by genetic counselors in returning secondary genetic findings to patients. J Genet Couns 2020;29:1234-44. [PMID: 32453499 DOI: 10.1002/jgc4.1292] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
110 Machini K, Ceyhan-Birsoy O, Azzariti DR, Sharma H, Rossetti P, Mahanta L, Hutchinson L, McLaughlin H, Green RC, Lebo M, Rehm HL; MedSeq Project. Analyzing and Reanalyzing the Genome: Findings from the MedSeq Project. Am J Hum Genet 2019;105:177-88. [PMID: 31256874 DOI: 10.1016/j.ajhg.2019.05.017] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 6.0] [Reference Citation Analysis]
111 Futema M, Taylor-Beadling A, Williams M, Humphries SE. Genetic testing for Familial Hypercholesterolaemia - Past, Present and Future. J Lipid Res 2021;:100139. [PMID: 34666015 DOI: 10.1016/j.jlr.2021.100139] [Reference Citation Analysis]
112 Pereira S, Oliver Robinson J, McGuire AL. Return of individual genomic research results: what do consent forms tell participants? Eur J Hum Genet 2016;24:1524-9. [PMID: 27329739 DOI: 10.1038/ejhg.2016.76] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 1.7] [Reference Citation Analysis]
113 Ishida H, Iguchi A, Aoe M, Takahashi T, Tamefusa K, Kanamitsu K, Fujiwara K, Washio K, Matsubara T, Tsukahara H, Sanada M, Shimada A. Panel-based next-generation sequencing identifies prognostic and actionable genes in childhood acute lymphoblastic leukemia and is suitable for clinical sequencing. Ann Hematol 2019;98:657-68. [PMID: 30446805 DOI: 10.1007/s00277-018-3554-8] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
114 Katsanis SH, Minear MA, Vorderstrasse A, Yang N, Reeves JW, Rakhra-Burris T, Cook-Deegan R, Ginsburg GS, Simmons LA. Perspectives on genetic and genomic technologies in an academic medical center: the duke experience. J Pers Med 2015;5:67-82. [PMID: 25854543 DOI: 10.3390/jpm5020067] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 1.4] [Reference Citation Analysis]
115 Buchtel KM, Leeth EA. Incidental Findings: The Importance of Pretest Counseling. Pediatr Neurol Briefs 2015;29:91. [PMID: 26933547 DOI: 10.15844/pedneurbriefs-29-12-2] [Reference Citation Analysis]
116 Horak P, Klink B, Heining C, Gröschel S, Hutter B, Fröhlich M, Uhrig S, Hübschmann D, Schlesner M, Eils R, Richter D, Pfütze K, Geörg C, Meißburger B, Wolf S, Schulz A, Penzel R, Herpel E, Kirchner M, Lier A, Endris V, Singer S, Schirmacher P, Weichert W, Stenzinger A, Schlenk RF, Schröck E, Brors B, von Kalle C, Glimm H, Fröhling S. Precision oncology based on omics data: The NCT Heidelberg experience. Int J Cancer 2017;141:877-86. [PMID: 28597939 DOI: 10.1002/ijc.30828] [Cited by in Crossref: 74] [Cited by in F6Publishing: 61] [Article Influence: 14.8] [Reference Citation Analysis]
117 Petersen GM. Familial pancreatic cancer. Semin Oncol 2016;43:548-53. [PMID: 27899186 DOI: 10.1053/j.seminoncol.2016.09.002] [Cited by in Crossref: 65] [Cited by in F6Publishing: 52] [Article Influence: 10.8] [Reference Citation Analysis]
118 Kaphingst KA, Ivanovich J, Lyons S, Biesecker B, Dresser R, Elrick A, Matsen C, Goodman M. Preferences for learning different types of genome sequencing results among young breast cancer patients: Role of psychological and clinical factors. Transl Behav Med 2018;8:71-9. [PMID: 29385583 DOI: 10.1093/tbm/ibx042] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 3.3] [Reference Citation Analysis]
119 Gutmann A. Ethics. The bioethics commission on incidental findings. Science 2013;342:1321-3. [PMID: 24337279 DOI: 10.1126/science.1248764] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.2] [Reference Citation Analysis]
120 Ingles J, Semsarian C. Conveying a probabilistic genetic test result to families with an inherited heart disease. Heart Rhythm 2014;11:1073-8. [DOI: 10.1016/j.hrthm.2014.03.017] [Cited by in Crossref: 45] [Cited by in F6Publishing: 41] [Article Influence: 5.6] [Reference Citation Analysis]
121 Damiati E, Borsani G, Giacopuzzi E. Amplicon-based semiconductor sequencing of human exomes: performance evaluation and optimization strategies. Hum Genet 2016;135:499-511. [PMID: 27003585 DOI: 10.1007/s00439-016-1656-8] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 2.8] [Reference Citation Analysis]
122 Botkin JR. Ethical issues in pediatric genetic testing and screening. Curr Opin Pediatr 2016;28:700-4. [PMID: 27606958 DOI: 10.1097/MOP.0000000000000418] [Cited by in Crossref: 22] [Cited by in F6Publishing: 12] [Article Influence: 5.5] [Reference Citation Analysis]
123 Rehm HL, Bale SJ, Bayrak-Toydemir P, Berg JS, Brown KK, Deignan JL, Friez MJ, Funke BH, Hegde MR, Lyon E; Working Group of the American College of Medical Genetics and Genomics Laboratory Quality Assurance Commitee. ACMG clinical laboratory standards for next-generation sequencing. Genet Med. 2013;15:733-747. [PMID: 23887774 DOI: 10.1038/gim.2013.92] [Cited by in Crossref: 605] [Cited by in F6Publishing: 503] [Article Influence: 67.2] [Reference Citation Analysis]
124 Lucassen A, Houlston RS. The challenges of genome analysis in the health care setting. Genes (Basel) 2014;5:576-85. [PMID: 25055201 DOI: 10.3390/genes5030576] [Cited by in Crossref: 18] [Cited by in F6Publishing: 11] [Article Influence: 2.3] [Reference Citation Analysis]
125 Jamuar SS, Tan EC. Clinical application of next-generation sequencing for Mendelian diseases. Hum Genomics 2015;9:10. [PMID: 26076878 DOI: 10.1186/s40246-015-0031-5] [Cited by in Crossref: 60] [Cited by in F6Publishing: 52] [Article Influence: 8.6] [Reference Citation Analysis]
126 Vicini P, Fields O, Lai E, Litwack ED, Martin AM, Morgan TM, Pacanowski MA, Papaluca M, Perez OD, Ringel MS. Precision medicine in the age of big data: The present and future role of large-scale unbiased sequencing in drug discovery and development. Clin Pharmacol Ther. 2016;99:198-207. [PMID: 26536838 DOI: 10.1002/cpt.293] [Cited by in Crossref: 30] [Cited by in F6Publishing: 22] [Article Influence: 4.3] [Reference Citation Analysis]
127 Reuter MS, Walker S, Thiruvahindrapuram B, Whitney J, Cohn I, Sondheimer N, Yuen RKC, Trost B, Paton TA, Pereira SL, Herbrick JA, Wintle RF, Merico D, Howe J, MacDonald JR, Lu C, Nalpathamkalam T, Sung WWL, Wang Z, Patel RV, Pellecchia G, Wei J, Strug LJ, Bell S, Kellam B, Mahtani MM, Bassett AS, Bombard Y, Weksberg R, Shuman C, Cohn RD, Stavropoulos DJ, Bowdin S, Hildebrandt MR, Wei W, Romm A, Pasceri P, Ellis J, Ray P, Meyn MS, Monfared N, Hosseini SM, Joseph-George AM, Keeley FW, Cook RA, Fiume M, Lee HC, Marshall CR, Davies J, Hazell A, Buchanan JA, Szego MJ, Scherer SW. The Personal Genome Project Canada: findings from whole genome sequences of the inaugural 56 participants. CMAJ 2018;190:E126-36. [PMID: 29431110 DOI: 10.1503/cmaj.171151] [Cited by in Crossref: 34] [Cited by in F6Publishing: 26] [Article Influence: 11.3] [Reference Citation Analysis]
128 Christensen KD, Savage SK, Huntington NL, Weitzman ER, Ziniel SI, Bacon PL, Cacioppo CN, Green RC, Holm IA. Preferences for the Return of Individual Results From Research on Pediatric Biobank Samples. J Empir Res Hum Res Ethics 2017;12:97-106. [PMID: 28421887 DOI: 10.1177/1556264617697839] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.6] [Reference Citation Analysis]
129 Hofstatter E, Mehra K, Yushak M, Pusztai L. Tumor profiling and the incidentalome: patient decisions and risks. Future Oncology 2015;11:3299-305. [DOI: 10.2217/fon.15.260] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
130 Eckstein L, Garrett JR, Berkman BE. A framework for analyzing the ethics of disclosing genetic research findings. J Law Med Ethics 2014;42:190-207. [PMID: 25040383 DOI: 10.1111/jlme.12135] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 3.3] [Reference Citation Analysis]
131 Wilkinson DJ, Barnett C, Savulescu J, Newson AJ. Genomic intensive care: should we perform genome testing in critically ill newborns? Arch Dis Child Fetal Neonatal Ed 2016;101:F94-8. [PMID: 26369368 DOI: 10.1136/archdischild-2015-308568] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 1.7] [Reference Citation Analysis]
132 Haller G, Alvarado DM, Willing MC, Braverman AC, Bridwell KH, Kelly M, Lenke LG, Luhmann SJ, Gurnett CA, Dobbs MB. Genetic Risk for Aortic Aneurysm in Adolescent Idiopathic Scoliosis. J Bone Joint Surg Am 2015;97:1411-7. [PMID: 26333736 DOI: 10.2106/JBJS.O.00290] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 0.9] [Reference Citation Analysis]
133 Spoonamore KG, Johnson NM. Who Pays? Coverage Challenges for Cardiovascular Genetic Testing in U.S. Patients. Front Cardiovasc Med 2016;3:14. [PMID: 27303673 DOI: 10.3389/fcvm.2016.00014] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.7] [Reference Citation Analysis]
134 Crawford SA, Gong CL, Yieh L, Randolph LM, Hay JW. Diagnosing newborns with suspected mitochondrial disorders: an economic evaluation comparing early exome sequencing to current typical care. Genet Med 2021. [PMID: 34040192 DOI: 10.1038/s41436-021-01210-0] [Reference Citation Analysis]
135 McCullough LB, Brothers KB, Chung WK, Joffe S, Koenig BA, Wilfond B, Yu JH; Clinical Sequencing Exploratory Research (CSER) Consortium Pediatrics Working Group. Professionally Responsible Disclosure of Genomic Sequencing Results in Pediatric Practice. Pediatrics 2015;136:e974-82. [PMID: 26371191 DOI: 10.1542/peds.2015-0624] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 2.6] [Reference Citation Analysis]
136 Córdoba M, González Morón D, Rodríguez-quiroga SA, Kauffman MA. Neurología genómica personalizada: el futuro es ahora. Neurología Argentina 2014;6:127-36. [DOI: 10.1016/j.neuarg.2014.03.002] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
137 Gehlert S, Mozersky J. Seeing Beyond the Margins: Challenges to Informed Inclusion of Vulnerable Populations in Research. J Law Med Ethics 2018;46:30-43. [PMID: 30093794 DOI: 10.1177/1073110518766006] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 3.3] [Reference Citation Analysis]
138 Etchegary H, Winsor M, Power A, Simmonds C. Public engagement with genomic medicine: a summary of town hall discussions. J Community Genet 2021;12:27-35. [PMID: 32865775 DOI: 10.1007/s12687-020-00485-1] [Reference Citation Analysis]
139 Hardart GE, Chung WK. Genetic testing of children for diseases that have onset in adulthood: the limits of family interests. Pediatrics 2014;134 Suppl 2:S104-10. [PMID: 25274875 DOI: 10.1542/peds.2014-1394F] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
140 Forrest IS, Chaudhary K, Vy HMT, Petrazzini BO, Bafna S, Jordan DM, Rocheleau G, Loos RJF, Nadkarni GN, Cho JH, Do R. Population-Based Penetrance of Deleterious Clinical Variants. JAMA 2022;327:350. [DOI: 10.1001/jama.2021.23686] [Reference Citation Analysis]
141 Malcikova J, Tausch E, Rossi D, Sutton LA, Soussi T, Zenz T, Kater AP, Niemann CU, Gonzalez D, Davi F, Gonzalez Diaz M, Moreno C, Gaidano G, Stamatopoulos K, Rosenquist R, Stilgenbauer S, Ghia P, Pospisilova S; European Research Initiative on Chronic Lymphocytic Leukemia (ERIC) — TP53 network. ERIC recommendations for TP53 mutation analysis in chronic lymphocytic leukemia-update on methodological approaches and results interpretation. Leukemia 2018;32:1070-80. [PMID: 29467486 DOI: 10.1038/s41375-017-0007-7] [Cited by in Crossref: 70] [Cited by in F6Publishing: 67] [Article Influence: 17.5] [Reference Citation Analysis]
142 Hackman P, Udd B, Bönnemann CG, Ferreiro A; Titinopathy Database Consortium. 219th ENMC International Workshop Titinopathies International database of titin mutations and phenotypes, Heemskerk, The Netherlands, 29 April-1 May 2016. Neuromuscul Disord 2017;27:396-407. [PMID: 28214268 DOI: 10.1016/j.nmd.2017.01.009] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 4.0] [Reference Citation Analysis]
143 Pant S, Weiner R, Marton MJ. Navigating the rapids: the development of regulated next-generation sequencing-based clinical trial assays and companion diagnostics. Front Oncol. 2014;4:78. [PMID: 24860780 DOI: 10.3389/fonc.2014.00078] [Cited by in Crossref: 60] [Cited by in F6Publishing: 46] [Article Influence: 7.5] [Reference Citation Analysis]
144 Brothers KB, Vassy JL, Green RC. Reconciling Opportunistic and Population Screening in Clinical Genomics. Mayo Clin Proc 2019;94:103-9. [PMID: 30611438 DOI: 10.1016/j.mayocp.2018.08.028] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 4.7] [Reference Citation Analysis]
145 Minari J, Brothers KB, Morrison M. Tensions in ethics and policy created by National Precision Medicine Programs. Hum Genomics 2018;12:22. [PMID: 29665847 DOI: 10.1186/s40246-018-0151-9] [Cited by in Crossref: 19] [Cited by in F6Publishing: 13] [Article Influence: 4.8] [Reference Citation Analysis]
146 Drury S, Williams H, Trump N, Boustred C, Lench N, Scott RH, Chitty LS; GOSGene. Exome sequencing for prenatal diagnosis of fetuses with sonographic abnormalities: Exome sequencing for prenatal diagnosis. Prenat Diagn 2015;35:1010-7. [DOI: 10.1002/pd.4675] [Cited by in Crossref: 141] [Cited by in F6Publishing: 107] [Article Influence: 20.1] [Reference Citation Analysis]
147 Bombard Y, Robson M, Offit K. Revealing the incidentalome when targeting the tumor genome. JAMA 2013;310:795-6. [PMID: 23982363 DOI: 10.1001/jama.2013.276573] [Cited by in Crossref: 47] [Cited by in F6Publishing: 41] [Article Influence: 5.2] [Reference Citation Analysis]
148 Ibrahim R, Pasic M, Yousef GM. Omics for personalized medicine: defining the current we swim in. Expert Rev Mol Diagn 2016;16:719-22. [PMID: 26959799 DOI: 10.1586/14737159.2016.1164601] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 3.3] [Reference Citation Analysis]
149 Appelbaum PS, Parens E, Waldman CR, Klitzman R, Fyer A, Martinez J, Price WN 2nd, Chung WK. Models of consent to return of incidental findings in genomic research. Hastings Cent Rep 2014;44:22-32. [PMID: 24919982 DOI: 10.1002/hast.328] [Cited by in Crossref: 51] [Cited by in F6Publishing: 44] [Article Influence: 6.4] [Reference Citation Analysis]
150 Lee RE, Henricks WH, Sirintrapun SJ. Laboratory Information Systems in Molecular Diagnostics: Why Molecular Diagnostics Data are Different. Adv Anat Pathol 2016;23:125-33. [PMID: 26849819 DOI: 10.1097/PAP.0000000000000109] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
151 Park JY, Clark P, Londin E, Sponziello M, Kricka LJ, Fortina P. Clinical exome performance for reporting secondary genetic findings. Clin Chem 2015;61:213-20. [PMID: 25414276 DOI: 10.1373/clinchem.2014.231456] [Cited by in Crossref: 28] [Cited by in F6Publishing: 22] [Article Influence: 3.5] [Reference Citation Analysis]
152 Henderson GE, Wolf SM, Kuczynski KJ, Joffe S, Sharp RR, Parsons DW, Knoppers BM, Yu JH, Appelbaum PS. The challenge of informed consent and return of results in translational genomics: empirical analysis and recommendations. J Law Med Ethics 2014;42:344-55. [PMID: 25264092 DOI: 10.1111/jlme.12151] [Cited by in Crossref: 48] [Cited by in F6Publishing: 45] [Article Influence: 8.0] [Reference Citation Analysis]
153 Bouvet D, Bodo S, Munier A, Guillerm E, Bertrand R, Colas C, Duval A, Coulet F, Muleris M. Methylation Tolerance-Based Functional Assay to Assess Variants of Unknown Significance in the MLH1 and MSH2 Genes and Identify Patients With Lynch Syndrome. Gastroenterology 2019;157:421-31. [PMID: 30998989 DOI: 10.1053/j.gastro.2019.03.071] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 3.3] [Reference Citation Analysis]
154 Sénécal K, Thys K, Vears DF, Van Assche K, Knoppers BM, Borry P. Legal approaches regarding health-care decisions involving minors: implications for next-generation sequencing. Eur J Hum Genet 2016;24:1559-64. [PMID: 27302841 DOI: 10.1038/ejhg.2016.61] [Cited by in Crossref: 9] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
155 Horiuchi Y, Matsubayashi H, Kiyozumi Y, Nishimura S, Higashigawa S, Kado N, Nagashima T, Mizuguchi M, Ohnami S, Arai M, Urakami K, Kusuhara M, Yamaguchi K. Disclosure of secondary findings in exome sequencing of 2480 Japanese cancer patients. Hum Genet 2021;140:321-31. [PMID: 32710294 DOI: 10.1007/s00439-020-02207-6] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
156 Tucker EJ, Grover SR, Bachelot A, Touraine P, Sinclair AH. Premature Ovarian Insufficiency: New Perspectives on Genetic Cause and Phenotypic Spectrum. Endocr Rev 2016;37:609-35. [PMID: 27690531 DOI: 10.1210/er.2016-1047] [Cited by in Crossref: 96] [Cited by in F6Publishing: 82] [Article Influence: 16.0] [Reference Citation Analysis]
157 Blasimme A, Brall C, Vayena E. Reporting Genetic Findings to Individual Research Participants: Guidelines From the Swiss Personalized Health Network. Front Genet 2020;11:585820. [PMID: 33362850 DOI: 10.3389/fgene.2020.585820] [Reference Citation Analysis]
158 Plöthner M, Frank M, von der Schulenburg JG. Cost analysis of whole genome sequencing in German clinical practice. Eur J Health Econ 2017;18:623-33. [PMID: 27380512 DOI: 10.1007/s10198-016-0815-0] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 3.3] [Reference Citation Analysis]
159 Elliott AM, Dragojlovic N, Campbell T, Adam S, Souich CD, Fryer M, Lehman A, Karnebeek CV, Lynd LD, Friedman JM. Utilization of telehealth in paediatric genome-wide sequencing: Health services implementation issues in the CAUSES Study. J Telemed Telecare 2021;:1357633X20982737. [PMID: 33470133 DOI: 10.1177/1357633X20982737] [Reference Citation Analysis]
160 Chrystoja CC, Diamandis EP. Whole genome sequencing as a diagnostic test: challenges and opportunities. Clin Chem 2014;60:724-33. [PMID: 24227285 DOI: 10.1373/clinchem.2013.209213] [Cited by in Crossref: 48] [Cited by in F6Publishing: 44] [Article Influence: 5.3] [Reference Citation Analysis]
161 Ackerman SL, Koenig BA. Understanding variations in secondary findings reporting practices across U.S. genome sequencing laboratories. AJOB Empirical Bioethics 2017;9:48-57. [DOI: 10.1080/23294515.2017.1405095] [Cited by in Crossref: 16] [Cited by in F6Publishing: 11] [Article Influence: 3.2] [Reference Citation Analysis]
162 Yannakou CK, Jones K, Ryland GL, Thompson ER, Reid G, Mcbean M, Trainer A, Westerman D, Blombery P. Incidental detection of germline variants of potential clinical significance by massively parallel sequencing in haematological malignancies. J Clin Pathol 2017;71:84-7. [DOI: 10.1136/jclinpath-2017-204481] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 2.6] [Reference Citation Analysis]
163 Thomas MJ, Battle RW. Something Old, Something New. Clinics in Sports Medicine 2015;34:517-37. [DOI: 10.1016/j.csm.2015.03.006] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
164 Ahlgrim NS, Garza K, Hoffman C, Rommelfanger KS. Prodromes and Preclinical Detection of Brain Diseases: Surveying the Ethical Landscape of Predicting Brain Health. eNeuro 2019;6:ENEURO. [PMID: 31221862 DOI: 10.1523/ENEURO.0439-18.2019] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
165 Kesserwan C, Friedman Ross L, Bradbury AR, Nichols KE. The Advantages and Challenges of Testing Children for Heritable Predisposition to Cancer. Am Soc Clin Oncol Educ Book 2016;35:251-69. [PMID: 27249705 DOI: 10.1200/EDBK_160621] [Cited by in Crossref: 12] [Cited by in F6Publishing: 2] [Article Influence: 2.4] [Reference Citation Analysis]
166 Anderson JA, Meyn MS, Shuman C, Zlotnik Shaul R, Mantella LE, Szego MJ, Bowdin S, Monfared N, Hayeems RZ. Parents perspectives on whole genome sequencing for their children: qualified enthusiasm? J Med Ethics 2017;43:535-9. [PMID: 27888232 DOI: 10.1136/medethics-2016-103564] [Cited by in Crossref: 35] [Cited by in F6Publishing: 30] [Article Influence: 5.8] [Reference Citation Analysis]
167 Kauffman TL, Irving SA, Leo MC, Gilmore MJ, Himes P, McMullen CK, Morris E, Schneider J, Wilfond BS, Goddard KAB. The NextGen Study: patient motivation for participation in genome sequencing for carrier status. Mol Genet Genomic Med 2017;5:508-15. [PMID: 28944234 DOI: 10.1002/mgg3.306] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 2.4] [Reference Citation Analysis]
168 Wang Q, Shashikant CS, Jensen M, Altman NS, Girirajan S. Novel metrics to measure coverage in whole exome sequencing datasets reveal local and global non-uniformity. Sci Rep 2017;7:885. [PMID: 28408746 DOI: 10.1038/s41598-017-01005-x] [Cited by in Crossref: 21] [Cited by in F6Publishing: 23] [Article Influence: 4.2] [Reference Citation Analysis]
169 Andreasen S, Agander TK, Bjørndal K, Erentaite D, Heegaard S, Larsen SR, Melchior LC, Tan Q, Ulhøi BP, Wessel I, Homøe P. Genetic rearrangements, hotspot mutations, and microRNA expression in the progression of metastatic adenoid cystic carcinoma of the salivary gland. Oncotarget 2018;9:19675-87. [PMID: 29731974 DOI: 10.18632/oncotarget.24800] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
170 Miller DT, Lee K, Gordon AS, Amendola LM, Adelman K, Bale SJ, Chung WK, Gollob MH, Harrison SM, Herman GE, Hershberger RE, Klein TE, McKelvey K, Richards CS, Vlangos CN, Stewart DR, Watson MS, Martin CL; ACMG Secondary Findings Working Group. Recommendations for reporting of secondary findings in clinical exome and genome sequencing, 2021 update: a policy statement of the American College of Medical Genetics and Genomics (ACMG). Genet Med 2021;23:1391-8. [PMID: 34012069 DOI: 10.1038/s41436-021-01171-4] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 9.0] [Reference Citation Analysis]
171 Wagner JK, Meyer MN. Genomic medicine and the "loss of chance" medical malpractice doctrine. HGG Adv 2021;2:100032. [PMID: 34250511 DOI: 10.1016/j.xhgg.2021.100032] [Reference Citation Analysis]
172 Modell SM, Citrin T, Kardia SLR. Laying Anchor: Inserting Precision Health into a Public Health Genetics Policy Course. Healthcare (Basel) 2018;6:E93. [PMID: 30081448 DOI: 10.3390/healthcare6030093] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
173 Bris C, Goudenege D, Desquiret-Dumas V, Charif M, Colin E, Bonneau D, Amati-Bonneau P, Lenaers G, Reynier P, Procaccio V. Bioinformatics Tools and Databases to Assess the Pathogenicity of Mitochondrial DNA Variants in the Field of Next Generation Sequencing. Front Genet 2018;9:632. [PMID: 30619459 DOI: 10.3389/fgene.2018.00632] [Cited by in Crossref: 30] [Cited by in F6Publishing: 22] [Article Influence: 7.5] [Reference Citation Analysis]
174 eMERGE Clinical Annotation Working Group. Frequency of genomic secondary findings among 21,915 eMERGE network participants. Genet Med 2020;22:1470-7. [PMID: 32546831 DOI: 10.1038/s41436-020-0810-9] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 7.0] [Reference Citation Analysis]
175 Duong B, Savarirayan R, Winship I. Incidental diagnosis of HLRCC following investigation for Asperger Syndrome: actionable and actioned. Familial Cancer 2016;15:25-9. [DOI: 10.1007/s10689-015-9829-5] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
176 Vora NL, Powell B, Brandt A, Strande N, Hardisty E, Gilmore K, Foreman AKM, Wilhelmsen K, Bizon C, Reilly J, Owen P, Powell CM, Skinner D, Rini C, Lyerly AD, Boggess KA, Weck K, Berg JS, Evans JP. Prenatal exome sequencing in anomalous fetuses: new opportunities and challenges. Genet Med. 2017;19:1207-1216. [PMID: 28518170 DOI: 10.1038/gim.2017.33] [Cited by in Crossref: 91] [Cited by in F6Publishing: 75] [Article Influence: 18.2] [Reference Citation Analysis]
177 Halverson CME, Connors LM, Wessinger BC, Clayton EW, Wiesner GL. Patient perspectives on variant reclassification after cancer susceptibility testing. Mol Genet Genomic Med 2020;8:e1275. [PMID: 32329193 DOI: 10.1002/mgg3.1275] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
178 Parker LS, Sankar PL, Boyer J, Jean Mcewen J, Kaufman D. Normative and conceptual ELSI research: what it is, and why it’s important. Genet Med 2019;21:505-9. [DOI: 10.1038/s41436-018-0065-x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
179 Raghuram Pillai P, Prows CA, Martin LJ, Myers MF. Decisional conflict among adolescents and parents making decisions about genomic sequencing results. Clin Genet 2020;97:312-20. [PMID: 31654527 DOI: 10.1111/cge.13658] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
180 Brison N, Van Den Bogaert K, Dehaspe L, van den Oever JM, Janssens K, Blaumeiser B, Peeters H, Van Esch H, Van Buggenhout G, Vogels A, de Ravel T, Legius E, Devriendt K, Vermeesch JR. Accuracy and clinical value of maternal incidental findings during noninvasive prenatal testing for fetal aneuploidies. Genet Med 2017;19:306-13. [PMID: 27584908 DOI: 10.1038/gim.2016.113] [Cited by in Crossref: 35] [Cited by in F6Publishing: 31] [Article Influence: 5.8] [Reference Citation Analysis]
181 Predham S, Hamilton S, Elliott AM, T. Gibson W. Case Report: Direct Access Genetic Testing and A False-Positive Result For Long QT Syndrome. J Genet Counsel 2016;25:25-31. [DOI: 10.1007/s10897-015-9882-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
182 Amor DJ. Future of whole genome sequencing: The future of whole genome sequencing. J Paediatr Child Health 2015;51:251-4. [DOI: 10.1111/jpc.12634] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
183 Tolchin B, Conwit R, Epstein LG, Russell JA; Ethics, Law, and Humanities Committee, a joint committee of the American Academy of Neurology, American Neurological Association, and Child Neurology Society. AAN position statement: Ethical issues in clinical research in neurology. Neurology 2020;94:661-9. [PMID: 32179700 DOI: 10.1212/WNL.0000000000009241] [Cited by in Crossref: 6] [Article Influence: 3.0] [Reference Citation Analysis]
184 Bhattacharjee A, Sokolsky T, Wyman SK, Reese MG, Puffenberger E, Strauss K, Morton H, Parad RB, Naylor EW. Development of DNA Confirmatory and High-Risk Diagnostic Testing for Newborns Using Targeted Next-Generation DNA Sequencing. Genet Med 2015;17:337-47. [DOI: 10.1038/gim.2014.117] [Cited by in Crossref: 42] [Cited by in F6Publishing: 37] [Article Influence: 5.3] [Reference Citation Analysis]
185 Fridriksdottir R, Jonsson AJ, Jensson BO, Sverrisson KO, Arnadottir GA, Skarphedinsdottir SJ, Katrinardottir H, Snaebjornsdottir S, Jonsson H, Eiriksson O, Oskarsson GR, Oddsson A, Jonasdottir A, Jonasdottir A, Sigurdsson GH, Indridason EP, Sigurdsson SB, Bjornsdottir G, Saemundsdottir J, Magnusson OT, Bjornsson HT, Thorsteinsdottir U, Sigurdsson TS, Sulem P, Sigurdsson MI, Stefansson K. Sequence variants in malignant hyperthermia genes in Iceland: classification and actionable findings in a population database. Eur J Hum Genet 2021;29:1819-24. [PMID: 34462577 DOI: 10.1038/s41431-021-00954-2] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
186 Riazi S, Kraeva N, Hopkins PM. Malignant Hyperthermia in the Post-Genomics Era: New Perspectives on an Old Concept. Anesthesiology 2018;128:168-80. [PMID: 28902675 DOI: 10.1097/ALN.0000000000001878] [Cited by in Crossref: 65] [Cited by in F6Publishing: 22] [Article Influence: 13.0] [Reference Citation Analysis]
187 De Clercq E, Kaye J, Wolf SM, Koenig BA, Elger BS. Returning Results in Biobank Research: Global Trends and Solutions. Genet Test Mol Biomarkers 2017;21:128-31. [PMID: 28146646 DOI: 10.1089/gtmb.2016.0394] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 1.8] [Reference Citation Analysis]
188 Mcveigh TP, Sweeney KJ, Kerin MJ, Gallagher DJ. A qualitative analysis of the attitudes of Irish patients towards participation in genetic-based research. Ir J Med Sci 2016;185:825-31. [DOI: 10.1007/s11845-015-1373-7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
189 Thevenon J, Duffourd Y, Masurel-Paulet A, Lefebvre M, Feillet F, El Chehadeh-Djebbar S, St-Onge J, Steinmetz A, Huet F, Chouchane M, Darmency-Stamboul V, Callier P, Thauvin-Robinet C, Faivre L, Rivière JB. Diagnostic odyssey in severe neurodevelopmental disorders: toward clinical whole-exome sequencing as a first-line diagnostic test. Clin Genet 2016;89:700-7. [PMID: 26757139 DOI: 10.1111/cge.12732] [Cited by in Crossref: 136] [Cited by in F6Publishing: 121] [Article Influence: 22.7] [Reference Citation Analysis]
190 Sabatello M. Regulating Gamete Donation in the U.S.: Ethical, Legal and Social Implications. Laws 2015;4:352-76. [PMID: 26388996 DOI: 10.3390/laws4030352] [Cited by in Crossref: 10] [Cited by in F6Publishing: 4] [Article Influence: 1.4] [Reference Citation Analysis]
191 Meagher KM, McGowan ML, Settersten RA Jr, Fishman JR, Juengst ET. Precisely Where Are We Going? Charting the New Terrain of Precision Prevention. Annu Rev Genomics Hum Genet 2017;18:369-87. [PMID: 28441061 DOI: 10.1146/annurev-genom-091416-035222] [Cited by in Crossref: 16] [Cited by in F6Publishing: 10] [Article Influence: 3.2] [Reference Citation Analysis]
192 Kochan DC, Winkler E, Lindor N, Shaibi GQ, Olson J, Caraballo PJ, Freimuth R, Pacyna JE, Breitkopf CR, Sharp RR, Kullo IJ. Challenges in returning results in a genomic medicine implementation study: the Return of Actionable Variants Empirical (RAVE) study. NPJ Genom Med 2020;5:19. [PMID: 32377377 DOI: 10.1038/s41525-020-0127-2] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
193 Kaufman D, Curnutte M, McGuire AL. Clinical integration of next generation sequencing: a policy analysis. J Law Med Ethics 2014;42 Suppl 1:5-8. [PMID: 25298287 DOI: 10.1111/jlme.12158] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
194 Kammermeier J, Drury S, James CT, Dziubak R, Ocaka L, Elawad M, Beales P, Lench N, Uhlig HH, Bacchelli C. Targeted gene panel sequencing in children with very early onset inflammatory bowel disease--evaluation and prospective analysis. J Med Genet. 2014;51:748-755. [PMID: 25194001 DOI: 10.1136/jmedgenet-2014-102624] [Cited by in Crossref: 62] [Cited by in F6Publishing: 57] [Article Influence: 7.8] [Reference Citation Analysis]
195 Iyer G, Utage P, Bailur S, Utage A, Srirambhatla A, Hasan Q. Familial Acute Necrotizing Encephalopathy: Evidence From Next Generation Sequencing of Digenic Inheritance. J Child Neurol 2020;35:393-7. [PMID: 32102593 DOI: 10.1177/0883073820902308] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
196 NCBI Resource Coordinators. Database resources of the National Center for Biotechnology Information. Nucleic Acids Res 2015;43:D6-17. [PMID: 25398906 DOI: 10.1093/nar/gku1130] [Cited by in Crossref: 213] [Cited by in F6Publishing: 193] [Article Influence: 26.6] [Reference Citation Analysis]
197 Yavarna T, Al-Dewik N, Al-Mureikhi M, Ali R, Al-Mesaifri F, Mahmoud L, Shahbeck N, Lakhani S, AlMulla M, Nawaz Z, Vitazka P, Alkuraya FS, Ben-Omran T. High diagnostic yield of clinical exome sequencing in Middle Eastern patients with Mendelian disorders. Hum Genet. 2015;134:967-980. [PMID: 26077850 DOI: 10.1007/s00439-015-1575-0] [Cited by in Crossref: 109] [Cited by in F6Publishing: 104] [Article Influence: 15.6] [Reference Citation Analysis]
198 Niogret J, Dalens L, Truntzer C, Chevrier S, Favier L, Lagrange A, Coudert B, Fraisse C, Foucher P, Zouak A, Westeel V, Goussot V, Dérangère V, Albuisson J, Arnould L, Boidot R, Kaderbhai CG, Ghiringhelli F. Does large NGS panel analysed using exome tumour sequencing improve the management of advanced non-small-cell lung cancers? Lung Cancer 2021;161:98-107. [PMID: 34560426 DOI: 10.1016/j.lungcan.2021.08.013] [Reference Citation Analysis]
199 Amendola LM, Muenzen K, Biesecker LG, Bowling KM, Cooper GM, Dorschner MO, Driscoll C, Foreman AKM, Golden-Grant K, Greally JM, Hindorff L, Kanavy D, Jobanputra V, Johnston JJ, Kenny EE, McNulty S, Murali P, Ou J, Powell BC, Rehm HL, Rolf B, Roman TS, Van Ziffle J, Guha S, Abhyankar A, Crosslin D, Venner E, Yuan B, Zouk H, Jarvik GP; CSER Sequencing and Diagnostic Yield working group. Variant Classification Concordance using the ACMG-AMP Variant Interpretation Guidelines across Nine Genomic Implementation Research Studies. Am J Hum Genet 2020;107:932-41. [PMID: 33108757 DOI: 10.1016/j.ajhg.2020.09.011] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 4.5] [Reference Citation Analysis]
200 Chen D, Zhu S. Whole-exome sequencing identifies an RS1 variant in a Chinese family with X-linked retinoschisis. Exp Ther Med 2021;22:1406. [PMID: 34675999 DOI: 10.3892/etm.2021.10842] [Reference Citation Analysis]
201 Lim EC, Brett M, Lai AH, Lee SP, Tan ES, Jamuar SS, Ng IS, Tan EC. Next-generation sequencing using a pre-designed gene panel for the molecular diagnosis of congenital disorders in pediatric patients. Hum Genomics 2015;9:33. [PMID: 26666243 DOI: 10.1186/s40246-015-0055-x] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 3.0] [Reference Citation Analysis]
202 Bernhardt BA, Roche MI, Perry DL, Scollon SR, Tomlinson AN, Skinner D. Experiences with obtaining informed consent for genomic sequencing. Am J Med Genet A 2015;167A:2635-46. [PMID: 26198374 DOI: 10.1002/ajmg.a.37256] [Cited by in Crossref: 66] [Cited by in F6Publishing: 64] [Article Influence: 9.4] [Reference Citation Analysis]
203 Demeure MJ. The Role of Precision Medicine in the Diagnosis and Treatment of Patients with Rare Cancers. Cancer Treat Res 2019;178:81-108. [PMID: 31209842 DOI: 10.1007/978-3-030-16391-4_3] [Cited by in Crossref: 2] [Article Influence: 0.7] [Reference Citation Analysis]
204 Buchanan AH, Manickam K, Meyer MN, Wagner JK, Hallquist MLG, Williams JL, Rahm AK, Williams MS, Chen ZE, Shah CK, Garg TK, Lazzeri AL, Schwartz MLB, Lindbuchler DM, Fan AL, Leeming R, Servano PO 3rd, Smith AL, Vogel VG, Abul-Husn NS, Dewey FE, Lebo MS, Mason-Suares HM, Ritchie MD, Davis FD, Carey DJ, Feinberg DT, Faucett WA, Ledbetter DH, Murray MF. Early cancer diagnoses through BRCA1/2 screening of unselected adult biobank participants. Genet Med 2018;20:554-8. [PMID: 29261187 DOI: 10.1038/gim.2017.145] [Cited by in Crossref: 29] [Cited by in F6Publishing: 26] [Article Influence: 5.8] [Reference Citation Analysis]
205 Tsiplova K, Zur RM, Marshall CR, Stavropoulos DJ, Pereira SL, Merico D, Young EJ, Sung WWL, Scherer SW, Ungar WJ. A microcosting and cost–consequence analysis of clinical genomic testing strategies in autism spectrum disorder. Genet Med 2017;19:1268-75. [DOI: 10.1038/gim.2017.47] [Cited by in Crossref: 35] [Cited by in F6Publishing: 34] [Article Influence: 7.0] [Reference Citation Analysis]
206 Egalite N, Groisman IJ, Godard B. Personalized medicine in oncology: ethical implications for the delivery of healthcare. Per Med 2014;11:659-68. [PMID: 29764052 DOI: 10.2217/pme.14.53] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
207 Kuhlen M, Borkhardt A. Cancer susceptibility syndromes in children in the area of broad clinical use of massive parallel sequencing. Eur J Pediatr 2015;174:987-97. [PMID: 25982339 DOI: 10.1007/s00431-015-2565-x] [Cited by in Crossref: 20] [Cited by in F6Publishing: 15] [Article Influence: 2.9] [Reference Citation Analysis]
208 Jang MA, Lee SH, Kim N, Ki CS. Frequency and spectrum of actionable pathogenic secondary findings in 196 Korean exomes. Genet Med 2015;17:1007-11. [PMID: 25856671 DOI: 10.1038/gim.2015.26] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 3.4] [Reference Citation Analysis]
209 Zatz M, Silva MVR, de Castro MV, Naslavsky MS. The 90 plus: longevity and COVID-19 survival. Mol Psychiatry 2022. [PMID: 35136227 DOI: 10.1038/s41380-022-01461-6] [Reference Citation Analysis]
210 Bonifati V. Genetics of Parkinson's disease--state of the art, 2013. Parkinsonism Relat Disord 2014;20 Suppl 1:S23-8. [PMID: 24262182 DOI: 10.1016/S1353-8020(13)70009-9] [Cited by in Crossref: 146] [Cited by in F6Publishing: 64] [Article Influence: 18.3] [Reference Citation Analysis]
211 Kaname T, Yanagi K, Naritomi K. A commentary on the promise of whole-exome sequencing in medical genetics. J Hum Genet 2014;59:117-8. [DOI: 10.1038/jhg.2014.7] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
212 Trinidad SB, Fullerton SM, Burke W. Looking for Trouble and Finding It. Am J Bioeth 2015;15:15-7. [PMID: 26147255 DOI: 10.1080/15265161.2015.1039731] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
213 Ormondroyd E, Harper AR, Thomson KL, Mackley MP, Martin J, Penkett CJ, Salatino S, Stark H, Stephens J, Watkins H. Secondary findings in inherited heart conditions: a genotype-first feasibility study to assess phenotype, behavioural and psychosocial outcomes. Eur J Hum Genet 2020;28:1486-96. [PMID: 32686758 DOI: 10.1038/s41431-020-0694-9] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
214 Yang C, Chou I, Cho D, Lin C, Huang H, Ho Y, Liu T, Li Y, Chang J. Whole exome sequencing in Dandy-Walker variant with intellectual disability reveals an activating CIP2A mutation as novel genetic cause. Neurogenetics 2018;19:157-63. [DOI: 10.1007/s10048-018-0548-6] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
215 Cutting E, Banchero M, Beitelshees AL, Cimino JJ, Fiol GD, Gurses AP, Hoffman MA, Jeng LJ, Kawamoto K, Kelemen M, Pincus HA, Shuldiner AR, Williams MS, Pollin TI, Overby CL. User-centered design of multi-gene sequencing panel reports for clinicians. J Biomed Inform 2016;63:1-10. [PMID: 27423699 DOI: 10.1016/j.jbi.2016.07.014] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
216 Gornick MC, Scherer AM, Sutton EJ, Ryan KA, Exe NL, Li M, Uhlmann WR, Kim SY, Roberts JS, De Vries RG. Effect of Public Deliberation on Attitudes toward Return of Secondary Results in Genomic Sequencing. J Genet Couns 2017;26:122-32. [PMID: 27307100 DOI: 10.1007/s10897-016-9987-0] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
217 Seifert BA, O'Daniel JM, Amin K, Marchuk DS, Patel NM, Parker JS, Hoyle AP, Mose LE, Marron A, Hayward MC, Bizon C, Wilhelmsen KC, Evans JP, Earp HS 3rd, Sharpless NE, Hayes DN, Berg JS. Germline Analysis from Tumor-Germline Sequencing Dyads to Identify Clinically Actionable Secondary Findings. Clin Cancer Res 2016;22:4087-94. [PMID: 27083775 DOI: 10.1158/1078-0432.CCR-16-0015] [Cited by in Crossref: 43] [Cited by in F6Publishing: 26] [Article Influence: 7.2] [Reference Citation Analysis]
218 Elger BS, De Clercq E. Returning Results: Let's Be Honest! Genet Test Mol Biomarkers 2017;21:134-9. [PMID: 28306398 DOI: 10.1089/gtmb.2016.0395] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
219 Santaló J, Berdasco M. Ethical implications of epigenetics in the era of personalized medicine. Clin Epigenetics 2022;14:44. [PMID: 35337378 DOI: 10.1186/s13148-022-01263-1] [Reference Citation Analysis]
220 Moret C, Mauron A, Fokstuen S, Makrythanasis P, Hurst SA. Defining categories of actionability for secondary findings in next-generation sequencing. J Med Ethics 2017;43:346-9. [DOI: 10.1136/medethics-2016-103677] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
221 Hicks JK, Shealy A, Schreiber A, Coleridge M, Noss R, Natowicz M, Moran R, Moss T, Erwin A, Eng C. Patient Decisions to Receive Secondary Pharmacogenomic Findings and Development of a Multidisciplinary Practice Model to Integrate Results Into Patient Care. Clin Transl Sci 2018;11:71-6. [PMID: 28749586 DOI: 10.1111/cts.12493] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
222 Chang W, Brohl AS, Patidar R, Sindiri S, Shern JF, Wei JS, Song YK, Yohe ME, Gryder B, Zhang S, Calzone KA, Shivaprasad N, Wen X, Badgett TC, Miettinen M, Hartman KR, League-Pascual JC, Trahair TN, Widemann BC, Merchant MS, Kaplan RN, Lin JC, Khan J. MultiDimensional ClinOmics for Precision Therapy of Children and Adolescent Young Adults with Relapsed and Refractory Cancer: A Report from the Center for Cancer Research. Clin Cancer Res 2016;22:3810-20. [PMID: 26994145 DOI: 10.1158/1078-0432.CCR-15-2717] [Cited by in Crossref: 52] [Cited by in F6Publishing: 31] [Article Influence: 8.7] [Reference Citation Analysis]
223 Feng YA, Stanaway IB, Connolly JJ, Denny JC, Luo Y, Weng C, Wei WQ, Weiss ST, Karlson EW, Smoller JW. Psychiatric manifestations of rare variation in medically actionable genes: a PheWAS approach. BMC Genomics 2022;23:385. [PMID: 35590255 DOI: 10.1186/s12864-022-08600-x] [Reference Citation Analysis]
224 Lucassen A, Widdershoven G, Metselaar S, Fenwick A, Parker M. Genetic Testing of Children: The Need for a Family Perspective. The American Journal of Bioethics 2014;14:26-8. [DOI: 10.1080/15265161.2013.879950] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 0.9] [Reference Citation Analysis]
225 Ross LF, Clayton EW. Ethical Issues in Newborn Sequencing Research: The Case Study of BabySeq. Pediatrics 2019;144:e20191031. [PMID: 31719124 DOI: 10.1542/peds.2019-1031] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 3.3] [Reference Citation Analysis]
226 Bacher U, Kohlmann A, Haferlach T. Mutational profiling in patients with MDS: ready for every-day use in the clinic? Best Pract Res Clin Haematol 2015;28:32-42. [PMID: 25659728 DOI: 10.1016/j.beha.2014.11.005] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 2.1] [Reference Citation Analysis]
227 Arslan Ateş E, Türkyilmaz A, Yıldırım Ö, Alavanda C, Polat H, Demir Ş, Çebi AH, Geçkinli BB, Güney Aİ, Ata P, Arman A. Secondary findings in 622 Turkish clinical exome sequencing data. J Hum Genet 2021. [PMID: 34050257 DOI: 10.1038/s10038-021-00936-8] [Reference Citation Analysis]
228 Appelbaum PS, Waldman CR, Fyer A, Klitzman R, Parens E, Martinez J, Price WN 2nd, Chung WK. Informed consent for return of incidental findings in genomic research. Genet Med 2014;16:367-73. [PMID: 24158054 DOI: 10.1038/gim.2013.145] [Cited by in Crossref: 48] [Cited by in F6Publishing: 41] [Article Influence: 5.3] [Reference Citation Analysis]
229 Borle K, Dey A, Carrion P, Austin J, Elliott AM; GenCOUNSEL Study. Genetic counseling research and COVID-19: A lesson in resiliency. J Genet Couns 2021. [PMID: 34510629 DOI: 10.1002/jgc4.1502] [Reference Citation Analysis]
230 Langlois PH, Scheuerle AE. Descriptive epidemiology of birth defects thought to arise by new mutation. Birth Defects Res A Clin Mol Teratol 2015;103:913-27. [PMID: 26228797 DOI: 10.1002/bdra.23412] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
231 Meric-Bernstam F, Johnson A, Holla V, Bailey AM, Brusco L, Chen K, Routbort M, Patel KP, Zeng J, Kopetz S, Davies MA, Piha-Paul SA, Hong DS, Eterovic AK, Tsimberidou AM, Broaddus R, Bernstam EV, Shaw KR, Mendelsohn J, Mills GB. A decision support framework for genomically informed investigational cancer therapy. J Natl Cancer Inst 2015;107:djv098. [PMID: 25863335 DOI: 10.1093/jnci/djv098] [Cited by in Crossref: 119] [Cited by in F6Publishing: 116] [Article Influence: 17.0] [Reference Citation Analysis]
232 Seaby EG, Pengelly RJ, Ennis S. Exome sequencing explained: a practical guide to its clinical application. Brief Funct Genomics 2016;15:374-84. [PMID: 26654982 DOI: 10.1093/bfgp/elv054] [Cited by in Crossref: 29] [Cited by in F6Publishing: 27] [Article Influence: 4.1] [Reference Citation Analysis]
233 Zierhut H, Schneider KW. Stem Cell Transplantation: Genetic Counselors as a Critical Part of the Process. Curr Genet Med Rep 2014;2:39-47. [DOI: 10.1007/s40142-014-0038-6] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
234 Manolio TA, Fowler DM, Starita LM, Haendel MA, MacArthur DG, Biesecker LG, Worthey E, Chisholm RL, Green ED, Jacob HJ, McLeod HL, Roden D, Rodriguez LL, Williams MS, Cooper GM, Cox NJ, Herman GE, Kingsmore S, Lo C, Lutz C, MacRae CA, Nussbaum RL, Ordovas JM, Ramos EM, Robinson PN, Rubinstein WS, Seidman C, Stranger BE, Wang H, Westerfield M, Bult C. Bedside Back to Bench: Building Bridges between Basic and Clinical Genomic Research. Cell 2017;169:6-12. [PMID: 28340351 DOI: 10.1016/j.cell.2017.03.005] [Cited by in Crossref: 80] [Cited by in F6Publishing: 61] [Article Influence: 16.0] [Reference Citation Analysis]
235 Henderson GE, Edwards TP, Cadigan RJ, Davis AM, Zimmer C, Conlon I, Weiner BJ. Stewardship practices of U.S. biobanks. Sci Transl Med 2013;5:215cm7. [PMID: 24337477 DOI: 10.1126/scitranslmed.3007362] [Cited by in Crossref: 26] [Cited by in F6Publishing: 20] [Article Influence: 3.3] [Reference Citation Analysis]
236 Miller FA, Hayeems RZ, Bytautas JP, Bedard PL, Ernst S, Hirte H, Hotte S, Oza A, Razak A, Welch S, Winquist E, Dancey J, Siu LL. Testing personalized medicine: patient and physician expectations of next-generation genomic sequencing in late-stage cancer care. Eur J Hum Genet 2014;22:391-5. [PMID: 23860039 DOI: 10.1038/ejhg.2013.158] [Cited by in Crossref: 72] [Cited by in F6Publishing: 62] [Article Influence: 8.0] [Reference Citation Analysis]
237 Seiffert DJ, McCarthy Veach P, LeRoy B, Guan W, Zierhut H. Beyond medical actionability: Public perceptions of important actions in response to hypothetical genetic testing results. J Genet Couns 2019;28:355-66. [PMID: 30710467 DOI: 10.1002/jgc4.1048] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
238 McGowan ML, Settersten RA Jr, Juengst ET, Fishman JR. Integrating genomics into clinical oncology: ethical and social challenges from proponents of personalized medicine. Urol Oncol 2014;32:187-92. [PMID: 24445286 DOI: 10.1016/j.urolonc.2013.10.009] [Cited by in Crossref: 30] [Cited by in F6Publishing: 25] [Article Influence: 3.8] [Reference Citation Analysis]
239 Schuelke M, Øien NC, Oldfors A. Myopathology in the times of modern genetics. Neuropathol Appl Neurobiol 2017;43:44-61. [DOI: 10.1111/nan.12374] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
240 Manolio TA, Bult CJ, Chisholm RL, Deverka PA, Ginsburg GS, Goldrich M, Jarvik GP, Mensah GA, Ramos EM, Relling MV, Roden DM, Rowley R, Williams MS, Green ED. Genomic medicine year in review: 2021. Am J Hum Genet 2021;108:2210-4. [PMID: 34861172 DOI: 10.1016/j.ajhg.2021.11.006] [Reference Citation Analysis]
241 Benson KA, White M, Allen NM, Byrne S, Carton R, Comerford E, Costello D, Doherty C, Dunleavey B, El-Naggar H, Gangadharan N, Heavin S, Kearney H, Lench NJ, Lynch J, McCormack M, Regan MO, Podesta K, Power K, Rogers AS, Steward CA, Sweeney B, Webb D, Fitzsimons M, Greally M, Delanty N, Cavalleri GL. A comparison of genomic diagnostics in adults and children with epilepsy and comorbid intellectual disability. Eur J Hum Genet 2020;28:1066-77. [PMID: 32238909 DOI: 10.1038/s41431-020-0610-3] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 5.0] [Reference Citation Analysis]
242 Brittain HK, Scott R, Thomas E. The rise of the genome and personalised medicine. Clin Med (Lond) 2017;17:545-51. [PMID: 29196356 DOI: 10.7861/clinmedicine.17-6-545] [Cited by in Crossref: 28] [Cited by in F6Publishing: 21] [Article Influence: 7.0] [Reference Citation Analysis]
243 Clayton EW, Ross LF, Rothstein MA. Correspondence on "Exploring the motivations of research participants who chose not to learn medically actionable secondary findings about themselves" by Schupmann et al. Genet Med 2021:S1098-3600(21)04139-3. [PMID: 34906493 DOI: 10.1016/j.gim.2021.08.017] [Reference Citation Analysis]
244 Berberich AJ, Hegele RA. The role of genetic testing in dyslipidaemia. Pathology 2019;51:184-92. [DOI: 10.1016/j.pathol.2018.10.014] [Cited by in Crossref: 21] [Cited by in F6Publishing: 17] [Article Influence: 7.0] [Reference Citation Analysis]
245 Andre F, Mardis E, Salm M, Soria JC, Siu LL, Swanton C. Prioritizing targets for precision cancer medicine. Ann Oncol. 2014;25:2295-2303. [PMID: 25344359 DOI: 10.1093/annonc/mdu478] [Cited by in Crossref: 94] [Cited by in F6Publishing: 87] [Article Influence: 11.8] [Reference Citation Analysis]
246 Paulo P, Maia S, Pinto C, Pinto P, Monteiro A, Peixoto A, Teixeira MR. Targeted next generation sequencing identifies functionally deleterious germline mutations in novel genes in early-onset/familial prostate cancer. PLoS Genet 2018;14:e1007355. [PMID: 29659569 DOI: 10.1371/journal.pgen.1007355] [Cited by in Crossref: 27] [Cited by in F6Publishing: 24] [Article Influence: 6.8] [Reference Citation Analysis]
247 Gibson J, Young S, Leng B, Zreik R, Rao A. Molecular diagnostic testing of cytology specimens: current applications and future considerations. Journal of the American Society of Cytopathology 2014;3:280-94. [DOI: 10.1016/j.jasc.2014.08.002] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 0.9] [Reference Citation Analysis]
248 Shah SN, Gammal RS, Amato MG, Alobaidly M, Reyes DD, Hasan S, Seger DL, Krier JB, Bates DW. Clinical Utility of Pharmacogenomic Data Collected by a Health-System Biobank to Predict and Prevent Adverse Drug Events. Drug Saf 2021;44:601-7. [PMID: 33620701 DOI: 10.1007/s40264-021-01050-6] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
249 Starkweather A, Coleman B, Barcelona de Mendoza V, Fu M, Taylor J, Henderson W, Kenner C, Walker D, Amankwaa L, Anderson C. Policy brief: Improve coverage of newborn genetic screening to include the Recommended Uniform Screening Panel and newborn screening registry. Nurs Outlook 2017;65:480-4. [PMID: 28601255 DOI: 10.1016/j.outlook.2017.04.009] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
250 Houdayer F, Putois O, Babonneau ML, Chaumet H, Joly L, Juif C, Michon CC, Staraci S, Cretin E, Delanoue S, Charron P, Chassagne A, Edery P, Gautier E, Lapointe AS, Thauvin-Robinet C, Sanlaville D, Gargiulo M, Faivre L. Secondary findings from next generation sequencing: Psychological and ethical issues. Family and patient perspectives. Eur J Med Genet 2019;62:103711. [PMID: 31265899 DOI: 10.1016/j.ejmg.2019.103711] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
251 Taylor JC, Martin HC, Lise S, Broxholme J, Cazier JB, Rimmer A, Kanapin A, Lunter G, Fiddy S, Allan C, Aricescu AR, Attar M, Babbs C, Becq J, Beeson D, Bento C, Bignell P, Blair E, Buckle VJ, Bull K, Cais O, Cario H, Chapel H, Copley RR, Cornall R, Craft J, Dahan K, Davenport EE, Dendrou C, Devuyst O, Fenwick AL, Flint J, Fugger L, Gilbert RD, Goriely A, Green A, Greger IH, Grocock R, Gruszczyk AV, Hastings R, Hatton E, Higgs D, Hill A, Holmes C, Howard M, Hughes L, Humburg P, Johnson D, Karpe F, Kingsbury Z, Kini U, Knight JC, Krohn J, Lamble S, Langman C, Lonie L, Luck J, McCarthy D, McGowan SJ, McMullin MF, Miller KA, Murray L, Németh AH, Nesbit MA, Nutt D, Ormondroyd E, Oturai AB, Pagnamenta A, Patel SY, Percy M, Petousi N, Piazza P, Piret SE, Polanco-Echeverry G, Popitsch N, Powrie F, Pugh C, Quek L, Robbins PA, Robson K, Russo A, Sahgal N, van Schouwenburg PA, Schuh A, Silverman E, Simmons A, Sørensen PS, Sweeney E, Taylor J, Thakker RV, Tomlinson I, Trebes A, Twigg SR, Uhlig HH, Vyas P, Vyse T, Wall SA, Watkins H, Whyte MP, Witty L, Wright B, Yau C, Buck D, Humphray S, Ratcliffe PJ, Bell JI, Wilkie AO, Bentley D, Donnelly P, McVean G. Factors influencing success of clinical genome sequencing across a broad spectrum of disorders. Nat Genet 2015;47:717-26. [PMID: 25985138 DOI: 10.1038/ng.3304] [Cited by in Crossref: 220] [Cited by in F6Publishing: 185] [Article Influence: 31.4] [Reference Citation Analysis]
252 Bennette CS, Gallego CJ, Burke W, Jarvik GP, Veenstra DL. The cost-effectiveness of returning incidental findings from next-generation genomic sequencing. Genet Med 2015;17:587-95. [PMID: 25394171 DOI: 10.1038/gim.2014.156] [Cited by in Crossref: 65] [Cited by in F6Publishing: 62] [Article Influence: 8.1] [Reference Citation Analysis]
253 Seo J, Ivanovich J, Goodman MS, Biesecker BB, Kaphingst KA. Information Topics of Greatest Interest for Return of Genome Sequencing Results among Women Diagnosed with Breast Cancer at a Young Age. J Genet Couns 2017;26:511-21. [PMID: 27542972 DOI: 10.1007/s10897-016-0006-2] [Cited by in Crossref: 2] [Article Influence: 0.3] [Reference Citation Analysis]
254 Wright CF, Fitzgerald TW, Jones WD, Clayton S, McRae JF, van Kogelenberg M, King DA, Ambridge K, Barrett DM, Bayzetinova T, Bevan AP, Bragin E, Chatzimichali EA, Gribble S, Jones P, Krishnappa N, Mason LE, Miller R, Morley KI, Parthiban V, Prigmore E, Rajan D, Sifrim A, Swaminathan GJ, Tivey AR, Middleton A, Parker M, Carter NP, Barrett JC, Hurles ME, FitzPatrick DR, Firth HV; DDD study. Genetic diagnosis of developmental disorders in the DDD study: a scalable analysis of genome-wide research data. Lancet 2015;385:1305-14. [PMID: 25529582 DOI: 10.1016/S0140-6736(14)61705-0] [Cited by in Crossref: 422] [Cited by in F6Publishing: 232] [Article Influence: 52.8] [Reference Citation Analysis]
255 [DOI: 10.1101/084251] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
256 Everett JN, Gustafson SL, Raymond VM. Traditional roles in a non-traditional setting: genetic counseling in precision oncology. J Genet Couns 2014;23:655-60. [PMID: 24578120 DOI: 10.1007/s10897-014-9698-3] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 2.6] [Reference Citation Analysis]
257 Thodeson DM, Park JY. Genomic testing in pediatric epilepsy. Cold Spring Harb Mol Case Stud 2019;5:a004135. [PMID: 31371349 DOI: 10.1101/mcs.a004135] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
258 Spector-bagdady K. Reconceptualizing Consent for Direct-to-Consumer Health Services. Am J Law Med 2015;41:568-616. [DOI: 10.1177/0098858815622191] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 10.0] [Reference Citation Analysis]
259 Bombard Y, Clausen M, Shickh S, Mighton C, Casalino S, Kim THM, Muir SM, Carlsson L, Baxter N, Scheer A, Elser C, Eisen A, Panchal S, Graham T, Aronson M, Piccinin C, Mancuso T, Semotiuk K, Evans M, Carroll JC, Offit K, Robson M, Hamilton JG, Glogowski E, Schrader K, Kim RH, Lerner-Ellis J, Thorpe KE, Laupacis A; Incidental Genomics Study Team. Effectiveness of the Genomics ADvISER decision aid for the selection of secondary findings from genomic sequencing: a randomized clinical trial. Genet Med 2020;22:727-35. [PMID: 31822848 DOI: 10.1038/s41436-019-0702-z] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
260 Nakamura Y, Onodera S, Takano M, Katakura A, Nomura T, Azuma T. Development of a targeted gene panel for the diagnosis of Gorlin syndrome. International Journal of Oral and Maxillofacial Surgery 2022. [DOI: 10.1016/j.ijom.2022.03.054] [Reference Citation Analysis]
261 Adam S, Birch PH, Coe RR, Bansback N, Jones AL, Connolly MB, Demos MK, Toyota EB, Farrer MJ, Friedman JM. Assessing an Interactive Online Tool to Support Parents' Genomic Testing Decisions. J Genet Couns 2018. [PMID: 30033481 DOI: 10.1007/s10897-018-0281-1] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
262 Turbitt E, Halliday JL, Metcalfe SA. Key Informants’ Perspectives of Implementing Chromosomal Microarrays Into Clinical Practice in Australia. Twin Res Hum Genet 2013;16:833-9. [DOI: 10.1017/thg.2013.43] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
263 Erickson LA. Incidental findings in medical imaging and genetic testing: opportunities and challenges. Mayo Clin Proc 2014;89:715-7. [PMID: 24943690 DOI: 10.1016/j.mayocp.2014.04.011] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
264 Hood L, Rowen L. The Human Genome Project: big science transforms biology and medicine. Genome Med. 2013;5:79. [PMID: 24040834 DOI: 10.1186/gm483] [Cited by in Crossref: 85] [Cited by in F6Publishing: 54] [Article Influence: 9.4] [Reference Citation Analysis]
265 Vetsch J, Wakefield CE, Techakesari P, Warby M, Ziegler DS, O'Brien TA, Drinkwater C, Neeman N, Tucker K. Healthcare professionals' attitudes toward cancer precision medicine: A systematic review. Semin Oncol 2019;46:291-303. [PMID: 31221444 DOI: 10.1053/j.seminoncol.2019.05.001] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
266 Pritchard AL, Johansson PA, Nathan V, Howlie M, Symmons J, Palmer JM, Hayward NK. Germline mutations in candidate predisposition genes in individuals with cutaneous melanoma and at least two independent additional primary cancers. PLoS One 2018;13:e0194098. [PMID: 29641532 DOI: 10.1371/journal.pone.0194098] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 2.5] [Reference Citation Analysis]
267 Korngiebel DM, McMullen CK, Amendola LM, Berg JS, Davis JV, Gilmore MJ, Harding CO, Himes P, Jarvik GP, Kauffman TL, Kennedy KA, Simpson DK, Leo MC, Lynch FL, Quigley DI, Reiss JA, Richards CS, Rope AF, Schneider JL, Goddard KA, Wilfond BS. Generating a taxonomy for genetic conditions relevant to reproductive planning. Am J Med Genet A 2016;170:565-73. [PMID: 26889673 DOI: 10.1002/ajmg.a.37513] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 3.0] [Reference Citation Analysis]
268 Lee E, Le T, Zhu Y, Elakis G, Turner A, Lo W, Venselaar H, Verrenkamp CA, Snow N, Mowat D, Kirk EP, Sachdev R, Smith J, Brown NJ, Wallis M, Barnett C, McKenzie F, Freckmann ML, Collins F, Chopra M, Gregersen N, Hayes I, Rajagopalan S, Tan TY, Stark Z, Savarirayan R, Yeung A, Adès L, Gattas M, Gibson K, Gabbett M, Amor DJ, Lattanzi W, Boyd S, Haan E, Gianoutsos M, Cox TC, Buckley MF, Roscioli T. A craniosynostosis massively parallel sequencing panel study in 309 Australian and New Zealand patients: findings and recommendations. Genet Med 2018;20:1061-8. [PMID: 29215649 DOI: 10.1038/gim.2017.214] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 4.6] [Reference Citation Analysis]
269 Sobel ME, Dreyfus JC, Dillehay McKillip K, Kolarcik C, Muller WA, Scott MJ, Siegal GP, Wadosky K, O'Leary TJ. Return of Individual Research Results: A Guide for Biomedical Researchers Utilizing Human Biospecimens. Am J Pathol 2020;190:918-33. [PMID: 32201265 DOI: 10.1016/j.ajpath.2020.01.014] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
270 He KY, Ge D, He MM. Big Data Analytics for Genomic Medicine. Int J Mol Sci 2017;18:E412. [PMID: 28212287 DOI: 10.3390/ijms18020412] [Cited by in Crossref: 77] [Cited by in F6Publishing: 43] [Article Influence: 15.4] [Reference Citation Analysis]
271 Rhodes A, Rosman L, Cahill J, Ingles J, Murray B, Tichnell C, James CA, Sears SF. Minding the Genes: a Multidisciplinary Approach towards Genetic Assessment of Cardiovascular Disease. J Genet Couns 2017;26:224-31. [PMID: 27695998 DOI: 10.1007/s10897-016-0017-z] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 2.2] [Reference Citation Analysis]
272 Green RC, Lupski JR, Biesecker LG. Reporting genomic sequencing results to ordering clinicians: incidental, but not exceptional. JAMA 2013;310:365-6. [PMID: 23917280 DOI: 10.1001/jama.2013.41703] [Cited by in Crossref: 62] [Cited by in F6Publishing: 59] [Article Influence: 6.9] [Reference Citation Analysis]
273 Dewey FE, Grove ME, Pan C, Goldstein BA, Bernstein JA, Chaib H, Merker JD, Goldfeder RL, Enns GM, David SP, Pakdaman N, Ormond KE, Caleshu C, Kingham K, Klein TE, Whirl-Carrillo M, Sakamoto K, Wheeler MT, Butte AJ, Ford JM, Boxer L, Ioannidis JP, Yeung AC, Altman RB, Assimes TL, Snyder M, Ashley EA, Quertermous T. Clinical interpretation and implications of whole-genome sequencing. JAMA 2014;311:1035-45. [PMID: 24618965 DOI: 10.1001/jama.2014.1717] [Cited by in Crossref: 313] [Cited by in F6Publishing: 262] [Article Influence: 39.1] [Reference Citation Analysis]
274 Fuse N, Sakurai-Yageta M, Katsuoka F, Danjoh I, Shimizu R, Tamiya G, Nagami F, Kawame H, Higuchi S, Kinoshita K, Kure S, Yamamoto M. Establishment of Integrated Biobank for Precision Medicine and Personalized Healthcare: The Tohoku Medical Megabank Project. JMA J 2019;2:113-22. [PMID: 33615021 DOI: 10.31662/jmaj.2019-0014] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 2.3] [Reference Citation Analysis]
275 Cheon JY, Mozersky J, Cook-Deegan R. Variants of uncertain significance in BRCA: a harbinger of ethical and policy issues to come? Genome Med 2014;6:121. [PMID: 25593598 DOI: 10.1186/s13073-014-0121-3] [Cited by in Crossref: 57] [Cited by in F6Publishing: 49] [Article Influence: 7.1] [Reference Citation Analysis]
276 Titerlea V, Dembélé D, Mandel JL, Laporte J. Attitudes towards Genetic Information Delivered by High-Throughput Sequencing among Molecular Geneticists, Genetic Counselors, Medical Advisors and Students in France. Eur J Med Genet 2020;63:103770. [PMID: 31536829 DOI: 10.1016/j.ejmg.2019.103770] [Reference Citation Analysis]
277 Burke W, Antommaria AH, Bennett R, Botkin J, Clayton EW, Henderson GE, Holm IA, Jarvik GP, Khoury MJ, Knoppers BM, Press NA, Ross LF, Rothstein MA, Saal H, Uhlmann WR, Wilfond B, Wolf SM, Zimmern R. Recommendations for returning genomic incidental findings? We need to talk! Genet Med 2013;15:854-9. [PMID: 23907645 DOI: 10.1038/gim.2013.113] [Cited by in Crossref: 209] [Cited by in F6Publishing: 194] [Article Influence: 23.2] [Reference Citation Analysis]
278 Holm IA, Savage SK, Green RC, Juengst E, McGuire A, Kornetsky S, Brewster SJ, Joffe S, Taylor P. Guidelines for return of research results from pediatric genomic studies: deliberations of the Boston Children's Hospital Gene Partnership Informed Cohort Oversight Board. Genet Med 2014;16:547-52. [PMID: 24406460 DOI: 10.1038/gim.2013.190] [Cited by in Crossref: 31] [Cited by in F6Publishing: 37] [Article Influence: 3.9] [Reference Citation Analysis]
279 Mackley M, McGuire K, Taylor J, Watkins H, Ormondroyd E. From Genotype to Phenotype. Circ Genom Precis Med 2018;11:e002316. [PMID: 30354302 DOI: 10.1161/CIRCGEN.118.002316] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 1.3] [Reference Citation Analysis]
280 Lennerz JK, McLaughlin HM, Baron JM, Rasmussen D, Sumbada Shin M, Berners-Lee N, Miller Batten J, Swoboda KJ, Gala MK, Winter HS, Schmahmann JD, Sweetser DA, Boswell M, Pacula M, Stenzinger A, Le LP, Hynes W, Rehm HL, Klibanski A, Black-Schaffer SW, Golden JA, Louis DN, Weiss ST, Iafrate AJ. Health Care Infrastructure for Financially Sustainable Clinical Genomics. J Mol Diagn 2016;18:697-706. [PMID: 27471182 DOI: 10.1016/j.jmoldx.2016.04.003] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
281 Raymond VM, Gray SW, Roychowdhury S, Joffe S, Chinnaiyan AM, Parsons DW, Plon SE; Clinical Sequencing Exploratory Research Consortium Tumor Working Group. Germline Findings in Tumor-Only Sequencing: Points to Consider for Clinicians and Laboratories. J Natl Cancer Inst 2016;108:djv351. [PMID: 26590952 DOI: 10.1093/jnci/djv351] [Cited by in Crossref: 58] [Cited by in F6Publishing: 46] [Article Influence: 8.3] [Reference Citation Analysis]
282 Su X, Kang PB, Russell JA, Simmons Z. Ethical issues in the evaluation of adults with suspected genetic neuromuscular disorders. Muscle Nerve 2016;54:997-1006. [PMID: 27615030 DOI: 10.1002/mus.25400] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
283 Benn P, Chapman AR, Erickson K, Defrancesco MS, Wilkins-haug L, Egan JFX, Schulkin J. Obstetricians and gynecologists' practice and opinions of expanded carrier testing and noninvasive prenatal testing: Expanded carrier and noninvasive testing. Prenat Diagn 2014;34:145-52. [DOI: 10.1002/pd.4272] [Cited by in Crossref: 55] [Cited by in F6Publishing: 52] [Article Influence: 6.1] [Reference Citation Analysis]
284 Chitty LS, Friedman JM, Langlois S. Current controversies in prenatal diagnosis 2: should a fetal exome be used in the assessment of a dysmorphic or malformed fetus? Prenat Diagn 2016;36:15-9. [PMID: 26525746 DOI: 10.1002/pd.4718] [Cited by in Crossref: 13] [Cited by in F6Publishing: 8] [Article Influence: 1.9] [Reference Citation Analysis]
285 Hurlimann T, Jaitovich Groisman I, Godard B. Exploring neurologists' perspectives on the return of next generation sequencing results to their patients: a needed step in the development of guidelines. BMC Med Ethics 2018;19:81. [PMID: 30268121 DOI: 10.1186/s12910-018-0320-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
286 Peltekova I, Buhas D, Stern L, Kirby E, Yusuf A, Elsabbagh M. Enhancing the Impact of Genomics Research in Autism through Integration of Research Results into Routine Care Pathways-A Case Series. J Pers Med 2021;11:755. [PMID: 34442399 DOI: 10.3390/jpm11080755] [Reference Citation Analysis]
287 Cummings CA, Peters E, Lacroix L, Andre F, Lackner MR. The Role of Next-Generation Sequencing in Enabling Personalized Oncology Therapy. Clin Transl Sci 2016;9:283-92. [PMID: 27860319 DOI: 10.1111/cts.12429] [Cited by in Crossref: 27] [Cited by in F6Publishing: 24] [Article Influence: 4.5] [Reference Citation Analysis]
288 Federoff M, Schottlaender LV, Houlden H, Singleton A. Multiple system atrophy: the application of genetics in understanding etiology. Clin Auton Res 2015;25:19-36. [PMID: 25687905 DOI: 10.1007/s10286-014-0267-5] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
289 Ploug T, Holm S. Clinical genome sequencing and population preferences for information about 'incidental' findings-From medically actionable genes (MAGs) to patient actionable genes (PAGs). PLoS One 2017;12:e0179935. [PMID: 28671958 DOI: 10.1371/journal.pone.0179935] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 3.8] [Reference Citation Analysis]
290 Ibuki T, Yamamoto K, Matsui K. Differences in Conceptual Understanding of the "Actionability" of Incidental Findings and the Resultant Difference in Ethical Responsibility: An Empirical Study in Japan. AJOB Empir Bioeth 2020;11:187-94. [PMID: 32615058 DOI: 10.1080/23294515.2020.1784308] [Reference Citation Analysis]
291 Hutchinson N, Capron A, Doussau A. Research Participants Should Have the Option to Be Notified of Results of Unknown but Potential Significance. Am J Bioeth 2019;19:78-80. [PMID: 31544684 DOI: 10.1080/15265161.2019.1572830] [Reference Citation Analysis]
292 Al-Shamsi A, Hertecant JL, Souid AK, Al-Jasmi FA. Whole exome sequencing diagnosis of inborn errors of metabolism and other disorders in United Arab Emirates. Orphanet J Rare Dis 2016;11:94. [PMID: 27391121 DOI: 10.1186/s13023-016-0474-3] [Cited by in Crossref: 27] [Cited by in F6Publishing: 23] [Article Influence: 4.5] [Reference Citation Analysis]
293 Karczewski KJ, Snyder MP. Integrative omics for health and disease. Nat Rev Genet 2018;19:299-310. [PMID: 29479082 DOI: 10.1038/nrg.2018.4] [Cited by in Crossref: 313] [Cited by in F6Publishing: 258] [Article Influence: 78.3] [Reference Citation Analysis]
294 Jain A, Gandhi S, Koshy R, Scaria V. Incidental and clinically actionable genetic variants in 1005 whole exomes and genomes from Qatar. Mol Genet Genomics 2018;293:919-29. [PMID: 29557500 DOI: 10.1007/s00438-018-1431-8] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 2.5] [Reference Citation Analysis]
295 Du C, Pusey BN, Adams CJ, Lau CC, Bone WP, Gahl WA, Markello TC, Adams DR. Explorations to improve the completeness of exome sequencing. BMC Med Genomics 2016;9:56. [PMID: 27568008 DOI: 10.1186/s12920-016-0216-3] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
296 Black L, Avard D, Zawati MH, Knoppers BM, Hébert J, Sauvageau G; Leucegene Project. Funding considerations for the disclosure of genetic incidental findings in biobank research. Clin Genet 2013;84:397-406. [PMID: 23662709 DOI: 10.1111/cge.12190] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 1.9] [Reference Citation Analysis]
297 Bradbury AR. Implementation of Precision Cancer Medicine: Progress and the Path to Realizing the Promise of Tumor Sequencing. J Oncol Pract 2019;15:297-9. [PMID: 31112480 DOI: 10.1200/JOP.19.00176] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
298 NCBI Resource Coordinators. Database resources of the National Center for Biotechnology Information. Nucleic Acids Res 2016;44:D7-19. [PMID: 26615191 DOI: 10.1093/nar/gkv1290] [Cited by in Crossref: 779] [Cited by in F6Publishing: 628] [Article Influence: 111.3] [Reference Citation Analysis]
299 Jalkh N, Mehawej C, Chouery E. Actionable Exomic Secondary Findings in 280 Lebanese Participants. Front Genet 2020;11:208. [PMID: 32231684 DOI: 10.3389/fgene.2020.00208] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
300 Gripp KW, Baker L, Telegrafi A, Monaghan KG. The role of objective facial analysis using FDNA in making diagnoses following whole exome analysis. Report of two patients with mutations in the BAF complex genes. Am J Med Genet 2016;170:1754-62. [DOI: 10.1002/ajmg.a.37672] [Cited by in Crossref: 27] [Cited by in F6Publishing: 25] [Article Influence: 4.5] [Reference Citation Analysis]
301 Schully SD, Lam TK, Dotson WD, Chang CQ, Aronson N, Birkeland ML, Brewster SJ, Boccia S, Buchanan AH, Calonge N, Calzone K, Djulbegovic B, Goddard KA, Klein RD, Klein TE, Lau J, Long R, Lyman GH, Morgan RL, Palmer CG, Relling MV, Rubinstein WS, Swen JJ, Terry SF, Williams MS, Khoury MJ. Evidence synthesis and guideline development in genomic medicine: current status and future prospects. Genet Med 2015;17:63-7. [PMID: 24946156 DOI: 10.1038/gim.2014.69] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 1.5] [Reference Citation Analysis]
302 Dumbrava EI, Brusco L, Daniels M, Wathoo C, Shaw K, Lu K, Zheng X, Strong L, Litton J, Arun B, Eterovic AK, Routbort M, Patel K, Qi Y, Piha-Paul S, Subbiah V, Hong D, Rodon J, Kopetz S, Mendelsohn J, Mills GB, Chen K, Meric-Bernstam F. Expanded analysis of secondary germline findings from matched tumor/normal sequencing identifies additional clinically significant mutations. JCO Precis Oncol 2019;3. [PMID: 31517177 DOI: 10.1200/PO.18.00143] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
303 Carethers JM. DNA testing and molecular screening for colon cancer. Clin Gastroenterol Hepatol. 2014;12:377-381. [PMID: 24355100 DOI: 10.1016/j.cgh.2013.12.007] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 2.3] [Reference Citation Analysis]
304 Marron JM, DuBois SG, Glade Bender J, Kim A, Crompton BD, Meyer SC, Janeway KA, Mack JW. Patient/parent perspectives on genomic tumor profiling of pediatric solid tumors: The Individualized Cancer Therapy (iCat) experience. Pediatr Blood Cancer 2016;63:1974-82. [PMID: 27429135 DOI: 10.1002/pbc.26137] [Cited by in Crossref: 28] [Cited by in F6Publishing: 23] [Article Influence: 4.7] [Reference Citation Analysis]
305 Hegde M, Bale S, Bayrak-Toydemir P, Gibson J, Jeng LJ, Joseph L, Laser J, Lubin IM, Miller CE, Ross LF, Rothberg PG, Tanner AK, Vitazka P, Mao R. Reporting incidental findings in genomic scale clinical sequencing--a clinical laboratory perspective: a report of the Association for Molecular Pathology. J Mol Diagn 2015;17:107-17. [PMID: 25684271 DOI: 10.1016/j.jmoldx.2014.10.004] [Cited by in Crossref: 41] [Cited by in F6Publishing: 34] [Article Influence: 5.9] [Reference Citation Analysis]
306 Gesbert C, Torregrosa C, Mamzer MF. [From incidentaloma to secondary discovery]. Med Sci (Paris) 2020;36:1054-8. [PMID: 33151867 DOI: 10.1051/medsci/2020188] [Reference Citation Analysis]
307 Uber R, Wright E. Pharmacogenomics implementation and multidisciplinary genomics collaboration: Real-world experience from Geisinger. Am J Health Syst Pharm 2022:zxac065. [PMID: 35279024 DOI: 10.1093/ajhp/zxac065] [Reference Citation Analysis]
308 Wolyniec K, Sharp J, Lazarakis S, Mileshkin L, Schofield P. Understanding and information needs of cancer patients regarding treatment‐focused genomic testing: A systematic review. Psycho‐Oncology 2020;29:632-8. [DOI: 10.1002/pon.5351] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 3.5] [Reference Citation Analysis]
309 Rahman N. Realizing the promise of cancer predisposition genes. Nature. 2014;505:302-308. [PMID: 24429628 DOI: 10.1038/nature12981] [Cited by in Crossref: 326] [Cited by in F6Publishing: 281] [Article Influence: 40.8] [Reference Citation Analysis]
310 Hart RK, Rico R, Hare E, Garcia J, Westbrook J, Fusaro VA. A Python package for parsing, validating, mapping and formatting sequence variants using HGVS nomenclature. Bioinformatics 2015;31:268-70. [PMID: 25273102 DOI: 10.1093/bioinformatics/btu630] [Cited by in Crossref: 27] [Cited by in F6Publishing: 19] [Article Influence: 3.4] [Reference Citation Analysis]
311 Friedman JM, Cornel MC, Goldenberg AJ, Lister KJ, Sénécal K, Vears DF; Global Alliance for Genomics and Health Regulatory and Ethics Working Group Paediatric Task Team. Genomic newborn screening: public health policy considerations and recommendations. BMC Med Genomics 2017;10:9. [PMID: 28222731 DOI: 10.1186/s12920-017-0247-4] [Cited by in Crossref: 38] [Cited by in F6Publishing: 35] [Article Influence: 7.6] [Reference Citation Analysis]
312 Malek J, Slashinski MJ, Robinson JO, Gutierrez AM, Parsons DW, Plon SE, McCullough LB, McGuire AL. Parental Perspectives on Whole Exome Sequencing in Pediatric Cancer: A Typology of Perceived Utility. JCO Precis Oncol 2017;1. [PMID: 31886451 DOI: 10.1200/PO.17.00010] [Cited by in Crossref: 10] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
313 Patel AP, Dron JS, Wang M, Pirruccello JP, Ng K, Natarajan P, Lebo M, Ellinor PT, Aragam KG, Khera AV. Association of Pathogenic DNA Variants Predisposing to Cardiomyopathy With Cardiovascular Disease Outcomes and All-Cause Mortality. JAMA Cardiol 2022. [PMID: 35544052 DOI: 10.1001/jamacardio.2022.0901] [Reference Citation Analysis]
314 Lohn Z, Adam S, Birch PH, Friedman JM. Incidental findings from clinical genome-wide sequencing: a review. J Genet Couns 2014;23:463-73. [PMID: 23709124 DOI: 10.1007/s10897-013-9604-4] [Cited by in Crossref: 29] [Cited by in F6Publishing: 27] [Article Influence: 3.2] [Reference Citation Analysis]
315 Yu JH, Appelbaum PS, Brothers KB, Joffe S, Kauffman TL, Koenig BA, Prince AE, Scollon S, Wolf SM, Bernhardt BA, Wilfond BS; Clinical Sequencing Exploratory Research (CSER) Consortium Informed Consent and Governance Working Group. Consent for clinical genome sequencing: considerations from the Clinical Sequencing Exploratory Research Consortium. Per Med 2019;16:325-33. [PMID: 31313633 DOI: 10.2217/pme-2018-0076] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
316 Vissers LELM, van Nimwegen KJM, Schieving JH, Kamsteeg EJ, Kleefstra T, Yntema HG, Pfundt R, van der Wilt GJ, Krabbenborg L, Brunner HG, van der Burg S, Grutters J, Veltman JA, Willemsen MAAP. A clinical utility study of exome sequencing versus conventional genetic testing in pediatric neurology. Genet Med 2017;19:1055-63. [PMID: 28333917 DOI: 10.1038/gim.2017.1] [Cited by in Crossref: 120] [Cited by in F6Publishing: 97] [Article Influence: 24.0] [Reference Citation Analysis]
317 Lynce F, Isaacs C. How Far Do We Go With Genetic Evaluation? Gene, Panel, and Tumor Testing. Am Soc Clin Oncol Educ Book 2016;35:e72-8. [PMID: 27249773 DOI: 10.1200/EDBK_160391] [Cited by in Crossref: 15] [Article Influence: 3.0] [Reference Citation Analysis]
318 Strong KA, Derse AR, Dimmock DP, Zusevics KL, Jeruzal J, Worthey E, Bick D, Scharer G, La Pean Kirschner A, Spellecy R, Farrell MH, Geurts J, Veith R, May T. In the absence of evidentiary harm, existing societal norms regarding parental authority should prevail. Am J Bioeth 2014;14:24-6. [PMID: 24592835 DOI: 10.1080/15265161.2013.879959] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
319 Shirts BH, Salama JS, Aronson SJ, Chung WK, Gray SW, Hindorff LA, Jarvik GP, Plon SE, Stoffel EM, Tarczy-Hornoch PZ, Van Allen EM, Weck KE, Chute CG, Freimuth RR, Grundmeier RW, Hartzler AL, Li R, Peissig PL, Peterson JF, Rasmussen LV, Starren JB, Williams MS, Overby CL. CSER and eMERGE: current and potential state of the display of genetic information in the electronic health record. J Am Med Inform Assoc 2015;22:1231-42. [PMID: 26142422 DOI: 10.1093/jamia/ocv065] [Cited by in Crossref: 33] [Cited by in F6Publishing: 48] [Article Influence: 4.7] [Reference Citation Analysis]
320 Vesteghem C, Brøndum RF, Sønderkær M, Sommer M, Schmitz A, Bødker JS, Dybkær K, El-Galaly TC, Bøgsted M. Implementing the FAIR Data Principles in precision oncology: review of supporting initiatives. Brief Bioinform 2020;21:936-45. [PMID: 31263868 DOI: 10.1093/bib/bbz044] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 8.0] [Reference Citation Analysis]
321 Dehnavi AZ, Heidari E, Rasulinezhad M, Heidari M, Ashrafi MR, Hosseini MM, Sadeghzadeh F, Fallah MS, Rostampour N, Bahraini A, Garshasbi M, Tavasoli AR. ACER3-related leukoencephalopathy: expanding the clinical and imaging findings spectrum due to novel variants. Hum Genomics 2021;15:45. [PMID: 34281620 DOI: 10.1186/s40246-021-00345-0] [Reference Citation Analysis]
322 Brunfeldt M, Teare H, Soini S, Kääriäinen H. Perceptions of legislation relating to the sharing of genomic biobank results with donors-a survey of BBMRI-ERIC biobanks. Eur J Hum Genet 2018;26:324-9. [PMID: 29330544 DOI: 10.1038/s41431-017-0049-3] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
323 Shaibi GQ, Kullo IJ, Singh DP, Sharp RR, De Filippis E, Cuellar I, Hernandez V, Levey S, Radecki Breitkopf C, Olson JE, Cerhan JR, Mandarino LJ, Thibodeau SN, Lindor NM. Developing a Process for Returning Medically Actionable Genomic Variants to Latino Patients in a Federally Qualified Health Center. Public Health Genomics 2018;21:77-84. [PMID: 30522109 DOI: 10.1159/000494488] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
324 Ye Y, Li W, Wang G, Zhan L, Lin J, Li T, Zhang J. Identification of a novel COL10A1: c.1952 G>T variant in a family with Schmid metaphyseal chondrodysplasia and development of a noninvasive prenatal testing method. Mol Genet Genomic Med 2021;9:e1758. [PMID: 34423584 DOI: 10.1002/mgg3.1758] [Reference Citation Analysis]
325 Foulkes WD, Knoppers BM, Turnbull C. Population genetic testing for cancer susceptibility: founder mutations to genomes. Nat Rev Clin Oncol 2016;13:41-54. [PMID: 26483301 DOI: 10.1038/nrclinonc.2015.173] [Cited by in Crossref: 63] [Cited by in F6Publishing: 54] [Article Influence: 9.0] [Reference Citation Analysis]
326 Schultz CL, Alderfer MA, Lindell RB, McClain Z, Zelley K, Nichols KE, Ford CA. The Influence of Adolescence on Parents' Perspectives of Testing and Discussing Inherited Cancer Predisposition. J Genet Couns 2018. [PMID: 29909594 DOI: 10.1007/s10897-018-0267-z] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
327 Hillman SC, Willams D, Carss KJ, McMullan DJ, Hurles ME, Kilby MD. Prenatal exome sequencing for fetuses with structural abnormalities: the next step. Ultrasound Obstet Gynecol 2015;45:4-9. [PMID: 25157891 DOI: 10.1002/uog.14653] [Cited by in Crossref: 44] [Cited by in F6Publishing: 35] [Article Influence: 5.5] [Reference Citation Analysis]
328 Kelly MA, Leader JB, Wain KE, Bodian D, Oetjens MT, Ledbetter DH, Martin CL, Strande NT. Leveraging population-based exome screening to impact clinical care: The evolution of variant assessment in the Geisinger MyCode research project. Am J Med Genet C Semin Med Genet 2021;187:83-94. [PMID: 33576083 DOI: 10.1002/ajmg.c.31887] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
329 Mariño MA. Incidentalomas: concept, relevance and challenges for medical practice. Rev Bras Med Fam Comunidade 2015;10:1-9. [DOI: 10.5712/rbmfc10(35)1053] [Cited by in Crossref: 4] [Article Influence: 0.6] [Reference Citation Analysis]
330 Kiryluk K, Goldstein DB, Rowe JW, Gharavi AG, Wapner R, Chung WK. Precision Medicine in Internal Medicine. Ann Intern Med 2019;170:635-42. [PMID: 31035290 DOI: 10.7326/M18-0425] [Cited by in Crossref: 9] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
331 Vears DF, Metcalfe SA. Carrier testing in children and adolescents. Eur J Med Genet 2015;58:659-67. [PMID: 26563495 DOI: 10.1016/j.ejmg.2015.11.006] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
332 Monaghan KG, Leach NT, Pekarek D, Prasad P, Rose NC; ACMG Professional Practice and Guidelines Committee. The use of fetal exome sequencing in prenatal diagnosis: a points to consider document of the American College of Medical Genetics and Genomics (ACMG). Genet Med 2020;22:675-80. [PMID: 31911674 DOI: 10.1038/s41436-019-0731-7] [Cited by in Crossref: 41] [Cited by in F6Publishing: 28] [Article Influence: 20.5] [Reference Citation Analysis]
333 Abicht A, Schön U, Laner A, Holinski-Feder E, Diebold I. Actionable secondary findings in arrhythmogenic right ventricle cardiomyopathy genes: impact and challenge of genetic counseling. Cardiovasc Diagn Ther 2021;11:637-49. [PMID: 33968641 DOI: 10.21037/cdt-20-585] [Reference Citation Analysis]
334 Hart MR, Biesecker BB, Blout CL, Christensen KD, Amendola LM, Bergstrom KL, Biswas S, Bowling KM, Brothers KB, Conlin LK, Cooper GM, Dulik MC, East KM, Everett JN, Finnila CR, Ghazani AA, Gilmore MJ, Goddard KAB, Jarvik GP, Johnston JJ, Kauffman TL, Kelley WV, Krier JB, Lewis KL, McGuire AL, McMullen C, Ou J, Plon SE, Rehm HL, Richards CS, Romasko EJ, Miren Sagardia A, Spinner NB, Thompson ML, Turbitt E, Vassy JL, Wilfond BS, Veenstra DL, Berg JS, Green RC, Biesecker LG, Hindorff LA. Secondary findings from clinical genomic sequencing: prevalence, patient perspectives, family history assessment, and health-care costs from a multisite study. Genet Med 2019;21:1100-10. [PMID: 30287922 DOI: 10.1038/s41436-018-0308-x] [Cited by in Crossref: 54] [Cited by in F6Publishing: 50] [Article Influence: 13.5] [Reference Citation Analysis]
335 Pendrick DM, Oberg JA, Hsiao SJ, Chung WK, Koval C, Sireci A, Kuo JH, Satwani P, Glasser CL, Sulis ML, Mansukhani MM, Glade Bender JL. Identification of a secondary RET mutation in a pediatric patient with relapsed acute myeloid leukemia leads to the diagnosis and treatment of asymptomatic metastatic medullary thyroid cancer in a parent: a case for sequencing the germline. Cold Spring Harb Mol Case Stud 2019;5:a003889. [PMID: 30936199 DOI: 10.1101/mcs.a003889] [Cited by in Crossref: 2] [Article Influence: 0.7] [Reference Citation Analysis]
336 Lewis ACF, Knoppers BM, Green RC. An international policy on returning genomic research results. Genome Med 2021;13:115. [PMID: 34266500 DOI: 10.1186/s13073-021-00928-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
337 Klingstrom T, Bongcam-Rudloff E, Reichel J. Legal & ethical compliance when sharing biospecimen. Brief Funct Genomics 2018;17:1-7. [PMID: 28460118 DOI: 10.1093/bfgp/elx008] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
338 Eckstein L, Otlowski M. Strategies to Guide the Return of Genomic Research Findings: An Australian Perspective. J Bioeth Inq 2018;15:403-15. [PMID: 29767375 DOI: 10.1007/s11673-018-9856-7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
339 Hippman C, Nislow C. Pharmacogenomic Testing: Clinical Evidence and Implementation Challenges. J Pers Med 2019;9:E40. [PMID: 31394823 DOI: 10.3390/jpm9030040] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 6.3] [Reference Citation Analysis]
340 Rexach J, Lee H, Martinez-Agosto JA, Németh AH, Fogel BL. Clinical application of next-generation sequencing to the practice of neurology. Lancet Neurol 2019;18:492-503. [PMID: 30981321 DOI: 10.1016/S1474-4422(19)30033-X] [Cited by in Crossref: 35] [Cited by in F6Publishing: 11] [Article Influence: 17.5] [Reference Citation Analysis]
341 Leppig KA, Thiese HA, Carrel D, Crosslin DR, Dorschner MO, Gordon AS, Hartzler A, Ralston J, Scrol A, Larson EB, Jarvik GP. Building a family network from genetic testing. Mol Genet Genomic Med 2017;5:122-9. [PMID: 28361098 DOI: 10.1002/mgg3.259] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
342 Thomas DM, James PA, Ballinger ML. Clinical implications of genomics for cancer risk genetics. Lancet Oncol 2015;16:e303-8. [PMID: 26065615 DOI: 10.1016/S1470-2045(15)70026-4] [Cited by in Crossref: 13] [Cited by in F6Publishing: 7] [Article Influence: 1.9] [Reference Citation Analysis]
343 Burke W, Appelbaum P, Dame L, Marshall P, Press N, Pyeritz R, Sharp R, Juengst E. The translational potential of research on the ethical, legal, and social implications of genomics. Genet Med 2015;17:12-20. [PMID: 24946153 DOI: 10.1038/gim.2014.74] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.4] [Reference Citation Analysis]
344 Committee on Genetics and the Society for Maternal-Fetal Medicine. Committee Opinion No.682: Microarrays and Next-Generation Sequencing Technology: The Use of Advanced Genetic Diagnostic Tools in Obstetrics and Gynecology. Obstet Gynecol 2016;128:e262-8. [PMID: 27875474 DOI: 10.1097/AOG.0000000000001817] [Cited by in Crossref: 116] [Cited by in F6Publishing: 38] [Article Influence: 23.2] [Reference Citation Analysis]
345 Allyse M, Minear MA, Berson E, Sridhar S, Rote M, Hung A, Chandrasekharan S. Non-invasive prenatal testing: a review of international implementation and challenges. Int J Womens Health 2015;7:113-26. [PMID: 25653560 DOI: 10.2147/IJWH.S67124] [Cited by in Crossref: 178] [Cited by in F6Publishing: 58] [Article Influence: 25.4] [Reference Citation Analysis]
346 Lillie N, Prows CA, McGowan ML, Blumling AA, Myers MF. Experiences of adolescents and their parents after receiving adolescents' genomic screening results. J Genet Couns 2021. [PMID: 34695272 DOI: 10.1002/jgc4.1528] [Reference Citation Analysis]
347 Baskovich B, Hiraki S, Oddoux C, Ostrer H, Upadhyay K. Response to Zlotogora and Meiner. Genet Med 2016;18:530. [PMID: 26656652 DOI: 10.1038/gim.2015.170] [Reference Citation Analysis]
348 Tan N, Amendola LM, O'Daniel JM, Burt A, Horike-Pyne MJ, Boshe L, Henderson GE, Rini C, Roche MI, Hisama FM, Burke W, Wilfond B, Jarvik GP. Is "incidental finding" the best term?: a study of patients' preferences. Genet Med 2017;19:176-81. [PMID: 27490114 DOI: 10.1038/gim.2016.96] [Cited by in Crossref: 29] [Cited by in F6Publishing: 24] [Article Influence: 4.8] [Reference Citation Analysis]
349 McLaughlin HM, Ceyhan-Birsoy O, Christensen KD, Kohane IS, Krier J, Lane WJ, Lautenbach D, Lebo MS, Machini K, MacRae CA, Azzariti DR, Murray MF, Seidman CE, Vassy JL, Green RC, Rehm HL; MedSeq Project. A systematic approach to the reporting of medically relevant findings from whole genome sequencing. BMC Med Genet 2014;15:134. [PMID: 25714468 DOI: 10.1186/s12881-014-0134-1] [Cited by in Crossref: 63] [Cited by in F6Publishing: 57] [Article Influence: 7.9] [Reference Citation Analysis]
350 Roberts JS, Dolinoy D, Tarini B. Emerging issues in public health genomics. Annu Rev Genomics Hum Genet 2014;15:461-80. [PMID: 25184533 DOI: 10.1146/annurev-genom-090413-025514] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 3.3] [Reference Citation Analysis]
351 McGowan ML, Prows CA, DeJonckheere M, Brinkman WB, Vaughn L, Myers MF. Adolescent and Parental Attitudes About Return of Genomic Research Results: Focus Group Findings Regarding Decisional Preferences. J Empir Res Hum Res Ethics 2018;13:371-82. [PMID: 29806518 DOI: 10.1177/1556264618776613] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 3.8] [Reference Citation Analysis]
352 Alford RL, Arnos KS, Fox M, Lin JW, Palmer CG, Pandya A, Rehm HL, Robin NH, Scott DA, Yoshinaga-Itano C; ACMG Working Group on Update of Genetics Evaluation Guidelines for the Etiologic Diagnosis of Congenital Hearing Loss., Professional Practice and Guidelines Committee. American College of Medical Genetics and Genomics guideline for the clinical evaluation and etiologic diagnosis of hearing loss. Genet Med 2014;16:347-55. [PMID: 24651602 DOI: 10.1038/gim.2014.2] [Cited by in Crossref: 125] [Cited by in F6Publishing: 91] [Article Influence: 15.6] [Reference Citation Analysis]
353 Landstrom AP, Dailey-Schwartz AL, Rosenfeld JA, Yang Y, McLean MJ, Miyake CY, Valdes SO, Fan Y, Allen HD, Penny DJ, Kim JJ. Interpreting Incidentally Identified Variants in Genes Associated With Catecholaminergic Polymorphic Ventricular Tachycardia in a Large Cohort of Clinical Whole-Exome Genetic Test Referrals. Circ Arrhythm Electrophysiol 2017;10:e004742. [PMID: 28404607 DOI: 10.1161/CIRCEP.116.004742] [Cited by in Crossref: 21] [Cited by in F6Publishing: 14] [Article Influence: 4.2] [Reference Citation Analysis]
354 Lee K, Abraham RS. Next-generation sequencing for inborn errors of immunity. Hum Immunol 2021:S0198-8859(21)00061-6. [PMID: 33715910 DOI: 10.1016/j.humimm.2021.02.011] [Reference Citation Analysis]
355 Oberg JA, Glade Bender JL, Sulis ML, Pendrick D, Sireci AN, Hsiao SJ, Turk AT, Dela Cruz FS, Hibshoosh H, Remotti H, Zylber RJ, Pang J, Diolaiti D, Koval C, Andrews SJ, Garvin JH, Yamashiro DJ, Chung WK, Emerson SG, Nagy PL, Mansukhani MM, Kung AL. Implementation of next generation sequencing into pediatric hematology-oncology practice: moving beyond actionable alterations. Genome Med 2016;8:133. [PMID: 28007021 DOI: 10.1186/s13073-016-0389-6] [Cited by in Crossref: 81] [Cited by in F6Publishing: 77] [Article Influence: 13.5] [Reference Citation Analysis]
356 Evans BJ. Economic regulation of next-generation sequencing. J Law Med Ethics 2014;42 Suppl 1:51-66. [PMID: 25298291 DOI: 10.1111/jlme.12162] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.2] [Reference Citation Analysis]
357 Dal-Ré R, Katsanis N, Katsanis S, Parker LS, Ayuso C. Managing incidental genomic findings in clinical trials: fulfillment of the principle of justice. PLoS Med 2014;11:e1001584. [PMID: 24453945 DOI: 10.1371/journal.pmed.1001584] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 1.6] [Reference Citation Analysis]
358 Townsend A, Adam S, Birch PH, Friedman JM. Paternalism and the ACMG recommendations on genomic incidental findings: patients seen but not heard. Genet Med 2013;15:751-2. [DOI: 10.1038/gim.2013.105] [Cited by in Crossref: 40] [Cited by in F6Publishing: 32] [Article Influence: 4.4] [Reference Citation Analysis]
359 Rini C, Roche MI, Lin FC, Foreman AKM, Khan CM, Griesemer I, Waltz M, Lee K, O'Daniel JM, Evans JP, Berg JS, Henderson GE. Burden or benefit? Effects of providing education about and the option to request additional genomic findings from diagnostic exome sequencing: A randomized controlled trial. Patient Educ Couns 2021:S0738-3991(21)00291-3. [PMID: 33966955 DOI: 10.1016/j.pec.2021.04.026] [Reference Citation Analysis]
360 Wynn J. Genomic Testing: a Genetic Counselor's Personal Reflection on Three Years of Consenting and Testing. J Genet Couns 2016;25:691-7. [PMID: 26242468 DOI: 10.1007/s10897-015-9868-y] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 2.6] [Reference Citation Analysis]
361 Bennett NC, Farah CS. Next-generation sequencing in clinical oncology: next steps towards clinical validation. Cancers (Basel) 2014;6:2296-312. [PMID: 25412366 DOI: 10.3390/cancers6042296] [Cited by in Crossref: 37] [Cited by in F6Publishing: 34] [Article Influence: 4.6] [Reference Citation Analysis]
362 Regier DA, Peacock SJ, Pataky R, van der Hoek K, Jarvik GP, Hoch J, Veenstra D. Societal preferences for the return of incidental findings from clinical genomic sequencing: a discrete-choice experiment. CMAJ 2015;187:E190-7. [PMID: 25754703 DOI: 10.1503/cmaj.140697] [Cited by in Crossref: 63] [Cited by in F6Publishing: 51] [Article Influence: 9.0] [Reference Citation Analysis]
363 Shashi V, McConkie-Rosell A, Schoch K, Kasturi V, Rehder C, Jiang YH, Goldstein DB, McDonald MT. Practical considerations in the clinical application of whole-exome sequencing. Clin Genet 2016;89:173-81. [PMID: 25678066 DOI: 10.1111/cge.12569] [Cited by in Crossref: 42] [Cited by in F6Publishing: 32] [Article Influence: 6.0] [Reference Citation Analysis]
364 Xi Y, Chen G, Lei C, Wu J, Zhang S, Xiao M, Zhang W, Zhang Y, Sun X. Expanded carrier screening in Chinese patients seeking the help of assisted reproductive technology. Mol Genet Genomic Med 2020;8:e1340. [PMID: 32573981 DOI: 10.1002/mgg3.1340] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
365 Lebo MS, Baxter SM. New molecular genetic tests in the diagnosis of heart disease. Clin Lab Med 2014;34:137-56, vii-viii. [PMID: 24507793 DOI: 10.1016/j.cll.2013.11.011] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
366 Sommen M, Wuyts W, Van Camp G. Molecular diagnostics for hereditary hearing loss in children. Expert Rev Mol Diagn 2017;17:751-60. [PMID: 28593790 DOI: 10.1080/14737159.2017.1340834] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
367 Hayeems RZ, Boycott KM. Genome-wide sequencing technologies: A primer for paediatricians. Paediatr Child Health 2018;23:191-7. [PMID: 29769805 DOI: 10.1093/pch/pxx152] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.2] [Reference Citation Analysis]
368 Bredenoord AL, de Vries MC, van Delden H. The Right to an Open Future Concerning Genetic Information. The American Journal of Bioethics 2014;14:21-3. [DOI: 10.1080/15265161.2013.879952] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 1.9] [Reference Citation Analysis]
369 Warren-Gash C, Kroese M, Burton H, Pharoah P. Implications of using whole genome sequencing to test unselected populations for high risk breast cancer genes: a modelling study. Hered Cancer Clin Pract 2016;14:12. [PMID: 27252788 DOI: 10.1186/s13053-016-0052-7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
370 Robson ME, Bradbury AR, Arun B, Domchek SM, Ford JM, Hampel HL, Lipkin SM, Syngal S, Wollins DS, Lindor NM. American Society of Clinical Oncology Policy Statement Update: Genetic and Genomic Testing for Cancer Susceptibility. J Clin Oncol. 2015;33:3660-3667. [PMID: 26324357 DOI: 10.1200/jco.2015.63.0996] [Cited by in Crossref: 324] [Cited by in F6Publishing: 141] [Article Influence: 46.3] [Reference Citation Analysis]
371 Shen T, Lee A, Shen C, Lin CJ. The long tail and rare disease research: the impact of next-generation sequencing for rare Mendelian disorders. Genet Res (Camb) 2015;97:e15. [PMID: 26365496 DOI: 10.1017/S0016672315000166] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 1.9] [Reference Citation Analysis]
372 Lekstutiene J, Holm S, Gefenas E. Biobanks and Individual Health Related Findings: from an Obstacle to an Incentive. Sci Eng Ethics 2021;27:55. [PMID: 34379215 DOI: 10.1007/s11948-021-00330-9] [Reference Citation Analysis]
373 Hershberger RE, Givertz MM, Ho CY, Judge DP, Kantor PF, McBride KL, Morales A, Taylor MRG, Vatta M, Ware SM. Genetic Evaluation of Cardiomyopathy-A Heart Failure Society of America Practice Guideline. J Card Fail. 2018;24:281-302. [PMID: 29567486 DOI: 10.1016/j.cardfail.2018.03.004] [Cited by in Crossref: 137] [Cited by in F6Publishing: 101] [Article Influence: 34.3] [Reference Citation Analysis]
374 Maggi E, Patterson NE, Montagna C. Technological advances in precision medicine and drug development. Expert Rev Precis Med Drug Dev 2016;1:331-43. [PMID: 27622214 DOI: 10.1080/23808993.2016.1176527] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
375 Pezeshkpoor B, Oldenburg J, Pavlova A. Experiences in Routine Genetic Analysis of Hereditary Hemorrhagic, Thrombotic, and Platelet Disorders. Hamostaseologie 2022. [PMID: 35226963 DOI: 10.1055/a-1726-4793] [Reference Citation Analysis]
376 Burns C, James C, Ingles J. Communication of genetic information to families with inherited rhythm disorders. Heart Rhythm 2018;15:780-6. [PMID: 29175646 DOI: 10.1016/j.hrthm.2017.11.024] [Cited by in Crossref: 21] [Cited by in F6Publishing: 17] [Article Influence: 4.2] [Reference Citation Analysis]
377 Bombard Y, King Wong E, Lemmens T. Insurance and Genetic Information. In: John Wiley & Sons Ltd, editor. eLS. Chichester: John Wiley & Sons, Ltd; 2001. pp. 1-9. [DOI: 10.1002/9780470015902.a0005203.pub3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
378 Ameratunga R, Lehnert K, Woon ST. All Patients With Common Variable Immunodeficiency Disorders (CVID) Should Be Routinely Offered Diagnostic Genetic Testing. Front Immunol 2019;10:2678. [PMID: 31824486 DOI: 10.3389/fimmu.2019.02678] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 2.3] [Reference Citation Analysis]
379 Gambin T, Jhangiani SN, Below JE, Campbell IM, Wiszniewski W, Muzny DM, Staples J, Morrison AC, Bainbridge MN, Penney S, McGuire AL, Gibbs RA, Lupski JR, Boerwinkle E. Secondary findings and carrier test frequencies in a large multiethnic sample. Genome Med 2015;7:54. [PMID: 26195989 DOI: 10.1186/s13073-015-0171-1] [Cited by in Crossref: 43] [Cited by in F6Publishing: 35] [Article Influence: 6.1] [Reference Citation Analysis]
380 Vears DF, Sénécal K, Borry P. Reporting practices for unsolicited and secondary findings from next-generation sequencing technologies: Perspectives of laboratory personnel. Hum Mutat 2017;38:905-11. [PMID: 28512758 DOI: 10.1002/humu.23259] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 4.6] [Reference Citation Analysis]
381 Yang Y, Muzny DM, Reid JG, Bainbridge MN, Willis A, Ward PA, Braxton A, Beuten J, Xia F, Niu Z, Hardison M, Person R, Bekheirnia MR, Leduc MS, Kirby A, Pham P, Scull J, Wang M, Ding Y, Plon SE, Lupski JR, Beaudet AL, Gibbs RA, Eng CM. Clinical whole-exome sequencing for the diagnosis of mendelian disorders. N Engl J Med 2013;369:1502-11. [PMID: 24088041 DOI: 10.1056/NEJMoa1306555] [Cited by in Crossref: 1291] [Cited by in F6Publishing: 712] [Article Influence: 143.4] [Reference Citation Analysis]
382 Zawati MH, Parry D, Knoppers BM. The best interests of the child and the return of results in genetic research: international comparative perspectives. BMC Med Ethics 2014;15:72. [PMID: 25280986 DOI: 10.1186/1472-6939-15-72] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 2.1] [Reference Citation Analysis]
383 Schellevis RL, van Dijk EHC, Breukink MB, Keunen JEE, Santen GWE, Hoyng CB, de Jong EK, Boon CJF, den Hollander AI. Exome sequencing in families with chronic central serous chorioretinopathy. Mol Genet Genomic Med 2019;7:e00576. [PMID: 30724488 DOI: 10.1002/mgg3.576] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
384 Bylstra Y, Davila S, Lim WK, Wu R, Teo JX, Kam S, Lysaght T, Rozen S, Teh BT, Yeo KK, Cook SA, Tan P, Jamuar SS. Implementation of genomics in medical practice to deliver precision medicine for an Asian population. NPJ Genom Med 2019;4:12. [PMID: 31231544 DOI: 10.1038/s41525-019-0085-8] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 3.3] [Reference Citation Analysis]
385 Biesecker LG. Overcalling secondary findings. Genet Med 2016;18:416. [PMID: 26986879 DOI: 10.1038/gim.2016.19] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
386 Van Driest SL, Wells QS, Stallings S, Bush WS, Gordon A, Nickerson DA, Kim JH, Crosslin DR, Jarvik GP, Carrell DS, Ralston JD, Larson EB, Bielinski SJ, Olson JE, Ye Z, Kullo IJ, Abul-Husn NS, Scott SA, Bottinger E, Almoguera B, Connolly J, Chiavacci R, Hakonarson H, Rasmussen-Torvik LJ, Pan V, Persell SD, Smith M, Chisholm RL, Kitchner TE, He MM, Brilliant MH, Wallace JR, Doheny KF, Shoemaker MB, Li R, Manolio TA, Callis TE, Macaya D, Williams MS, Carey D, Kapplinger JD, Ackerman MJ, Ritchie MD, Denny JC, Roden DM. Association of Arrhythmia-Related Genetic Variants With Phenotypes Documented in Electronic Medical Records. JAMA 2016;315:47-57. [PMID: 26746457 DOI: 10.1001/jama.2015.17701] [Cited by in Crossref: 118] [Cited by in F6Publishing: 106] [Article Influence: 19.7] [Reference Citation Analysis]
387 Jarvik GP, Amendola LM, Berg JS, Brothers K, Clayton EW, Chung W, Evans BJ, Evans JP, Fullerton SM, Gallego CJ, Garrison NA, Gray SW, Holm IA, Kullo IJ, Lehmann LS, McCarty C, Prows CA, Rehm HL, Sharp RR, Salama J, Sanderson S, Van Driest SL, Williams MS, Wolf SM, Wolf WA, Burke W; eMERGE Act-ROR Committee and CERC Committee., CSER Act-ROR Working Group. Return of genomic results to research participants: the floor, the ceiling, and the choices in between. Am J Hum Genet 2014;94:818-26. [PMID: 24814192 DOI: 10.1016/j.ajhg.2014.04.009] [Cited by in Crossref: 244] [Cited by in F6Publishing: 220] [Article Influence: 30.5] [Reference Citation Analysis]
388 Vassy JL, Lautenbach DM, McLaughlin HM, Kong SW, Christensen KD, Krier J, Kohane IS, Feuerman LZ, Blumenthal-Barby J, Roberts JS, Lehmann LS, Ho CY, Ubel PA, MacRae CA, Seidman CE, Murray MF, McGuire AL, Rehm HL, Green RC; MedSeq Project. The MedSeq Project: a randomized trial of integrating whole genome sequencing into clinical medicine. Trials 2014;15:85. [PMID: 24645908 DOI: 10.1186/1745-6215-15-85] [Cited by in Crossref: 98] [Cited by in F6Publishing: 90] [Article Influence: 12.3] [Reference Citation Analysis]
389 Lee K, Berg JS, Milko L, Crooks K, Lu M, Bizon C, Owen P, Wilhelmsen KC, Weck KE, Evans JP, Garg S. High Diagnostic Yield of Whole Exome Sequencing in Participants With Retinal Dystrophies in a Clinical Ophthalmology Setting. Am J Ophthalmol 2015;160:354-363.e9. [PMID: 25910913 DOI: 10.1016/j.ajo.2015.04.026] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 2.9] [Reference Citation Analysis]
390 Green RC, Goddard KAB, Jarvik GP, Amendola LM, Appelbaum PS, Berg JS, Bernhardt BA, Biesecker LG, Biswas S, Blout CL, Bowling KM, Brothers KB, Burke W, Caga-Anan CF, Chinnaiyan AM, Chung WK, Clayton EW, Cooper GM, East K, Evans JP, Fullerton SM, Garraway LA, Garrett JR, Gray SW, Henderson GE, Hindorff LA, Holm IA, Lewis MH, Hutter CM, Janne PA, Joffe S, Kaufman D, Knoppers BM, Koenig BA, Krantz ID, Manolio TA, McCullough L, McEwen J, McGuire A, Muzny D, Myers RM, Nickerson DA, Ou J, Parsons DW, Petersen GM, Plon SE, Rehm HL, Roberts JS, Robinson D, Salama JS, Scollon S, Sharp RR, Shirts B, Spinner NB, Tabor HK, Tarczy-Hornoch P, Veenstra DL, Wagle N, Weck K, Wilfond BS, Wilhelmsen K, Wolf SM, Wynn J, Yu JH; CSER Consortium. Clinical Sequencing Exploratory Research Consortium: Accelerating Evidence-Based Practice of Genomic Medicine. Am J Hum Genet 2016;98:1051-66. [PMID: 27181682 DOI: 10.1016/j.ajhg.2016.04.011] [Cited by in Crossref: 96] [Cited by in F6Publishing: 89] [Article Influence: 16.0] [Reference Citation Analysis]
391 Candelaria GDTP, Antunes ADA, Pastorino AC, Dorna MDB, Zanardo EA, Dias AT, Sugayama SMM, Odone-filho V, Kulikowski LD, Garanito MP. Novel FERMT3 and PTPRQ Mutations Associated with Leukocyte Adhesion Deficiency-III and Sensorineural Hearing Loss. J Pediatr Genet. [DOI: 10.1055/s-0041-1733948] [Reference Citation Analysis]
392 Strom SP. Current practices and guidelines for clinical next-generation sequencing oncology testing. Cancer Biol Med 2016;13:3-11. [PMID: 27144058 DOI: 10.28092/j.issn.2095-3941.2016.0004] [Cited by in F6Publishing: 28] [Reference Citation Analysis]
393 Priest JR, Ceresnak SR, Dewey FE, Malloy-Walton LE, Dunn K, Grove ME, Perez MV, Maeda K, Dubin AM, Ashley EA. Molecular diagnosis of long QT syndrome at 10 days of life by rapid whole genome sequencing. Heart Rhythm 2014;11:1707-13. [PMID: 24973560 DOI: 10.1016/j.hrthm.2014.06.030] [Cited by in Crossref: 36] [Cited by in F6Publishing: 26] [Article Influence: 4.5] [Reference Citation Analysis]
394 Wolf SM, Annas GJ, Elias S. Point-counterpoint. Patient autonomy and incidental findings in clinical genomics. Science 2013;340:1049-50. [PMID: 23686341 DOI: 10.1126/science.1239119] [Cited by in Crossref: 178] [Cited by in F6Publishing: 143] [Article Influence: 19.8] [Reference Citation Analysis]
395 Ball MP, Bobe JR, Chou MF, Clegg T, Estep PW, Lunshof JE, Vandewege W, Zaranek A, Church GM. Harvard Personal Genome Project: lessons from participatory public research. Genome Med 2014;6:10. [PMID: 24713084 DOI: 10.1186/gm527] [Cited by in Crossref: 59] [Cited by in F6Publishing: 44] [Article Influence: 7.4] [Reference Citation Analysis]
396 Tack V, Dufraing K, Deans ZC, van Krieken HJ, Dequeker EMC. The ins and outs of molecular pathology reporting. Virchows Arch 2017;471:199-207. [PMID: 28343306 DOI: 10.1007/s00428-017-2108-0] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.4] [Reference Citation Analysis]
397 Van Ness B. Applications and limitations in translating genomics to clinical practice. Transl Res 2016;168:1-5. [PMID: 26001594 DOI: 10.1016/j.trsl.2015.04.012] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 0.9] [Reference Citation Analysis]
398 Wang J, Liao J, Zhang J, Cheng WY, Hakenberg J, Ma M, Webb BD, Ramasamudram-Chakravarthi R, Karger L, Mehta L, Kornreich R, Diaz GA, Li S, Edelmann L, Chen R. ClinLabGeneticist: a tool for clinical management of genetic variants from whole exome sequencing in clinical genetic laboratories. Genome Med 2015;7:77. [PMID: 26338694 DOI: 10.1186/s13073-015-0207-6] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
399 Matsui K, Yamamoto K, Tashiro S, Ibuki T. A systematic approach to the disclosure of genomic findings in clinical practice and research: a proposed framework with colored matrix and decision-making pathways. BMC Med Ethics 2021;22:168. [PMID: 34953504 DOI: 10.1186/s12910-021-00738-9] [Reference Citation Analysis]
400 Murray MF, Giovanni MA, Doyle DL, Harrison SM, Lyon E, Manickam K, Monaghan KG, Rasmussen SA, Scheuner MT, Palomaki GE, Watson MS; ACMG Board of Directors. DNA-based screening and population health: a points to consider statement for programs and sponsoring organizations from the American College of Medical Genetics and Genomics (ACMG). Genet Med 2021;23:989-95. [PMID: 33727704 DOI: 10.1038/s41436-020-01082-w] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Article Influence: 6.0] [Reference Citation Analysis]
401 Lázaro-Muñoz G, Farrell MS, Crowley JJ, Filmyer DM, Shaughnessy RA, Josiassen RC, Sullivan PF. Improved ethical guidance for the return of results from psychiatric genomics research. Mol Psychiatry 2018;23:15-23. [PMID: 29158581 DOI: 10.1038/mp.2017.228] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 4.4] [Reference Citation Analysis]
402 Char DS, Cho M, Magnus D. Whole genome sequencing in critically ill children. Lancet Respir Med 2015;3:264-6. [PMID: 25704991 DOI: 10.1016/S2213-2600(15)00006-5] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.9] [Reference Citation Analysis]
403 Nestor JG, Groopman EE, Gharavi AG. Towards precision nephrology: the opportunities and challenges of genomic medicine. J Nephrol 2018;31:47-60. [PMID: 29043570 DOI: 10.1007/s40620-017-0448-0] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
404 Narayanan S, Blumberg B, Clayman ML, Pan V, Wicklund C. Exploring the Issues Surrounding Clinical Exome Sequencing in the Prenatal Setting. J Genet Counsel 2018;27:1228-37. [DOI: 10.1007/s10897-018-0245-5] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 2.8] [Reference Citation Analysis]
405 Lenardo M, Lo B, Lucas CL. Genomics of Immune Diseases and New Therapies. Annu Rev Immunol 2016;34:121-49. [PMID: 26735698 DOI: 10.1146/annurev-immunol-041015-055620] [Cited by in Crossref: 32] [Cited by in F6Publishing: 25] [Article Influence: 4.6] [Reference Citation Analysis]
406 Wienholtz NKF, Christensen CE, Haugaard JH, Zhang DG, Ashina M, Thyssen JP, Egeberg A. Cohort profile: COpenhagen ROsacea COhort (COROCO) and COpenhagen MIgraine COhort (COMICO). BMJ Open 2020;10:e039445. [PMID: 32819957 DOI: 10.1136/bmjopen-2020-039445] [Reference Citation Analysis]
407 Stenson PD, Mort M, Ball EV, Shaw K, Phillips A, Cooper DN. The Human Gene Mutation Database: building a comprehensive mutation repository for clinical and molecular genetics, diagnostic testing and personalized genomic medicine. Hum Genet. 2014;133:1-9. [PMID: 24077912 DOI: 10.1007/s00439-013-1358-4] [Cited by in Crossref: 872] [Cited by in F6Publishing: 779] [Article Influence: 109.0] [Reference Citation Analysis]
408 Middleton A, Morley KI, Bragin E, Firth HV, Hurles ME, Wright CF, Parker M; Deciphering Developmental Disorders Study. No expectation to share incidental findings in genomic research. Lancet 2015;385:1289-90. [PMID: 25529584 DOI: 10.1016/S0140-6736(14)62119-X] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 1.6] [Reference Citation Analysis]
409 Birkeland AC, Uhlmann WR, Brenner JC, Shuman AG. Getting personal: Head and neck cancer management in the era of genomic medicine. Head Neck 2016;38 Suppl 1:E2250-8. [PMID: 25995036 DOI: 10.1002/hed.24132] [Cited by in Crossref: 6] [Cited by in F6Publishing: 12] [Article Influence: 0.9] [Reference Citation Analysis]
410 Hylind R, Smith M, Rasmussen-Torvik L, Aufox S. Great expectations: patient perspectives and anticipated utility of non-diagnostic genomic-sequencing results. J Community Genet 2018;9:19-26. [PMID: 28656483 DOI: 10.1007/s12687-017-0314-8] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.2] [Reference Citation Analysis]
411 Hufnagel SB, Martin LJ, Cassedy A, Hopkin RJ, Antommaria AH. Adolescents' preferences regarding disclosure of incidental findings in genomic sequencing that are not medically actionable in childhood. Am J Med Genet A 2016;170:2083-8. [PMID: 27149544 DOI: 10.1002/ajmg.a.37730] [Cited by in Crossref: 21] [Cited by in F6Publishing: 16] [Article Influence: 3.5] [Reference Citation Analysis]
412 Mori T, Hosomichi K, Chiga M, Mandai S, Nakaoka H, Sohara E, Okado T, Rai T, Sasaki S, Inoue I, Uchida S. Comprehensive genetic testing approach for major inherited kidney diseases, using next-generation sequencing with a custom panel. Clin Exp Nephrol 2017;21:63-75. [PMID: 26920127 DOI: 10.1007/s10157-016-1252-1] [Cited by in Crossref: 28] [Cited by in F6Publishing: 25] [Article Influence: 4.7] [Reference Citation Analysis]
413 Christensen KD, Phillips KA, Green RC, Dukhovny D. Cost Analyses of Genomic Sequencing: Lessons Learned from the MedSeq Project. Value Health 2018;21:1054-61. [PMID: 30224109 DOI: 10.1016/j.jval.2018.06.013] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
414 Dahary D, Golan Y, Mazor Y, Zelig O, Barshir R, Twik M, Iny Stein T, Rosner G, Kariv R, Chen F, Zhang Q, Shen Y, Safran M, Lancet D, Fishilevich S. Genome analysis and knowledge-driven variant interpretation with TGex. BMC Med Genomics 2019;12:200. [PMID: 31888639 DOI: 10.1186/s12920-019-0647-8] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
415 Deininger KM, Page RL 2nd, Lee YM, Kauffman YS, Johnson SG, Oreschak K, Aquilante CL. Non-interventional cardiologists' perspectives on the role of pharmacogenomic testing in cardiovascular medicine. Per Med 2019;16:123-32. [PMID: 30543145 DOI: 10.2217/pme-2018-0099] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
416 Egalite N, Groisman IJ, Godard B. Genetic Counseling Practice in Next Generation Sequencing Research: Implications for the Ethical Oversight of the Informed Consent Process. J Genet Counsel 2014;23:661-70. [DOI: 10.1007/s10897-014-9703-x] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 2.0] [Reference Citation Analysis]
417 Machini K, Douglas J, Braxton A, Tsipis J, Kramer K. Genetic counselors' views and experiences with the clinical integration of genome sequencing. J Genet Couns 2014;23:496-505. [PMID: 24671342 DOI: 10.1007/s10897-014-9709-4] [Cited by in Crossref: 37] [Cited by in F6Publishing: 32] [Article Influence: 4.6] [Reference Citation Analysis]
418 Roche MI, Palmer CG. Next generation genetic counseling: introduction to the special issue. J Genet Couns 2014;23:439-44. [PMID: 24838698 DOI: 10.1007/s10897-014-9729-0] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
419 Plöthner M, Frank M, Graf von der Schulenburg JM. [Whole-genome sequencing in German clinical practice : Economic impacts of its use in selected areas of application]. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 2017;60:143-50. [PMID: 27999872 DOI: 10.1007/s00103-016-2492-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
420 Manase D, D'Alessandro LC, Manickaraj AK, Al Turki S, Hurles ME, Mital S. High throughput exome coverage of clinically relevant cardiac genes. BMC Med Genomics 2014;7:67. [PMID: 25496018 DOI: 10.1186/s12920-014-0067-8] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
421 AlFayyad I, Al-Tannir M, Abu-Shaheen A, AlGhamdi S. To disclose, or not to disclose? Perspectives of clinical genomics professionals toward returning incidental findings from genomic research. BMC Med Ethics 2021;22:101. [PMID: 34315465 DOI: 10.1186/s12910-021-00670-y] [Reference Citation Analysis]
422 Au L. Recent scientific/intellectual movements in biomedicine. Soc Sci Med 2021;278:113950. [PMID: 33910065 DOI: 10.1016/j.socscimed.2021.113950] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
423 Morgan TM. Genomic Screening: The Mutation and the Mustard Seed. J Law Med Ethics 2018;46:541-6. [PMID: 30146977 DOI: 10.1177/1073110518782963] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
424 Mogensen J, van Tintelen JP, Fokstuen S, Elliott P, van Langen IM, Meder B, Richard P, Syrris P, Caforio AL, Adler Y, Anastasakis A, Gimeno JR, Klingel K, Linhart A, Imazio M, Pinto Y, Newbery R, Schmidtke J, Charron P. The current role of next-generation DNA sequencing in routine care of patients with hereditary cardiovascular conditions: a viewpoint paper of the European Society of Cardiology working group on myocardial and pericardial diseases and members of the European Society of Human Genetics. Eur Heart J 2015;36:1367-70. [PMID: 25845928 DOI: 10.1093/eurheartj/ehv122] [Cited by in Crossref: 56] [Cited by in F6Publishing: 39] [Article Influence: 8.0] [Reference Citation Analysis]
425 Shieh JT. Implications of genetic testing in noncompaction/hypertrabeculation. Am J Med Genet C Semin Med Genet 2013;163C:206-11. [PMID: 23843345 DOI: 10.1002/ajmg.c.31371] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
426 Hodgson J, Metcalfe S, Gaff C, Donath S, Delatycki MB, Winship I, Skene L, Aitken M, Halliday J. Outcomes of a randomised controlled trial of a complex genetic counselling intervention to improve family communication. Eur J Hum Genet 2016;24:356-60. [PMID: 26130486 DOI: 10.1038/ejhg.2015.122] [Cited by in Crossref: 40] [Cited by in F6Publishing: 36] [Article Influence: 5.7] [Reference Citation Analysis]
427 Ormondroyd E, Mackley MP, Blair E, Craft J, Knight JC, Taylor J, Taylor JC, Wilkie AO, Watkins H. Insights from early experience of a Rare Disease Genomic Medicine Multidisciplinary Team: a qualitative study. Eur J Hum Genet 2017;25:680-6. [PMID: 28327571 DOI: 10.1038/ejhg.2017.37] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 3.0] [Reference Citation Analysis]
428 Remec ZI, Trebusak Podkrajsek K, Repic Lampret B, Kovac J, Groselj U, Tesovnik T, Battelino T, Debeljak M. Next-Generation Sequencing in Newborn Screening: A Review of Current State. Front Genet 2021;12:662254. [PMID: 34122514 DOI: 10.3389/fgene.2021.662254] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
429 McVeigh E, Jones H, Black G, Hall G. The psychosocial and service delivery impact of genomic testing for inherited retinal dystrophies. J Community Genet 2019;10:425-34. [PMID: 30680631 DOI: 10.1007/s12687-019-00406-x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
430 Bijlsma RM, Bredenoord AL, Gadellaa-Hooijdonk CG, Lolkema MP, Sleijfer S, Voest EE, Ausems MG, Steeghs N. Unsolicited findings of next-generation sequencing for tumor analysis within a Dutch consortium: clinical daily practice reconsidered. Eur J Hum Genet 2016;24:1496-500. [PMID: 27071717 DOI: 10.1038/ejhg.2016.27] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 3.0] [Reference Citation Analysis]
431 Yates CL, Monaghan KG, Copenheaver D, Retterer K, Scuffins J, Kucera CR, Friedman B, Richard G, Juusola J. Whole-exome sequencing on deceased fetuses with ultrasound anomalies: expanding our knowledge of genetic disease during fetal development. Genet Med. 2017;19:1171-1178. [PMID: 28425981 DOI: 10.1038/gim.2017.31] [Cited by in Crossref: 65] [Cited by in F6Publishing: 56] [Article Influence: 13.0] [Reference Citation Analysis]
432 Gollob MH, Hershberger RE, Gordon AS, Harrison SM, Lee K, Martin CL, Miller DT; ACMG Secondary Findings Working Group. Response to McGurk et al. Genet Med 2021:S1098-3600(21)05373-9. [PMID: 34906521 DOI: 10.1016/j.gim.2021.10.021] [Reference Citation Analysis]
433 Lewis KL, Facio FM, Berrios CD. Using the diffusion of innovations model to guide participant engagement in the genomics era. J Genet Couns 2019;28:419-27. [PMID: 30653790 DOI: 10.1002/jgc4.1090] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
434 Sankaran VG, Gallagher PG. Applications of high-throughput DNA sequencing to benign hematology. Blood 2013;122:3575-82. [PMID: 24021670 DOI: 10.1182/blood-2013-07-460337] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 1.8] [Reference Citation Analysis]
435 Cuglievan B, Subbiah V, Wang H, Morani A, Meric-Bernstam F, Holla V, Herzog CE. Response to Mammalian Target of Rapamycin-Based Therapy and Incidental Finding of Lynch Syndrome in a Patient With Solid Pseudopapillary Neoplasm of the Pancreas With AKT1_E17K Mutation. JCO Precis Oncol 2018;2. [PMID: 31650099 DOI: 10.1200/PO.18.00182] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
436 Benton MC, Smith RA, Haupt LM, Sutherland HG, Dunn PJ, Albury CL, Maksemous N, Lea R, Griffiths L. Variant Call Format-Diagnostic Annotation and Reporting Tool: A Customizable Analysis Pipeline for Identification of Clinically Relevant Genetic Variants in Next-Generation Sequencing Data. J Mol Diagn 2019;21:951-60. [PMID: 31442673 DOI: 10.1016/j.jmoldx.2019.07.001] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
437 Bombard Y, Miller FA, Hayeems RZ, Barg C, Cressman C, Carroll JC, Wilson BJ, Little J, Avard D, Painter-Main M, Allanson J, Giguere Y, Chakraborty P. Public views on participating in newborn screening using genome sequencing. Eur J Hum Genet 2014;22:1248-54. [PMID: 24549052 DOI: 10.1038/ejhg.2014.22] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 2.0] [Reference Citation Analysis]
438 Horn R, Parker M. Opening Pandora's box?: ethical issues in prenatal whole genome and exome sequencing. Prenat Diagn 2018;38:20-5. [PMID: 28695688 DOI: 10.1002/pd.5114] [Cited by in Crossref: 48] [Cited by in F6Publishing: 45] [Article Influence: 9.6] [Reference Citation Analysis]
439 Richmond PA, Av-Shalom TV, Fornes O, Modi B, Elliott AM, Wasserman WW. GeneBreaker: Variant simulation to improve the diagnosis of Mendelian rare genetic diseases. Hum Mutat 2021;42:346-58. [PMID: 33368787 DOI: 10.1002/humu.24163] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
440 Sajan SA, Ganesh J, Shinde DN, Powis Z, Scarano MI, Stone J, Winter S, Tang S. Biallelic disruption of PKDCC is associated with a skeletal disorder characterised by rhizomelic shortening of extremities and dysmorphic features. J Med Genet 2019;56:850-4. [PMID: 30478137 DOI: 10.1136/jmedgenet-2018-105639] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
441 Zhu X, Yang M, Zhao P, Li S, Zhang L, Huang L, Huang Y, Fei P, Yang Y, Zhang S, Xu H, Yuan Y, Zhang X, Zhu X, Ma S, Hao F, Sundaresan P, Zhu W, Yang Z. Catenin α 1 mutations cause familial exudative vitreoretinopathy by overactivating Norrin/β-catenin signaling. J Clin Invest 2021;131:139869. [PMID: 33497368 DOI: 10.1172/JCI139869] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
442 Sajan SA, Powis Z, Helbig KL, Nagakura H, Immken L, Tang S, Alcaraz WA. Diagnostic exome sequencing identifies GLI2 haploinsufficiency and chromosome 20 uniparental disomy in a patient with developmental anomalies. Clin Case Rep 2018;6:1208-13. [PMID: 29988648 DOI: 10.1002/ccr3.1575] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
443 Thiffault I, Farrow E, Zellmer L, Berrios C, Miller N, Gibson M, Caylor R, Jenkins J, Faller D, Soden S, Saunders C. Clinical genome sequencing in an unbiased pediatric cohort. Genet Med 2019;21:303-10. [PMID: 30008475 DOI: 10.1038/s41436-018-0075-8] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 5.0] [Reference Citation Analysis]
444 Srivastava S, Cohen JS, Vernon H, Barañano K, McClellan R, Jamal L, Naidu S, Fatemi A. Clinical whole exome sequencing in child neurology practice. Ann Neurol 2014;76:473-83. [PMID: 25131622 DOI: 10.1002/ana.24251] [Cited by in Crossref: 163] [Cited by in F6Publishing: 144] [Article Influence: 20.4] [Reference Citation Analysis]
445 Savatt JM, Myers SM. Genetic Testing in Neurodevelopmental Disorders. Front Pediatr 2021;9:526779. [PMID: 33681094 DOI: 10.3389/fped.2021.526779] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 9.0] [Reference Citation Analysis]
446 Bush L. In the Best Interest of the Child: Psychological and Ethical Reflections on Traditions, Contexts, and Perspectives in Pediatric Clinical Genomics. The American Journal of Bioethics 2014;14:16-8. [DOI: 10.1080/15265161.2013.879962] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
447 Cragun D, Kinney AY, Pal T. Care delivery considerations for widespread and equitable implementation of inherited cancer predisposition testing. Expert Rev Mol Diagn 2017;17:57-70. [PMID: 27910721 DOI: 10.1080/14737159.2017.1267567] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 2.2] [Reference Citation Analysis]
448 Tabor HK, Auer PL, Jamal SM, Chong JX, Yu JH, Gordon AS, Graubert TA, O'Donnell CJ, Rich SS, Nickerson DA, Bamshad MJ; NHLBI Exome Sequencing Project. Pathogenic variants for Mendelian and complex traits in exomes of 6,517 European and African Americans: implications for the return of incidental results. Am J Hum Genet 2014;95:183-93. [PMID: 25087612 DOI: 10.1016/j.ajhg.2014.07.006] [Cited by in Crossref: 63] [Cited by in F6Publishing: 57] [Article Influence: 7.9] [Reference Citation Analysis]
449 Kalia SS, Adelman K, Bale SJ, Chung WK, Eng C, Evans JP, Herman GE, Hufnagel SB, Klein TE, Korf BR, McKelvey KD, Ormond KE, Richards CS, Vlangos CN, Watson M, Martin CL, Miller DT. Recommendations for reporting of secondary findings in clinical exome and genome sequencing, 2016 update (ACMG SF v2.0): a policy statement of the American College of Medical Genetics and Genomics. Genet Med 2017;19:249-55. [PMID: 27854360 DOI: 10.1038/gim.2016.190] [Cited by in Crossref: 910] [Cited by in F6Publishing: 761] [Article Influence: 151.7] [Reference Citation Analysis]
450 Szego MJ, Meyn MS, Shuman C, Zlotnik Shaul R, Anderson JA, Bowdin S, Monfared N, Hayeems RZ. Views from the clinic: Healthcare provider perspectives on whole genome sequencing in paediatrics. Eur J Med Genet 2019;62:350-6. [PMID: 30503855 DOI: 10.1016/j.ejmg.2018.11.029] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
451 Maclachlan A, Watson SP, Morgan NV. Inherited platelet disorders: Insight from platelet genomics using next-generation sequencing. Platelets 2017;28:14-9. [PMID: 27348543 DOI: 10.1080/09537104.2016.1195492] [Cited by in Crossref: 24] [Cited by in F6Publishing: 19] [Article Influence: 4.0] [Reference Citation Analysis]
452 Biesecker LG. Incidental variants are critical for genomics. Am J Hum Genet 2013;92:648-51. [PMID: 23643378 DOI: 10.1016/j.ajhg.2013.04.001] [Cited by in Crossref: 32] [Cited by in F6Publishing: 27] [Article Influence: 3.6] [Reference Citation Analysis]
453 O'Rawe JA, Fang H, Rynearson S, Robison R, Kiruluta ES, Higgins G, Eilbeck K, Reese MG, Lyon GJ. Integrating precision medicine in the study and clinical treatment of a severely mentally ill person. PeerJ 2013;1:e177. [PMID: 24109560 DOI: 10.7717/peerj.177] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
454 Clift KE, Halverson CM, Fiksdal AS, Kumbamu A, Sharp RR, McCormick JB. Patients' views on incidental findings from clinical exome sequencing. Appl Transl Genom 2015;4:38-43. [PMID: 26937348 DOI: 10.1016/j.atg.2015.02.005] [Cited by in Crossref: 63] [Cited by in F6Publishing: 55] [Article Influence: 9.0] [Reference Citation Analysis]
455 Worthey EA. Analysis and Annotation of Whole-Genome or Whole-Exome Sequencing Derived Variants for Clinical Diagnosis. Curr Protoc Hum Genet 2017;95:9.24.1-9.24.28. [PMID: 29044471 DOI: 10.1002/cphg.49] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 1.4] [Reference Citation Analysis]
456 Shukralla A, Carton R, Benson KA, El Naggar H, Lacey A, Cavalleri G, Delanty N. Whole exome sequencing studies in epilepsy: A deep analysis of the published literature. Am J Med Genet A 2022. [PMID: 35088532 DOI: 10.1002/ajmg.a.62655] [Reference Citation Analysis]
457 Walsh R, Cook SA. Issues and Challenges in Diagnostic Sequencing for Inherited Cardiac Conditions. Clin Chem 2017;63:116-28. [PMID: 27879323 DOI: 10.1373/clinchem.2016.254698] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
458 Mor-Shaked H, Rips J, Gershon Naamat S, Reich A, Elpeleg O, Meiner V, Harel T. Parental exome analysis identifies shared carrier status for a second recessive disorder in couples with an affected child. Eur J Hum Genet 2021;29:455-62. [PMID: 33223529 DOI: 10.1038/s41431-020-00756-y] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
459 Zierhut HA, Campbell CA, Mitchell AG, Lemke AA, Mills R, Bishop JR. Collaborative Counseling Considerations for Pharmacogenomic Tests. Pharmacotherapy 2017;37:990-9. [DOI: 10.1002/phar.1980] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 3.2] [Reference Citation Analysis]
460 Meyts I, Bosch B, Bolze A, Boisson B, Itan Y, Belkadi A, Pedergnana V, Moens L, Picard C, Cobat A, Bossuyt X, Abel L, Casanova JL. Exome and genome sequencing for inborn errors of immunity. J Allergy Clin Immunol 2016;138:957-69. [PMID: 27720020 DOI: 10.1016/j.jaci.2016.08.003] [Cited by in Crossref: 105] [Cited by in F6Publishing: 96] [Article Influence: 21.0] [Reference Citation Analysis]
461 Chandler N, Best S, Hayward J, Faravelli F, Mansour S, Kivuva E, Tapon D, Male A, Devile C, Chitty LS. Rapid prenatal diagnosis using targeted exome sequencing: a cohort study to assess feasibility and potential impact on prenatal counseling and pregnancy management. Genet Med 2018;20:1430-7. [DOI: 10.1038/gim.2018.30] [Cited by in Crossref: 60] [Cited by in F6Publishing: 55] [Article Influence: 15.0] [Reference Citation Analysis]
462 Shelton CA, Whitcomb DC. Genetics and treatment options for recurrent acute and chronic pancreatitis. Curr Treat Options Gastroenterol 2014;12:359-71. [PMID: 24954874 DOI: 10.1007/s11938-014-0022-y] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 2.1] [Reference Citation Analysis]
463 Brownstein CA, Beggs AH, Homer N, Merriman B, Yu TW, Flannery KC, DeChene ET, Towne MC, Savage SK, Price EN, Holm IA, Luquette LJ, Lyon E, Majzoub J, Neupert P, McCallie D Jr, Szolovits P, Willard HF, Mendelsohn NJ, Temme R, Finkel RS, Yum SW, Medne L, Sunyaev SR, Adzhubey I, Cassa CA, de Bakker PI, Duzkale H, Dworzyński P, Fairbrother W, Francioli L, Funke BH, Giovanni MA, Handsaker RE, Lage K, Lebo MS, Lek M, Leshchiner I, MacArthur DG, McLaughlin HM, Murray MF, Pers TH, Polak PP, Raychaudhuri S, Rehm HL, Soemedi R, Stitziel NO, Vestecka S, Supper J, Gugenmus C, Klocke B, Hahn A, Schubach M, Menzel M, Biskup S, Freisinger P, Deng M, Braun M, Perner S, Smith RJ, Andorf JL, Huang J, Ryckman K, Sheffield VC, Stone EM, Bair T, Black-Ziegelbein EA, Braun TA, Darbro B, DeLuca AP, Kolbe DL, Scheetz TE, Shearer AE, Sompallae R, Wang K, Bassuk AG, Edens E, Mathews K, Moore SA, Shchelochkov OA, Trapane P, Bossler A, Campbell CA, Heusel JW, Kwitek A, Maga T, Panzer K, Wassink T, Van Daele D, Azaiez H, Booth K, Meyer N, Segal MM, Williams MS, Tromp G, White P, Corsmeier D, Fitzgerald-Butt S, Herman G, Lamb-Thrush D, McBride KL, Newsom D, Pierson CR, Rakowsky AT, Maver A, Lovrečić L, Palandačić A, Peterlin B, Torkamani A, Wedell A, Huss M, Alexeyenko A, Lindvall JM, Magnusson M, Nilsson D, Stranneheim H, Taylan F, Gilissen C, Hoischen A, van Bon B, Yntema H, Nelen M, Zhang W, Sager J, Zhang L, Blair K, Kural D, Cariaso M, Lennon GG, Javed A, Agrawal S, Ng PC, Sandhu KS, Krishna S, Veeramachaneni V, Isakov O, Halperin E, Friedman E, Shomron N, Glusman G, Roach JC, Caballero J, Cox HC, Mauldin D, Ament SA, Rowen L, Richards DR, San Lucas FA, Gonzalez-Garay ML, Caskey CT, Bai Y, Huang Y, Fang F, Zhang Y, Wang Z, Barrera J, Garcia-Lobo JM, González-Lamuño D, Llorca J, Rodriguez MC, Varela I, Reese MG, De La Vega FM, Kiruluta E, Cargill M, Hart RK, Sorenson JM, Lyon GJ, Stevenson DA, Bray BE, Moore BM, Eilbeck K, Yandell M, Zhao H, Hou L, Chen X, Yan X, Chen M, Li C, Yang C, Gunel M, Li P, Kong Y, Alexander AC, Albertyn ZI, Boycott KM, Bulman DE, Gordon PM, Innes AM, Knoppers BM, Majewski J, Marshall CR, Parboosingh JS, Sawyer SL, Samuels ME, Schwartzentruber J, Kohane IS, Margulies DM. An international effort towards developing standards for best practices in analysis, interpretation and reporting of clinical genome sequencing results in the CLARITY Challenge. Genome Biol 2014;15:R53. [PMID: 24667040 DOI: 10.1186/gb-2014-15-3-r53] [Cited by in Crossref: 80] [Cited by in F6Publishing: 65] [Article Influence: 10.0] [Reference Citation Analysis]
464 Kurian AW, Hare EE, Mills MA, Kingham KE, McPherson L, Whittemore AS, McGuire V, Ladabaum U, Kobayashi Y, Lincoln SE. Clinical evaluation of a multiple-gene sequencing panel for hereditary cancer risk assessment. J Clin Oncol. 2014;32:2001-2009. [PMID: 24733792 DOI: 10.1200/jco.2013.53.6607] [Cited by in Crossref: 322] [Cited by in F6Publishing: 171] [Article Influence: 40.3] [Reference Citation Analysis]
465 Lynch JA, Sharp RR, Aufox SA, Bland ST, Blout C, Bowen DJ, Buchanan AH, Halverson C, Harr M, Hebbring SJ, Henrikson N, Hoell C, Holm IA, Jarvik G, Kullo IJ, Kochan DC, Larson EB, Lazzeri A, Leppig KA, Madden J, Marasa M, Myers MF, Peterson J, Prows CA, Kulchak Rahm A, Ralston J, Milo Rasouly H, Scrol A, Smith ME, Sturm A, Stuttgen K, Wiesner G, Williams MS, Wynn J, Williams JL. Understanding the Return of Genomic Sequencing Results Process: Content Review of Participant Summary Letters in the eMERGE Research Network. J Pers Med 2020;10:E38. [PMID: 32413979 DOI: 10.3390/jpm10020038] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
466 Poste G, Compton CC, Barker AD. The national biomarker development alliance: confronting the poor productivity of biomarker research and development. Expert Rev Mol Diagn 2015;15:211-8. [PMID: 25420639 DOI: 10.1586/14737159.2015.974561] [Cited by in Crossref: 25] [Cited by in F6Publishing: 19] [Article Influence: 3.1] [Reference Citation Analysis]
467 Wohler E, Martin R, Griffith S, Rodrigues EDS, Antonescu C, Posey JE, Coban-Akdemir Z, Jhangiani SN, Doheny KF, Lupski JR, Valle D, Hamosh A, Sobreira N. PhenoDB, GeneMatcher and VariantMatcher, tools for analysis and sharing of sequence data. Orphanet J Rare Dis 2021;16:365. [PMID: 34407837 DOI: 10.1186/s13023-021-01916-z] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
468 Dyke SO, Dove ES, Knoppers BM. Sharing health-related data: a privacy test? NPJ Genom Med 2016;1:160241-6. [PMID: 27990299 DOI: 10.1038/npjgenmed.2016.24] [Cited by in Crossref: 28] [Cited by in F6Publishing: 21] [Article Influence: 4.7] [Reference Citation Analysis]
469 Muchada IF, Wilmshurst JM, Laing N, Haf Davies E, Fieggen K. A qualitative study exploring caregivers’ experiences, perspectives, and expectations for precision medicine in epilepsy in South Africa. Epilepsy & Behavior 2021;117:107873. [DOI: 10.1016/j.yebeh.2021.107873] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
470 Haga SB, Zhao JQ. Stakeholder views on returning research results. Adv Genet 2013;84:41-81. [PMID: 24262096 DOI: 10.1016/B978-0-12-407703-4.00002-5] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.4] [Reference Citation Analysis]
471 Ghazani AA, Oliver NM, St Pierre JP, Garofalo A, Rainville IR, Hiller E, Treacy DJ, Rojas-Rudilla V, Wood S, Bair E, Parello M, Huang F, Giannakis M, Wilson FH, Stover EH, Corsello SM, Nguyen T, Rana HQ, Church AJ, Lowenstein C, Cibulskis C, Amin-Mansour A, Heng J, Brais L, Santos A, Bauer P, Waldron A, Lo P, Gorman M, Lydon CA, Welch M, McNamara P, Gabriel S, Sholl LM, Lindeman NI, Garber JE, Joffe S, Van Allen EM, Gray SW, Ja Nne PA, Garraway LA, Wagle N. Assigning clinical meaning to somatic and germ-line whole-exome sequencing data in a prospective cancer precision medicine study. Genet Med 2017;19:787-95. [PMID: 28125075 DOI: 10.1038/gim.2016.191] [Cited by in Crossref: 27] [Cited by in F6Publishing: 26] [Article Influence: 5.4] [Reference Citation Analysis]
472 Tomlinson AN, Skinner D, Perry DL, Scollon SR, Roche MI, Bernhardt BA. "Not Tied Up Neatly with a Bow": Professionals' Challenging Cases in Informed Consent for Genomic Sequencing. J Genet Couns 2016;25:62-72. [PMID: 25911622 DOI: 10.1007/s10897-015-9842-8] [Cited by in Crossref: 36] [Cited by in F6Publishing: 33] [Article Influence: 5.1] [Reference Citation Analysis]
473 Murphy Bollinger J, Bridges JF, Mohamed A, Kaufman D. Public preferences for the return of research results in genetic research: a conjoint analysis. Genet Med 2014;16:932-9. [PMID: 24854226 DOI: 10.1038/gim.2014.50] [Cited by in Crossref: 32] [Cited by in F6Publishing: 31] [Article Influence: 4.0] [Reference Citation Analysis]
474 Xu D, Wang C, Khan A, Shang N, He Z, Gordon A, Kullo IJ, Murphy S, Ni Y, Wei WQ, Gharavi A, Kiryluk K, Weng C, Ionita-Laza I. Quantitative disease risk scores from EHR with applications to clinical risk stratification and genetic studies. NPJ Digit Med 2021;4:116. [PMID: 34302027 DOI: 10.1038/s41746-021-00488-3] [Reference Citation Analysis]
475 Krier JB, Kalia SS, Green RC. Genomic sequencing in clinical practice: applications, challenges, and opportunities. Dialogues Clin Neurosci 2016;18:299-312. [PMID: 27757064 [PMID: 27757064 DOI: 10.31887/dcns.2016.18.3/jkrier] [Cited by in Crossref: 33] [Article Influence: 6.6] [Reference Citation Analysis]
476 Levenson D. Patients and families generally welcome secondary genomic findings: support for return of incidental findings may encourage shift toward predictive genetic testing. Am J Med Genet A 2014;164A:ix-x. [PMID: 24449202 DOI: 10.1002/ajmg.a.36418] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
477 Stenson PD, Mort M, Ball EV, Evans K, Hayden M, Heywood S, Hussain M, Phillips AD, Cooper DN. The Human Gene Mutation Database: towards a comprehensive repository of inherited mutation data for medical research, genetic diagnosis and next-generation sequencing studies. Hum Genet 2017;136:665-77. [PMID: 28349240 DOI: 10.1007/s00439-017-1779-6] [Cited by in Crossref: 776] [Cited by in F6Publishing: 1] [Article Influence: 155.2] [Reference Citation Analysis]
478 Wellesley DG, Lucassen A. Prenatal diagnosis of chromosomal imbalances. Arch Dis Child Fetal Neonatal Ed 2014;99:F338-41. [PMID: 24792776 DOI: 10.1136/archdischild-2013-304835] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
479 Blackburn HL, Schroeder B, Turner C, Shriver CD, Ellsworth DL, Ellsworth RE. Management of Incidental Findings in the Era of Next-generation Sequencing. Curr Genomics 2015;16:159-74. [PMID: 26069456 DOI: 10.2174/1389202916666150317232930] [Cited by in Crossref: 33] [Cited by in F6Publishing: 25] [Article Influence: 4.7] [Reference Citation Analysis]
480 Wu Y, Yu H, Zheng SL, Feng B, Kapron AL, Na R, Boyle JL, Shah S, Shi Z, Ewing CM, Wiley KE, Luo J, Walsh PC, Carter HB, Helfand BT, Cooney KA, Xu J, Isaacs WB. Germline mutations in PPFIBP2 are associated with lethal prostate cancer. Prostate 2018;78:1222-8. [PMID: 30043417 DOI: 10.1002/pros.23697] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
481 Vanderver A, Simons C, Helman G, Crawford J, Wolf NI, Bernard G, Pizzino A, Schmidt JL, Takanohashi A, Miller D, Khouzam A, Rajan V, Ramos E, Chowdhury S, Hambuch T, Ru K, Baillie GJ, Grimmond SM, Caldovic L, Devaney J, Bloom M, Evans SH, Murphy JLP, McNeill N, Fogel BL, Schiffmann R, van der Knaap MS, Taft RJ; Leukodystrophy Study Group. Whole exome sequencing in patients with white matter abnormalities. Ann Neurol 2016;79:1031-7. [PMID: 27159321 DOI: 10.1002/ana.24650] [Cited by in Crossref: 76] [Cited by in F6Publishing: 70] [Article Influence: 12.7] [Reference Citation Analysis]
482 Zhang J, Walsh MF, Wu G, Edmonson MN, Gruber TA, Easton J, Hedges D, Ma X, Zhou X, Yergeau DA, Wilkinson MR, Vadodaria B, Chen X, McGee RB, Hines-Dowell S, Nuccio R, Quinn E, Shurtleff SA, Rusch M, Patel A, Becksfort JB, Wang S, Weaver MS, Ding L, Mardis ER, Wilson RK, Gajjar A, Ellison DW, Pappo AS, Pui CH, Nichols KE, Downing JR. Germline Mutations in Predisposition Genes in Pediatric Cancer. N Engl J Med. 2015;373:2336-2346. [PMID: 26580448 DOI: 10.1056/nejmoa1508054] [Cited by in Crossref: 582] [Cited by in F6Publishing: 297] [Article Influence: 83.1] [Reference Citation Analysis]
483 Posey JE, Harel T, Liu P, Rosenfeld JA, James RA, Coban Akdemir ZH, Walkiewicz M, Bi W, Xiao R, Ding Y, Xia F, Beaudet AL, Muzny DM, Gibbs RA, Boerwinkle E, Eng CM, Sutton VR, Shaw CA, Plon SE, Yang Y, Lupski JR. Resolution of Disease Phenotypes Resulting from Multilocus Genomic Variation. N Engl J Med 2017;376:21-31. [PMID: 27959697 DOI: 10.1056/NEJMoa1516767] [Cited by in Crossref: 340] [Cited by in F6Publishing: 199] [Article Influence: 56.7] [Reference Citation Analysis]
484 Fogel BL, Satya-Murti S, Cohen BH. Clinical exome sequencing in neurologic disease. Neurol Clin Pract 2016;6:164-76. [PMID: 27104068 DOI: 10.1212/CPJ.0000000000000239] [Cited by in Crossref: 37] [Cited by in F6Publishing: 15] [Article Influence: 6.2] [Reference Citation Analysis]
485 Wells SA Jr, Asa SL, Dralle H, Elisei R, Evans DB, Gagel RF, Lee N, Machens A, Moley JF, Pacini F, Raue F, Frank-Raue K, Robinson B, Rosenthal MS, Santoro M, Schlumberger M, Shah M, Waguespack SG; American Thyroid Association Guidelines Task Force on Medullary Thyroid Carcinoma. Revised American Thyroid Association guidelines for the management of medullary thyroid carcinoma. Thyroid 2015;25:567-610. [PMID: 25810047 DOI: 10.1089/thy.2014.0335] [Cited by in Crossref: 1099] [Cited by in F6Publishing: 794] [Article Influence: 183.2] [Reference Citation Analysis]
486 Hazin R, Brothers KB, Malin BA, Koenig BA, Sanderson SC, Rothstein MA, Williams MS, Clayton EW, Kullo IJ. Ethical, legal, and social implications of incorporating genomic information into electronic health records. Genet Med 2013;15:810-6. [PMID: 24030434 DOI: 10.1038/gim.2013.117] [Cited by in Crossref: 63] [Cited by in F6Publishing: 52] [Article Influence: 7.0] [Reference Citation Analysis]
487 Boyd SD, Galli SJ, Schrijver I, Zehnder JL, Ashley EA, Merker JD. A Balanced Look at the Implications of Genomic (and Other "Omics") Testing for Disease Diagnosis and Clinical Care. Genes (Basel) 2014;5:748-66. [PMID: 25257203 DOI: 10.3390/genes5030748] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
488 Ginsburg G. Medical genomics: Gather and use genetic data in health care. Nature 2014;508:451-3. [PMID: 24765668 DOI: 10.1038/508451a] [Cited by in Crossref: 39] [Cited by in F6Publishing: 27] [Article Influence: 4.9] [Reference Citation Analysis]
489 Daniels M, Wathoo C, Brusco L, Lu KH, Shaw K, Dumbrava EEI, Arun B, Strong L, Litton JK, Eterovic K, Aytac U, Mendelsohn J, Mills GB, Chen K, Meric-Bernstam F. Active Disclosure of Secondary Germline Findings to Deceased Research Participants' Personal Representatives: Process and Outcomes. JCO Precis Oncol 2017;1. [PMID: 31552380 DOI: 10.1200/po.17.00074] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
490 Timmermans S, Stivers T. The social utility of clinical exome sequencing. Patient Educ Couns 2018;101:221-6. [PMID: 28869057 DOI: 10.1016/j.pec.2017.08.010] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
491 Bacon PL, Harris ED, Ziniel SI, Savage SK, Weitzman ER, Green RC, Huntington NL, Holm IA. The development of a preference-setting model for the return of individual genomic research results. J Empir Res Hum Res Ethics 2015;10:107-20. [PMID: 25742675 DOI: 10.1177/1556264615572092] [Cited by in Crossref: 19] [Cited by in F6Publishing: 14] [Article Influence: 2.7] [Reference Citation Analysis]
492 Char DS. How should whole-genome sequencing be implemented in children? A consideration of the current limitations. Personalized Medicine 2016;13:33-42. [DOI: 10.2217/pme.15.44] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
493 Haga SB, Moaddeb J. Comparison of delivery strategies for pharmacogenetic testing services. Pharmacogenet Genomics 2014;24:139-45. [PMID: 24384556 DOI: 10.1097/FPC.0000000000000028] [Cited by in Crossref: 32] [Cited by in F6Publishing: 20] [Article Influence: 4.0] [Reference Citation Analysis]
494 Kaul KL, Sabatini LM, Tsongalis GJ, Caliendo AM, Olsen RJ, Ashwood ER, Bale S, Benirschke R, Carlow D, Funke BH, Grody WW, Hayden RT, Hegde M, Lyon E, Murata K, Pessin M, Press RD, Thomson RB. The Case for Laboratory Developed Procedures: Quality and Positive Impact on Patient Care. Acad Pathol 2017;4:2374289517708309. [PMID: 28815200 DOI: 10.1177/2374289517708309] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 2.4] [Reference Citation Analysis]
495 Scherr CL, Aufox S, Ross AA, Ramesh S, Wicklund CA, Smith M. What People Want to Know About Their Genes: A Critical Review of the Literature on Large-Scale Genome Sequencing Studies. Healthcare (Basel) 2018;6:E96. [PMID: 30096823 DOI: 10.3390/healthcare6030096] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 2.5] [Reference Citation Analysis]
496 Morello-Frosch R, Varshavsky J, Liboiron M, Brown P, Brody JG. Communicating results in post-Belmont era biomonitoring studies: lessons from genetics and neuroimaging research. Environ Res 2015;136:363-72. [PMID: 25460657 DOI: 10.1016/j.envres.2014.10.001] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 2.4] [Reference Citation Analysis]
497 Kim J, Luo W, Wang M, Wegman-Ostrosky T, Frone MN, Johnston JJ, Nickerson ML, Rotunno M, Li SA, Achatz MI, Brodie SA, Dean M, de Andrade KC, Fortes FP, Gianferante M, Khincha P, McMaster ML, McReynolds LJ, Pemov A, Pinheiro M, Santiago KM, Alter BP, Caporaso NE, Gadalla SM, Goldin LR, Greene MH, Loud J, Yang XR, Freedman ND, Gapstur SM, Gaudet MM, Calista D, Ghiorzo P, Fargnoli MC, Nagore E, Peris K, Puig S, Landi MT, Hicks B, Zhu B, Liu J, Sampson JN, Chanock SJ, Mirabello LJ, Morton LM, Biesecker LG, Tucker MA, Savage SA, Goldstein AM, Stewart DR. Prevalence of pathogenic/likely pathogenic variants in the 24 cancer genes of the ACMG Secondary Findings v2.0 list in a large cancer cohort and ethnicity-matched controls. Genome Med 2018;10:99. [PMID: 30583724 DOI: 10.1186/s13073-018-0607-5] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
498 Kaiwar C, Mcallister TM, Lazaridis KN, Klee EW. Preemptive sequencing in the genomic medicine era. Expert Review of Precision Medicine and Drug Development 2017;2:91-8. [DOI: 10.1080/23808993.2017.1322898] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.6] [Reference Citation Analysis]
499 van der Ven AT, Connaughton DM, Ityel H, Mann N, Nakayama M, Chen J, Vivante A, Hwang DY, Schulz J, Braun DA, Schmidt JM, Schapiro D, Schneider R, Warejko JK, Daga A, Majmundar AJ, Tan W, Jobst-Schwan T, Hermle T, Widmeier E, Ashraf S, Amar A, Hoogstraaten CA, Hugo H, Kitzler TM, Kause F, Kolvenbach CM, Dai R, Spaneas L, Amann K, Stein DR, Baum MA, Somers MJG, Rodig NM, Ferguson MA, Traum AZ, Daouk GH, Bogdanović R, Stajić N, Soliman NA, Kari JA, El Desoky S, Fathy HM, Milosevic D, Al-Saffar M, Awad HS, Eid LA, Selvin A, Senguttuvan P, Sanna-Cherchi S, Rehm HL, MacArthur DG, Lek M, Laricchia KM, Wilson MW, Mane SM, Lifton RP, Lee RS, Bauer SB, Lu W, Reutter HM, Tasic V, Shril S, Hildebrandt F. Whole-Exome Sequencing Identifies Causative Mutations in Families with Congenital Anomalies of the Kidney and Urinary Tract. J Am Soc Nephrol 2018;29:2348-61. [PMID: 30143558 DOI: 10.1681/ASN.2017121265] [Cited by in Crossref: 64] [Cited by in F6Publishing: 37] [Article Influence: 16.0] [Reference Citation Analysis]
500 Nishikawa A, Mitsuhashi S, Miyata N, Nishino I. Targeted massively parallel sequencing and histological assessment of skeletal muscles for the molecular diagnosis of inherited muscle disorders. J Med Genet 2017;54:104-10. [DOI: 10.1136/jmedgenet-2016-104073] [Cited by in Crossref: 34] [Cited by in F6Publishing: 29] [Article Influence: 5.7] [Reference Citation Analysis]
501 Swaminathan R, Huang Y, Astbury C, Fitzgerald-Butt S, Miller K, Cole J, Bartlett C, Lin S. Clinical exome sequencing reports: current informatics practice and future opportunities. J Am Med Inform Assoc 2017;24:1184-91. [PMID: 28535206 DOI: 10.1093/jamia/ocx048] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
502 Mellis R, Chandler N, Chitty LS. Next-generation sequencing and the impact on prenatal diagnosis. Expert Rev Mol Diagn 2018;18:689-99. [PMID: 29962246 DOI: 10.1080/14737159.2018.1493924] [Cited by in Crossref: 18] [Cited by in F6Publishing: 13] [Article Influence: 4.5] [Reference Citation Analysis]
503 Loveday C, Josephs K, Chubb D, Gunning A, Izatt L, Tischkowitz M, Ellard S, Turnbull C. p.Val804Met, the Most Frequent Pathogenic Mutation in RET, Confers a Very Low Lifetime Risk of Medullary Thyroid Cancer. J Clin Endocrinol Metab 2018;103:4275-82. [PMID: 29590403 DOI: 10.1210/jc.2017-02529] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 5.3] [Reference Citation Analysis]
504 Dy GK, Nesline MK, Papanicolau-Sengos A, DePietro P, LeVea CM, Early A, Chen H, Grand'Maison A, Boland P, Ernstoff MS, Edge S, Akers S, Opyrchal M, Chatta G, Odunsi K, Pabla S, Conroy JM, Glenn ST, DeFedericis HT, Burgher B, Andreas J, Giamo V, Qin M, Wang Y, Kanehira K, Lenzo FL, Frederick P, Lele S, Galluzzi L, Kuvshinoff B, Morrison C. Treatment recommendations to cancer patients in the context of FDA guidance for next generation sequencing. BMC Med Inform Decis Mak 2019;19:14. [PMID: 30658646 DOI: 10.1186/s12911-019-0743-x] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 3.7] [Reference Citation Analysis]
505 Richardson AM, Moyer AM, Hasadsri L, Abraham RS. Diagnostic Tools for Inborn Errors of Human Immunity (Primary Immunodeficiencies and Immune Dysregulatory Diseases). Curr Allergy Asthma Rep 2018;18:19. [PMID: 29470720 DOI: 10.1007/s11882-018-0770-1] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 2.3] [Reference Citation Analysis]
506 Liu J, Tong L, Song S, Niu Y, Li J, Wu X, Zhang J, Zai CC, Luo F, Wu J, Li H, Wong AHC, Sun R, Liu F, Li B. Novel and de novo mutations in pediatric refractory epilepsy. Mol Brain 2018;11:48. [PMID: 30185235 DOI: 10.1186/s13041-018-0392-5] [Cited by in Crossref: 25] [Cited by in F6Publishing: 21] [Article Influence: 6.3] [Reference Citation Analysis]
507 Hall MJ, Ruth KJ, Chen DY, Gross LM, Giri VN. Interest in genomic SNP testing for prostate cancer risk: a pilot survey. Hered Cancer Clin Pract 2015;13:11. [PMID: 25874018 DOI: 10.1186/s13053-015-0032-3] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
508 Celestino-Soper PB, Gao H, Lynnes TC, Lin H, Liu Y, Spoonamore KG, Chen PS, Vatta M. Validation and Utilization of a Clinical Next-Generation Sequencing Panel for Selected Cardiovascular Disorders. Front Cardiovasc Med 2017;4:11. [PMID: 28361054 DOI: 10.3389/fcvm.2017.00011] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
509 Rashkin MD, Bowes J, Dunaway K, Dhaliwal J, Loomis E, Riffle S, Washington NL, Ziegler C, Lu J, Levin E. Genetic counseling, 2030: An on-demand service tailored to the needs of a price conscious, genetically literate, and busy world. J Genet Couns 2019;28:456-65. [PMID: 30964579 DOI: 10.1002/jgc4.1123] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 3.5] [Reference Citation Analysis]
510 Rosenbaum JN, Berry AB, Church AJ, Crooks K, Gagan JR, López-Terrada D, Pfeifer JD, Rennert H, Schrijver I, Snow AN, Wu D, Ewalt MD. A Curriculum for Genomic Education of Molecular Genetic Pathology Fellows: A Report of the Association for Molecular Pathology Training and Education Committee. J Mol Diagn 2021:S1525-1578(21)00201-4. [PMID: 34245921 DOI: 10.1016/j.jmoldx.2021.07.001] [Reference Citation Analysis]
511 Kitamura Y, Kondo E, Urano M, Aoki R, Saito K. Target resequencing of neuromuscular disease-related genes using next-generation sequencing for patients with undiagnosed early-onset neuromuscular disorders. J Hum Genet 2016;61:931-42. [PMID: 27357428 DOI: 10.1038/jhg.2016.79] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 2.2] [Reference Citation Analysis]
512 Bick D, Jones M, Taylor SL, Taft RJ, Belmont J. Case for genome sequencing in infants and children with rare, undiagnosed or genetic diseases. J Med Genet 2019;56:783-91. [PMID: 31023718 DOI: 10.1136/jmedgenet-2019-106111] [Cited by in Crossref: 29] [Cited by in F6Publishing: 26] [Article Influence: 9.7] [Reference Citation Analysis]
513 Hallquist MLG, Tricou EP, Ormond KE, Savatt JM, Coughlin CR 2nd, Faucett WA, Hercher L, Levy HP, O'Daniel JM, Peay HL, Stosic M, Smith M, Uhlmann WR, Wand H, Wain KE, Buchanan AH. Application of a framework to guide genetic testing communication across clinical indications. Genome Med 2021;13:71. [PMID: 33926532 DOI: 10.1186/s13073-021-00887-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
514 Lefebvre M, Sanlaville D, Marle N, Thauvin-Robinet C, Gautier E, Chehadeh SE, Mosca-Boidron AL, Thevenon J, Edery P, Alex-Cordier MP, Till M, Lyonnet S, Cormier-Daire V, Amiel J, Philippe A, Romana S, Malan V, Afenjar A, Marlin S, Chantot-Bastaraud S, Bitoun P, Heron B, Piparas E, Morice-Picard F, Moutton S, Chassaing N, Vigouroux-Castera A, Lespinasse J, Manouvrier-Hanu S, Boute-Benejean O, Vincent-Delorme C, Petit F, Meur NL, Marti-Dramard M, Guerrot AM, Goldenberg A, Redon S, Ferrec C, Odent S, Caignec CL, Mercier S, Gilbert-Dussardier B, Toutain A, Arpin S, Blesson S, Mortemousque I, Schaefer E, Martin D, Philip N, Sigaudy S, Busa T, Missirian C, Giuliano F, Benailly HK, Kien PK, Leheup B, Benneteau C, Lambert L, Caumes R, Kuentz P, François I, Heron D, Keren B, Cretin E, Callier P, Julia S, Faivre L. Genetic counselling difficulties and ethical implications of incidental findings from array-CGH: a 7-year national survey. Clin Genet 2016;89:630-5. [PMID: 26582393 DOI: 10.1111/cge.12696] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
515 Thomas E, Mohammed S. Advances in Genetic Testing for Hereditary Cancer Syndromes. Recent Results Cancer Res 2016;205:1-15. [PMID: 27075345 DOI: 10.1007/978-3-319-29998-3_1] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
516 Ballinger ML, Goode DL, Ray-Coquard I, James PA, Mitchell G, Niedermayr E, Puri A, Schiffman JD, Dite GS, Cipponi A, Maki RG, Brohl AS, Myklebost O, Stratford EW, Lorenz S, Ahn SM, Ahn JH, Kim JE, Shanley S, Beshay V, Randall RL, Judson I, Seddon B, Campbell IG, Young MA, Sarin R, Blay JY, O'Donoghue SI, Thomas DM; International Sarcoma Kindred Study. Monogenic and polygenic determinants of sarcoma risk: an international genetic study. Lancet Oncol 2016;17:1261-71. [PMID: 27498913 DOI: 10.1016/S1470-2045(16)30147-4] [Cited by in Crossref: 109] [Cited by in F6Publishing: 57] [Article Influence: 18.2] [Reference Citation Analysis]
517 Sarkadi B, Liko I, Nyiro G, Igaz P, Butz H, Patocs A. Analytical Performance of NGS-Based Molecular Genetic Tests Used in the Diagnostic Workflow of Pheochromocytoma/Paraganglioma. Cancers (Basel) 2021;13:4219. [PMID: 34439371 DOI: 10.3390/cancers13164219] [Reference Citation Analysis]
518 Haer-Wigman L, van der Schoot V, Feenstra I, Vulto-van Silfhout AT, Gilissen C, Brunner HG, Vissers LELM, Yntema HG. 1 in 38 individuals at risk of a dominant medically actionable disease. Eur J Hum Genet 2019;27:325-30. [PMID: 30291343 DOI: 10.1038/s41431-018-0284-2] [Cited by in Crossref: 29] [Cited by in F6Publishing: 26] [Article Influence: 7.3] [Reference Citation Analysis]
519 Ngeow J, Eng C. Precision medicine in heritable cancer: when somatic tumour testing and germline mutations meet. NPJ Genom Med 2016;1:15006. [PMID: 29263804 DOI: 10.1038/npjgenmed.2015.6] [Cited by in Crossref: 24] [Cited by in F6Publishing: 20] [Article Influence: 4.0] [Reference Citation Analysis]
520 Oberg JA, Ruiz J, Ali-Shaw T, Schlechtweg KA, Ricci A, Kung AL, Chung WK, Appelbaum PS, Glade Bender JL, Levine JM. Whole-Genome and Whole-Exome Sequencing in Pediatric Oncology: An Assessment of Parent and Young Adult Patient Knowledge, Attitudes, and Expectations. JCO Precis Oncol 2018;2:PO. [PMID: 32913997 DOI: 10.1200/PO.17.00104] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
521 Lane BR, Bissonnette J, Waldherr T, Ritz-Holland D, Chesla D, Cottingham SL, Alberta S, Liu C, Thompson AB, Graveel C, MacKeigan JP, Noyes SL, Smith J, Lakhani N, Steensma MR; Spectrum Health Tumor Sequencing Advisory Board. Development of a Center for Personalized Cancer Care at a Regional Cancer Center: Feasibility Trial of an Institutional Tumor Sequencing Advisory Board. J Mol Diagn 2015;17:695-704. [PMID: 26331835 DOI: 10.1016/j.jmoldx.2015.07.003] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 1.7] [Reference Citation Analysis]
522 Pillar N, Isakov O, Weissglas-Volkov D, Botchan S, Friedman E, Arber N, Shomron N. Actionable clinical decisions based on comprehensive genomic evaluation in asymptomatic adults. Mol Genet Genomic Med 2015;3:433-9. [PMID: 26436109 DOI: 10.1002/mgg3.154] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.9] [Reference Citation Analysis]
523 Riazi S, Kraeva N, Muldoon SM, Dowling J, Ho C, Petre MA, Parness J, Dirksen RT, Rosenberg H. Malignant hyperthermia and the clinical significance of type-1 ryanodine receptor gene (RYR1) variants: proceedings of the 2013 MHAUS Scientific Conference. Can J Anaesth 2014;61:1040-9. [PMID: 25189431 DOI: 10.1007/s12630-014-0227-5] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 2.4] [Reference Citation Analysis]
524 Cléophat JE, Pelletier S, Déry A, Joly Y, Gagnon P, Marin A, Chiquette J, Gagnon B, Roy L, Bitzas V, Nabi H, Dorval M. Survey of palliative care providers' needs, perceived roles, and ethical concerns about addressing cancer family history at the end of life. Palliat Support Care 2021;19:217-22. [PMID: 32838822 DOI: 10.1017/S1478951520000759] [Reference Citation Analysis]
525 Mwaka E, Horn L. Researchers' Perspectives on Informed Consent and Ethical Review of Biobank Research in South Africa: A Cross-Sectional Study. J Empir Res Hum Res Ethics 2019;14:307-17. [PMID: 31378129 DOI: 10.1177/1556264619866991] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
526 Lázaro-Muñoz G, Conley JM, Davis AM, Prince AE, Cadigan RJ. Which Results to Return: Subjective Judgments in Selecting Medically Actionable Genes. Genet Test Mol Biomarkers 2017;21:184-94. [PMID: 28146641 DOI: 10.1089/gtmb.2016.0397] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 2.6] [Reference Citation Analysis]
527 Williams JL, Rahm AK, Zallen DT, Stuckey H, Fultz K, Fan AL, Bonhag M, Feldman L, Segal MM, Williams MS. Impact of a Patient-Facing Enhanced Genomic Results Report to Improve Understanding, Engagement, and Communication. J Genet Couns 2018;27:358-69. [PMID: 29204811 DOI: 10.1007/s10897-017-0176-6] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 3.6] [Reference Citation Analysis]
528 Hamilton JG, Edwards HM, Khoury MJ, Taplin SH. Cancer screening and genetics: a tale of two paradigms. Cancer Epidemiol Biomarkers Prev 2014;23:909-16. [PMID: 24706727 DOI: 10.1158/1055-9965.EPI-13-1016] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
529 Jurgens J, Ling H, Hetrick K, Pugh E, Schiettecatte F, Doheny K, Hamosh A, Avramopoulos D, Valle D, Sobreira N. Assessment of incidental findings in 232 whole-exome sequences from the Baylor-Hopkins Center for Mendelian Genomics. Genet Med 2015;17:782-8. [PMID: 25569433 DOI: 10.1038/gim.2014.196] [Cited by in Crossref: 30] [Cited by in F6Publishing: 29] [Article Influence: 4.3] [Reference Citation Analysis]
530 Damodaran S, Berger MF, Roychowdhury S. Clinical tumor sequencing: opportunities and challenges for precision cancer medicine. Am Soc Clin Oncol Educ Book. 2015;35:e175-e182. [PMID: 25993170 DOI: 10.14694/edbook_am.2015.35.e175] [Cited by in Crossref: 30] [Cited by in F6Publishing: 20] [Article Influence: 5.0] [Reference Citation Analysis]
531 Natarajan P, Gold NB, Bick AG, McLaughlin H, Kraft P, Rehm HL, Peloso GM, Wilson JG, Correa A, Seidman JG, Seidman CE, Kathiresan S, Green RC. Aggregate penetrance of genomic variants for actionable disorders in European and African Americans. Sci Transl Med 2016;8:364ra151. [PMID: 27831900 DOI: 10.1126/scitranslmed.aag2367] [Cited by in Crossref: 40] [Cited by in F6Publishing: 37] [Article Influence: 8.0] [Reference Citation Analysis]
532 Hagenkord J, Funke B, Qian E, Hegde M, Jacobs KB, Ferber M, Lebo M, Buchanan A, Bick D. Design and Reporting Considerations for Genetic Screening Tests. The Journal of Molecular Diagnostics 2020;22:599-609. [DOI: 10.1016/j.jmoldx.2020.01.014] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
533 Ayuso C, Millan JM, Dal-re R. Management and return of incidental genomic findings in clinical trials. Pharmacogenomics J 2015;15:1-5. [DOI: 10.1038/tpj.2014.62] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
534 Amendola LM, Dorschner MO, Robertson PD, Salama JS, Hart R, Shirts BH, Murray ML, Tokita MJ, Gallego CJ, Kim DS, Bennett JT, Crosslin DR, Ranchalis J, Jones KL, Rosenthal EA, Jarvik ER, Itsara A, Turner EH, Herman DS, Schleit J, Burt A, Jamal SM, Abrudan JL, Johnson AD, Conlin LK, Dulik MC, Santani A, Metterville DR, Kelly M, Foreman AK, Lee K, Taylor KD, Guo X, Crooks K, Kiedrowski LA, Raffel LJ, Gordon O, Machini K, Desnick RJ, Biesecker LG, Lubitz SA, Mulchandani S, Cooper GM, Joffe S, Richards CS, Yang Y, Rotter JI, Rich SS, O'Donnell CJ, Berg JS, Spinner NB, Evans JP, Fullerton SM, Leppig KA, Bennett RL, Bird T, Sybert VP, Grady WM, Tabor HK, Kim JH, Bamshad MJ, Wilfond B, Motulsky AG, Scott CR, Pritchard CC, Walsh TD, Burke W, Raskind WH, Byers P, Hisama FM, Rehm H, Nickerson DA, Jarvik GP. Actionable exomic incidental findings in 6503 participants: challenges of variant classification. Genome Res 2015;25:305-15. [PMID: 25637381 DOI: 10.1101/gr.183483.114] [Cited by in Crossref: 235] [Cited by in F6Publishing: 208] [Article Influence: 33.6] [Reference Citation Analysis]
535 Jamuar SS, Walsh CA. Genomic variants and variations in malformations of cortical development. Pediatr Clin North Am 2015;62:571-85. [PMID: 26022163 DOI: 10.1016/j.pcl.2015.03.002] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 3.3] [Reference Citation Analysis]
536 Bruwer Z, Algar U, Vorster A, Fieggen K, Davidson A, Goldberg P, Wainwright H, Ramesar R. Predictive genetic testing in children: constitutional mismatch repair deficiency cancer predisposing syndrome. J Genet Couns 2014;23:147-55. [PMID: 24122200 DOI: 10.1007/s10897-013-9659-2] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
537 Schaefer GO, Savulescu J. The Right to Know: A Revised Standard for Reporting Incidental Findings. Hastings Cent Rep 2018;48:22-32. [PMID: 29590521 DOI: 10.1002/hast.836] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 3.3] [Reference Citation Analysis]
538 Knoppers BM, Zawati MH, Sénécal K. Return of genetic testing results in the era of whole-genome sequencing. Nat Rev Genet 2015;16:553-9. [PMID: 26239711 DOI: 10.1038/nrg3960] [Cited by in Crossref: 98] [Cited by in F6Publishing: 88] [Article Influence: 14.0] [Reference Citation Analysis]
539 Connell PS, Berkman AM, Souder BM, Pirozzi EJ, Lovin JJ, Rosenfeld JA, Liu P, Tunuguntla H, Allen HD, Denfield SW, Kim JJ, Landstrom AP. Amino Acid-Level Signal-to-Noise Analysis Aids in Pathogenicity Prediction of Incidentally Identified TTN-Encoded Titin Truncating Variants. Circ Genom Precis Med 2021;14:e003131. [PMID: 33226272 DOI: 10.1161/CIRCGEN.120.003131] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
540 Koeppel F, Bobard A, Lefebvre C, Pedrero M, Deloger M, Boursin Y, Richon C, Chen-min-tao R, Robert G, Meurice G, Rouleau E, Michiels S, Massard C, Scoazec J, Solary E, Soria J, André F, Lacroix L. Added Value of Whole-Exome and Transcriptome Sequencing for Clinical Molecular Screenings of Advanced Cancer Patients With Solid Tumors: . The Cancer Journal 2018;24:153-62. [DOI: 10.1097/ppo.0000000000000322] [Cited by in Crossref: 10] [Cited by in F6Publishing: 1] [Article Influence: 2.5] [Reference Citation Analysis]
541 Lieberman S, Lahad A, Tomer A, Cohen C, Levy-Lahad E, Raz A. Population screening for BRCA1/BRCA2 mutations: lessons from qualitative analysis of the screening experience. Genet Med 2017;19:628-34. [PMID: 27906198 DOI: 10.1038/gim.2016.175] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 3.0] [Reference Citation Analysis]
542 Mccormick JB, Sharp RR, Farrugia G, Lindor NM, Babovic-vuksanovic D, Borad MJ, Bryce AH, Caselli RJ, Ferber MJ, Johnson KJ, Lazaridis KN, Mcwilliams RR, Murray JA, Parker AS, Schahl KA, Wieben ED. Genomic Medicine and Incidental Findings: Balancing Actionability and Patient Autonomy. Mayo Clinic Proceedings 2014;89:718-21. [DOI: 10.1016/j.mayocp.2014.04.008] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 1.5] [Reference Citation Analysis]
543 Núñez-Batalla F, Jáudenes-Casaubón C, Sequí-Canet JM, Vivanco-Allende A, Zubicaray-Ugarteche J, Cabanillas-Farpón R. Aetiological diagnosis of child deafness: CODEPEH recommendations. Acta Otorrinolaringol Esp 2017;68:43-55. [PMID: 27644946 DOI: 10.1016/j.otorri.2016.05.002] [Cited by in Crossref: 8] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
544 Bui ET, Anderson NK, Kassem L, McMahon FJ. Do participants in genome sequencing studies of psychiatric disorders wish to be informed of their results? A survey study. PLoS One 2014;9:e101111. [PMID: 24983240 DOI: 10.1371/journal.pone.0101111] [Cited by in Crossref: 22] [Cited by in F6Publishing: 24] [Article Influence: 2.8] [Reference Citation Analysis]
545 Shahmirzadi L, Chao EC, Palmaer E, Parra MC, Tang S, Gonzalez KD. Patient decisions for disclosure of secondary findings among the first 200 individuals undergoing clinical diagnostic exome sequencing. Genet Med 2014;16:395-9. [PMID: 24113345 DOI: 10.1038/gim.2013.153] [Cited by in Crossref: 75] [Cited by in F6Publishing: 71] [Article Influence: 8.3] [Reference Citation Analysis]
546 Meric-Bernstam F, Brusco L, Daniels M, Wathoo C, Bailey AM, Strong L, Shaw K, Lu K, Qi Y, Zhao H, Lara-Guerra H, Litton J, Arun B, Eterovic AK, Aytac U, Routbort M, Subbiah V, Janku F, Davies MA, Kopetz S, Mendelsohn J, Mills GB, Chen K. Incidental germline variants in 1000 advanced cancers on a prospective somatic genomic profiling protocol. Ann Oncol 2016;27:795-800. [PMID: 26787237 DOI: 10.1093/annonc/mdw018] [Cited by in Crossref: 93] [Cited by in F6Publishing: 76] [Article Influence: 15.5] [Reference Citation Analysis]
547 Tsai GJ, Garrett LT, Makhnoon S, Bowen DJ, Burke W, Shirts BH. Patient goals, motivations, and attitudes in a patient-driven variant reclassification study. J Genet Couns 2019;28:558-69. [PMID: 31163102 DOI: 10.1002/jgc4.1052] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
548 Muflih S, Al-Husein BA, Karasneh R, Alzoubi KH. Physicians' Attitudes and Ethical Obligations to Pharmacogenetic Testing. J Multidiscip Healthc 2020;13:249-58. [PMID: 32210569 DOI: 10.2147/JMDH.S245369] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
549 Elliott AM, Guimond C. Genetic counseling considerations in cerebral palsy. Mol Genet Metab 2021:S1096-7192(21)00755-1. [PMID: 34389249 DOI: 10.1016/j.ymgme.2021.07.004] [Reference Citation Analysis]
550 Chan SH, Lim WK, Ishak NDB, Li ST, Goh WL, Tan GS, Lim KH, Teo M, Young CNC, Malik S, Tan MH, Teh JYH, Chin FKC, Kesavan S, Selvarajan S, Tan P, Teh BT, Soo KC, Farid M, Quek R, Ngeow J. Germline Mutations in Cancer Predisposition Genes are Frequent in Sporadic Sarcomas. Sci Rep 2017;7:10660. [PMID: 28878254 DOI: 10.1038/s41598-017-10333-x] [Cited by in Crossref: 30] [Cited by in F6Publishing: 26] [Article Influence: 6.0] [Reference Citation Analysis]
551 Wynn J, Martinez J, Bulafka J, Duong J, Zhang Y, Chiuzan C, Preti J, Cremona ML, Jobanputra V, Fyer AJ, Klitzman RL, Appelbaum PS, Chung WK. Impact of Receiving Secondary Results from Genomic Research: A 12-Month Longitudinal Study. J Genet Couns 2018;27:709-22. [PMID: 29168042 DOI: 10.1007/s10897-017-0172-x] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 3.0] [Reference Citation Analysis]
552 Tomaselli GF, Barth AS. Ion Channel Diseases: an Update for 2016. Curr Treat Options Cardiovasc Med 2016;18:21. [PMID: 26899130 DOI: 10.1007/s11936-016-0442-1] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
553 Yu MHC, Mak CCY, Fung JLF, Lee M, Tsang MHY, Chau JFT, Chung PH, Yang W, Chan GCF, Lee SL, Lau YL, Tam PKH, Tang CSM, Yeung KS, Chung BHY. Actionable secondary findings in 1116 Hong Kong Chinese based on exome sequencing data. J Hum Genet 2021;66:637-41. [PMID: 33223521 DOI: 10.1038/s10038-020-00875-w] [Reference Citation Analysis]
554 Punetha J, Kesari A, Uapinyoying P, Giri M, Clarke NF, Waddell LB, North KN, Ghaoui R, O'Grady GL, Oates EC, Sandaradura SA, Bönnemann CG, Donkervoort S, Plotz PH, Smith EC, Tesi-Rocha C, Bertorini TE, Tarnopolsky MA, Reitter B, Hausmanowa-Petrusewicz I, Hoffman EP. Targeted Re-Sequencing Emulsion PCR Panel for Myopathies: Results in 94 Cases. J Neuromuscul Dis 2016;3:209-25. [PMID: 27854218 DOI: 10.3233/JND-160151] [Cited by in Crossref: 13] [Cited by in F6Publishing: 7] [Article Influence: 3.3] [Reference Citation Analysis]
555 Kwak SH, Chae J, Choi S, Kim MJ, Choi M, Chae JH, Cho EH, Hwang TJ, Jang SS, Kim JI, Park KS, Bang YJ. Findings of a 1303 Korean whole-exome sequencing study. Exp Mol Med 2017;49:e356. [PMID: 28706299 DOI: 10.1038/emm.2017.142] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 4.4] [Reference Citation Analysis]
556 Werner-lin A, Tomlinson A, Miller V, Bernhardt BA. Adolescent engagement during assent for exome sequencing. AJOB Empirical Bioethics 2016;7:275-84. [DOI: 10.1080/23294515.2016.1197983] [Cited by in Crossref: 8] [Article Influence: 1.3] [Reference Citation Analysis]
557 Klitzman R, Appelbaum PS, Chung W. Return of secondary genomic findings vs patient autonomy: implications for medical care. JAMA 2013;310:369-70. [PMID: 23917282 DOI: 10.1001/jama.2013.41709] [Cited by in Crossref: 54] [Cited by in F6Publishing: 55] [Article Influence: 6.0] [Reference Citation Analysis]
558 Carter TC, He MM. Challenges of Identifying Clinically Actionable Genetic Variants for Precision Medicine. J Healthc Eng 2016;2016. [PMID: 27195526 DOI: 10.1155/2016/3617572] [Cited by in Crossref: 21] [Cited by in F6Publishing: 15] [Article Influence: 5.3] [Reference Citation Analysis]
559 van den Berg S, Shen Y, Jones SJ, Gibson WT. Genetic counseling in direct-to-consumer exome sequencing: a case report. J Genet Couns 2014;23:742-53. [PMID: 24954083 DOI: 10.1007/s10897-014-9737-0] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
560 Volk A, Conboy E, Wical B, Patterson M, Kirmani S. Whole-Exome Sequencing in the Clinic: Lessons from Six Consecutive Cases from the Clinician's Perspective. Mol Syndromol 2015;6:23-31. [PMID: 25852444 DOI: 10.1159/000371598] [Cited by in Crossref: 21] [Cited by in F6Publishing: 14] [Article Influence: 3.0] [Reference Citation Analysis]
561 Lim Q, McGill BC, Quinn VF, Tucker KM, Mizrahi D, Patenaude AF, Warby M, Cohn RJ, Wakefield CE. Parents' attitudes toward genetic testing of children for health conditions: A systematic review. Clin Genet 2017;92:569-78. [PMID: 28170090 DOI: 10.1111/cge.12989] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 4.0] [Reference Citation Analysis]
562 Kaphingst KA, Ivanovich J, Biesecker BB, Dresser R, Seo J, Dressler LG, Goodfellow PJ, Goodman MS. Preferences for return of incidental findings from genome sequencing among women diagnosed with breast cancer at a young age. Clin Genet 2016;89:378-84. [PMID: 25871653 DOI: 10.1111/cge.12597] [Cited by in Crossref: 34] [Cited by in F6Publishing: 27] [Article Influence: 4.9] [Reference Citation Analysis]
563 Laberge AM. Recommending inclusion of HFE C282Y homozygotes in the ACMG actionable gene list: cop-out or stealth move toward population screening? Genet Med 2018;20:400-2. [PMID: 29048418 DOI: 10.1038/gim.2017.161] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
564 Germenis AE, Margaglione M, Pesquero JB, Farkas H, Cichon S, Csuka D, Lera AL, Rijavec M, Jolles S, Szilagyi A, Trascasa ML, Veronez CL, Drouet C, Zamanakou M, Andrejevic S, Aygören-pürsün E, Bara N, Bernstein J, Bork K, Bouillet L, Bova M, Boysen HH, Bygum A, Caballero T, Castaldo A, Christiansen S, Cicardi M, Fabiani J, Katelaris C, Dewald G, Gökmen NM, Gonzalez-quevedo MT, Gooi J, Grivcheva-panovska V, Grumach A, Hakl R, Hardy G, Jesenak M, Kaplan A, Kirschfink M, Köhalmi KV, Leibovich I, Longhurst HJ, Lumry W, Magerl M, Saguer IM, Nagy IB, Nieto S, Nordenfelt P, Porębski G, Psarros F, Reshef A, Riedl MA, Sheikh F, Peter S, Speletas M, Staevska M, Stobiecki M, Triggiani M, Veszeli N, Waserman S, Weber C, Wuillemin W, Zuraw B. International Consensus on the Use of Genetics in the Management of Hereditary Angioedema. The Journal of Allergy and Clinical Immunology: In Practice 2020;8:901-11. [DOI: 10.1016/j.jaip.2019.10.004] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 9.0] [Reference Citation Analysis]
565 Na R, Zheng SL, Han M, Yu H, Jiang D, Shah S, Ewing CM, Zhang L, Novakovic K, Petkewicz J, Gulukota K, Helseth DL Jr, Quinn M, Humphries E, Wiley KE, Isaacs SD, Wu Y, Liu X, Zhang N, Wang CH, Khandekar J, Hulick PJ, Shevrin DH, Cooney KA, Shen Z, Partin AW, Carter HB, Carducci MA, Eisenberger MA, Denmeade SR, McGuire M, Walsh PC, Helfand BT, Brendler CB, Ding Q, Xu J, Isaacs WB. Germline Mutations in ATM and BRCA1/2 Distinguish Risk for Lethal and Indolent Prostate Cancer and are Associated with Early Age at Death. Eur Urol 2017;71:740-7. [PMID: 27989354 DOI: 10.1016/j.eururo.2016.11.033] [Cited by in Crossref: 153] [Cited by in F6Publishing: 139] [Article Influence: 25.5] [Reference Citation Analysis]
566 Haga SB, Solomon BD. Considerations of pharmacogenetic testing in children. Pharmacogenomics 2016;17:975-7. [PMID: 27248426 DOI: 10.2217/pgs-2016-0073] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
567 Arndt AK, MacRae CA. Genetic testing in cardiovascular diseases. Curr Opin Cardiol 2014;29:235-40. [PMID: 24717670 DOI: 10.1097/HCO.0000000000000055] [Cited by in Crossref: 21] [Cited by in F6Publishing: 9] [Article Influence: 2.6] [Reference Citation Analysis]
568 Tuteja S, Limdi N. Pharmacogenetics in Cardiovascular Medicine. Curr Genet Med Rep 2016;4:119-29. [PMID: 29057167 DOI: 10.1007/s40142-016-0096-z] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
569 Rosier M, Guedj M, Calvas P, Julia S, Garnier C, Cambon-Thomsen A, Muñoz Sastre MT. Attitudes of French populations towards the disclosure of unsolicited findings in medical genetics. J Health Psychol 2021;26:1767-79. [PMID: 31707852 DOI: 10.1177/1359105319886622] [Reference Citation Analysis]
570 Douglas MP, Ladabaum U, Pletcher MJ, Marshall DA, Phillips KA. Economic evidence on identifying clinically actionable findings with whole-genome sequencing: a scoping review. Genet Med 2016;18:111-6. [PMID: 25996638 DOI: 10.1038/gim.2015.69] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 2.7] [Reference Citation Analysis]
571 Newey PJ. Clinical genetic testing in endocrinology: Current concepts and contemporary challenges. Clin Endocrinol 2019;91:587-607. [DOI: 10.1111/cen.14053] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
572 Sirisena ND, Neththikumara N, Wetthasinghe K, Dissanayake VH. Implementation of genomic medicine in Sri Lanka: Initial experience and challenges. Appl Transl Genom 2016;9:33-6. [PMID: 27354939 DOI: 10.1016/j.atg.2016.05.003] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
573 Jacobs C, Pichert G. Genetic Testing for Rare Cancer: The Wider Issues. Recent Results Cancer Res 2016;205:213-26. [PMID: 27075356 DOI: 10.1007/978-3-319-29998-3_12] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
574 Wade CH, Elliott KR. Young adults' attitudes toward pediatric whole-genome sequencing. Per Med 2016;13:541-52. [PMID: 29754547 DOI: 10.2217/pme-2016-0066] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
575 Kullo IJ, Haddad R, Prows CA, Holm I, Sanderson SC, Garrison NA, Sharp RR, Smith ME, Kuivaniemi H, Bottinger EP, Connolly JJ, Keating BJ, McCarty CA, Williams MS, Jarvik GP. Return of results in the genomic medicine projects of the eMERGE network. Front Genet 2014;5:50. [PMID: 24723935 DOI: 10.3389/fgene.2014.00050] [Cited by in Crossref: 23] [Cited by in F6Publishing: 29] [Article Influence: 2.9] [Reference Citation Analysis]
576 Seldin MF. The genetics of human autoimmune disease: A perspective on progress in the field and future directions. J Autoimmun 2015;64:1-12. [PMID: 26343334 DOI: 10.1016/j.jaut.2015.08.015] [Cited by in Crossref: 47] [Cited by in F6Publishing: 42] [Article Influence: 6.7] [Reference Citation Analysis]
577 Kuo CW, Hwu WL, Chien YH, Hsu C, Hung MZ, Lin IL, Lai F, Lee NC. Frequency and spectrum of actionable pathogenic secondary findings in Taiwanese exomes. Mol Genet Genomic Med 2020;8:e1455. [PMID: 32794656 DOI: 10.1002/mgg3.1455] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
578 Antoniou M, Kolamunnage-Dona R, Wason J, Bathia R, Billingham C, Bliss JM, Brown LC, Gillman A, Paul J, Jorgensen AL. Biomarker-guided trials: Challenges in practice. Contemp Clin Trials Commun 2019;16:100493. [PMID: 31788574 DOI: 10.1016/j.conctc.2019.100493] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.7] [Reference Citation Analysis]
579 Fogel BL. Genetic and genomic testing for neurologic disease in clinical practice. Handb Clin Neurol 2018;147:11-22. [PMID: 29325607 DOI: 10.1016/B978-0-444-63233-3.00002-6] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
580 eMERGE Consortium. Electronic address: agibbs@bcm.edu., eMERGE Consortium. Harmonizing Clinical Sequencing and Interpretation for the eMERGE III Network. Am J Hum Genet 2019;105:588-605. [PMID: 31447099 DOI: 10.1016/j.ajhg.2019.07.018] [Cited by in Crossref: 51] [Cited by in F6Publishing: 37] [Article Influence: 17.0] [Reference Citation Analysis]
581 Zhen JT, Syed J, Nguyen KA, Leapman MS, Agarwal N, Brierley K, Llor X, Hofstatter E, Shuch B. Genetic testing for hereditary prostate cancer: Current status and limitations. Cancer 2018;124:3105-17. [PMID: 29669169 DOI: 10.1002/cncr.31316] [Cited by in Crossref: 25] [Cited by in F6Publishing: 21] [Article Influence: 6.3] [Reference Citation Analysis]
582 Rigter T, van Aart CJ, Elting MW, Waisfisz Q, Cornel MC, Henneman L. Informed consent for exome sequencing in diagnostics: exploring first experiences and views of professionals and patients. Clin Genet 2014;85:417-22. [PMID: 24117109 DOI: 10.1111/cge.12299] [Cited by in Crossref: 34] [Cited by in F6Publishing: 27] [Article Influence: 3.8] [Reference Citation Analysis]
583 Lanza G, Calì F, Vinci M, Cosentino FII, Tripodi M, Spada RS, Cantone M, Bella R, Mattina T, Ferri R. A Customized Next-Generation Sequencing-Based Panel to Identify Novel Genetic Variants in Dementing Disorders: A Pilot Study. Neural Plast 2020;2020:8078103. [PMID: 32908482 DOI: 10.1155/2020/8078103] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
584 Schupmann W, Miner SA, Sullivan HK, Glover JR, Hall JE, Schurman SH, Berkman BE. Exploring the motivations of research participants who chose not to learn medically actionable secondary genetic findings about themselves. Genet Med 2021. [PMID: 34326490 DOI: 10.1038/s41436-021-01271-1] [Reference Citation Analysis]
585 Borry P, Shabani M, Howard HC. Is There a Right Time to Know? The Right Not to Know and Genetic Testing in Children. J Law Med Ethics 2014;42:19-27. [PMID: 26767473 DOI: 10.1111/jlme.12115] [Cited by in Crossref: 22] [Cited by in F6Publishing: 11] [Article Influence: 3.7] [Reference Citation Analysis]
586 Middleton A, Patch C, Wiggins J, Barnes K, Crawford G, Benjamin C, Bruce A; Association of Genetic Nurses and Counsellors in United Kingdom and Ireland. Position statement on opportunistic genomic screening from the Association of Genetic Nurses and Counsellors (UK and Ireland). Eur J Hum Genet 2014;22:955-6. [PMID: 24398792 DOI: 10.1038/ejhg.2013.301] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 2.4] [Reference Citation Analysis]
587 Chen K, Meric-Bernstam F. Whole Genome Sequencing in Cancer Clinics. EBioMedicine 2015;2:15-6. [PMID: 26137530 DOI: 10.1016/j.ebiom.2014.12.007] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
588 Caspar SM, Dubacher N, Kopps AM, Meienberg J, Henggeler C, Matyas G. Clinical sequencing: From raw data to diagnosis with lifetime value. Clin Genet 2018;93:508-19. [PMID: 29206278 DOI: 10.1111/cge.13190] [Cited by in Crossref: 47] [Cited by in F6Publishing: 38] [Article Influence: 15.7] [Reference Citation Analysis]
589 Caminsky NG, Mucaki EJ, Rogan PK. Interpretation of mRNA splicing mutations in genetic disease: review of the literature and guidelines for information-theoretical analysis. F1000Res 2014;3:282. [DOI: 10.12688/f1000research.5654.2] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
590 Bombard Y. Translating personalized genomic medicine into clinical practice: evidence, values, and health policy. Genome 2015;58:491-7. [PMID: 26577841 DOI: 10.1139/gen-2015-0145] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 1.4] [Reference Citation Analysis]
591 Khan CM, Moore EG, Leos C, Rini C. Patient hopes for diagnostic genomic sequencing: roles of uncertainty and social status. Eur J Hum Genet 2016;24:803-8. [PMID: 26395557 DOI: 10.1038/ejhg.2015.204] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
592 Alvarellos ML, McDonagh EM, Patel S, McLeod HL, Altman RB, Klein TE. PharmGKB summary: succinylcholine pathway, pharmacokinetics/pharmacodynamics. Pharmacogenet Genomics 2015;25:622-30. [PMID: 26398623 DOI: 10.1097/FPC.0000000000000170] [Cited by in Crossref: 16] [Cited by in F6Publishing: 6] [Article Influence: 2.7] [Reference Citation Analysis]
593 Ebbert MT, Wadsworth ME, Staley LA, Hoyt KL, Pickett B, Miller J, Duce J, Kauwe JS, Ridge PG; Alzheimer’s Disease Neuroimaging Initiative. Evaluating the necessity of PCR duplicate removal from next-generation sequencing data and a comparison of approaches. BMC Bioinformatics 2016;17 Suppl 7:239. [PMID: 27454357 DOI: 10.1186/s12859-016-1097-3] [Cited by in Crossref: 62] [Cited by in F6Publishing: 51] [Article Influence: 10.3] [Reference Citation Analysis]
594 Wright CF, Zimmern RL. Conceptual issues for screening in the genomic era - time for an update? Epidemiol Biostat Public Health 2014;11:e9944. [PMID: 26973821 DOI: 10.2427/9944] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
595 Boeldt DL, Cheung C, Ariniello L, Darst BF, Topol S, Schork NJ, Philis-Tsimikas A, Torkamani A, Fortmann AL, Bloss CS. Patient perspectives on whole-genome sequencing for undiagnosed diseases. Per Med 2017;14:17-25. [PMID: 29749824 DOI: 10.2217/pme-2016-0050] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
596 Aizawa Y, Nagami F, Ohashi N, Kato K. A proposal on the first Japanese practical guidance for the return of individual genomic results in research settings. J Hum Genet 2020;65:251-61. [PMID: 31873219 DOI: 10.1038/s10038-019-0697-y] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
597 Posey JE, Rosenfeld JA, James RA, Bainbridge M, Niu Z, Wang X, Dhar S, Wiszniewski W, Akdemir ZH, Gambin T, Xia F, Person RE, Walkiewicz M, Shaw CA, Sutton VR, Beaudet AL, Muzny D, Eng CM, Yang Y, Gibbs RA, Lupski JR, Boerwinkle E, Plon SE. Molecular diagnostic experience of whole-exome sequencing in adult patients. Genet Med 2016;18:678-85. [PMID: 26633545 DOI: 10.1038/gim.2015.142] [Cited by in Crossref: 120] [Cited by in F6Publishing: 113] [Article Influence: 17.1] [Reference Citation Analysis]
598 Christensen KD, Bernhardt BA, Jarvik GP, Hindorff LA, Ou J, Biswas S, Powell BC, Grundmeier RW, Machini K, Karavite DJ, Pennington JW, Krantz ID, Berg JS, Goddard KAB. Anticipated responses of early adopter genetic specialists and nongenetic specialists to unsolicited genomic secondary findings. Genet Med 2018;20:1186-95. [PMID: 29388940 DOI: 10.1038/gim.2017.243] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
599 Cook L, Schulze J. Connecting Gaucher and Parkinson Disease: Considerations for Clinical and Research Genetic Counseling Settings. J Genet Counsel 2017;26:1165-72. [DOI: 10.1007/s10897-017-0123-6] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
600 Srebniak MI, Van Opstal D, Joosten M, Diderich KE, de Vries FA, Riedijk S, Knapen MF, Go AT, Govaerts LC, Galjaard RJ. Whole-genome array as a first-line cytogenetic test in prenatal diagnosis. Ultrasound Obstet Gynecol 2015;45:363-72. [PMID: 25488734 DOI: 10.1002/uog.14745] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 2.5] [Reference Citation Analysis]
601 Vlahovich N, Fricker PA, Brown MA, Hughes D. Ethics of genetic testing and research in sport: a position statement from the Australian Institute of Sport. Br J Sports Med 2017;51:5-11. [PMID: 27899345 DOI: 10.1136/bjsports-2016-096661] [Cited by in Crossref: 29] [Cited by in F6Publishing: 18] [Article Influence: 4.8] [Reference Citation Analysis]
602 Jiang S, Anis AH, Cromwell I, Mohammadi T, Schrader KA, Lucas J, Armour CM, Clausen M, Bombard Y, Regier DA. Health-care practitioners' preferences for the return of secondary findings from next-generation sequencing: a discrete choice experiment. Genet Med 2020;22:2011-9. [PMID: 32820245 DOI: 10.1038/s41436-020-0927-x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
603 Ralefala D, Kasule M, Matshabane OP, Wonkam A, Matshaba M, de Vries J. Participants' Preferences and Reasons for Wanting Feedback of Individual Genetic Research Results From an HIV-TB Genomic Study: A Case Study From Botswana. J Empir Res Hum Res Ethics 2021;16:525-36. [PMID: 34662218 DOI: 10.1177/15562646211043985] [Reference Citation Analysis]
604 Wilson BJ, Nicholls SG. The Human Genome Project, and recent advances in personalized genomics. Risk Manag Healthc Policy. 2015;8:9-20. [PMID: 25733939 DOI: 10.2147/rmhp.s58728] [Cited by in Crossref: 39] [Cited by in F6Publishing: 14] [Article Influence: 5.6] [Reference Citation Analysis]
605 Mandelker D, Donoghue M, Talukdar S, Bandlamudi C, Srinivasan P, Vivek M, Jezdic S, Hanson H, Snape K, Kulkarni A, Hawkes L, Douillard JY, Wallace SE, Rial-Sebbag E, Meric-Bersntam F, George A, Chubb D, Loveday C, Ladanyi M, Berger MF, Taylor BS, Turnbull C. Germline-focussed analysis of tumour-only sequencing: recommendations from the ESMO Precision Medicine Working Group. Ann Oncol 2019;30:1221-31. [PMID: 31050713 DOI: 10.1093/annonc/mdz136] [Cited by in Crossref: 43] [Cited by in F6Publishing: 34] [Article Influence: 21.5] [Reference Citation Analysis]
606 Milani L, Leitsalu L, Metspalu A. An epidemiological perspective of personalized medicine: the Estonian experience. J Intern Med 2015;277:188-200. [PMID: 25339628 DOI: 10.1111/joim.12320] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 2.3] [Reference Citation Analysis]
607 Cavestro GM, Mannucci A, Zuppardo RA, Di Leo M, Stoffel E, Tonon G. Early onset sporadic colorectal cancer: Worrisome trends and oncogenic features. Digestive and Liver Disease 2018;50:521-32. [DOI: 10.1016/j.dld.2018.02.009] [Cited by in Crossref: 27] [Cited by in F6Publishing: 26] [Article Influence: 6.8] [Reference Citation Analysis]
608 Haga SB, Mills R. A review of consent practices and perspectives for pharmacogenetic testing. Pharmacogenomics 2016;17:1595-605. [PMID: 27533720 DOI: 10.2217/pgs-2016-0039] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
609 Sangkuhl K, Dirksen RT, Alvarellos ML, Altman RB, Klein TE. PharmGKB summary: very important pharmacogene information for CACNA1S. Pharmacogenet Genomics 2020;30:34-44. [PMID: 31851124 DOI: 10.1097/FPC.0000000000000393] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
610 Guadagnolo D, Mastromoro G, Di Palma F, Pizzuti A, Marchionni E. Prenatal Exome Sequencing: Background, Current Practice and Future Perspectives-A Systematic Review. Diagnostics (Basel) 2021;11:224. [PMID: 33540854 DOI: 10.3390/diagnostics11020224] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
611 Trifu SC, Vlăduţi A, Trifu AI. Genetic aspects in schizophrenia. Receptoral theories. Metabolic theories. Rom J Morphol Embryol 2020;61:25-32. [PMID: 32747892 DOI: 10.47162/RJME.61.1.03] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
612 Marks LJ, Oberg JA, Pendrick D, Sireci AN, Glasser C, Coval C, Zylber RJ, Chung WK, Pang J, Turk AT, Hsiao SJ, Mansukhani MM, Glade Bender JL, Kung AL, Sulis ML. Precision Medicine in Children and Young Adults with Hematologic Malignancies and Blood Disorders: The Columbia University Experience. Front Pediatr 2017;5:265. [PMID: 29312904 DOI: 10.3389/fped.2017.00265] [Cited by in Crossref: 14] [Cited by in F6Publishing: 9] [Article Influence: 2.8] [Reference Citation Analysis]
613 Gourna EG, Armstrong N, Wallace SE. Incidental findings from clinical sequencing in Greece: reporting experts' attitudes. J Community Genet 2014;5:383-93. [PMID: 25048384 DOI: 10.1007/s12687-014-0194-0] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
614 George AL Jr. Use of contemporary genetics in cardiovascular diagnosis. Circulation 2014;130:1971-80. [PMID: 25421045 DOI: 10.1161/CIRCULATIONAHA.114.006511] [Cited by in Crossref: 4] [Article Influence: 0.6] [Reference Citation Analysis]
615 Abul-Husn NS, Soper ER, Braganza GT, Rodriguez JE, Zeid N, Cullina S, Bobo D, Moscati A, Merkelson A, Loos RJF, Cho JH, Belbin GM, Suckiel SA, Kenny EE. Implementing genomic screening in diverse populations. Genome Med 2021;13:17. [PMID: 33546753 DOI: 10.1186/s13073-021-00832-y] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
616 Haga SB. Delivering pharmacogenetic testing to the masses: an achievable goal? Pharmacogenomics 2014;15:1-4. [DOI: 10.2217/pgs.13.211] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
617 Warby M, Wakefield CE, Vetsch J, Tucker KM. Families' and health care professionals' attitudes towards Li-Fraumeni syndrome testing in children: A systematic review. Clin Genet 2019;95:140-50. [PMID: 30191952 DOI: 10.1111/cge.13442] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
618 Sundby A, Boolsen MW, Burgdorf KS, Ullum H, Hansen TF, Middleton A, Mors O. Stakeholders in psychiatry and their attitudes toward receiving pertinent and incident findings in genomic research. Am J Med Genet A 2017;173:2649-58. [PMID: 28817238 DOI: 10.1002/ajmg.a.38380] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 3.2] [Reference Citation Analysis]
619 Clarke A. Genetics, Genomics, and Society. Genomics and Society. Elsevier; 2016. pp. 21-37. [DOI: 10.1016/b978-0-12-420195-8.00002-1] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
620 Tindale LC, Thiessen N, Leach S, Brooks-Wilson AR. Allele-Specific Transcript Abundance: A Pilot Study in Healthy Centenarians. J Gerontol A Biol Sci Med Sci 2020;75:1068-72. [PMID: 31504207 DOI: 10.1093/gerona/glz188] [Reference Citation Analysis]
621 Bradbury AR, Patrick-Miller L, Schwartz L, Egleston B, Sands CB, Chung WK, Glendon G, McDonald JA, Moore C, Rauch P, Tuchman L, Andrulis IL, Buys SS, Frost CJ, Keegan TH, Knight JA, Terry MB, John EM, Daly MB. Psychosocial Adjustment in School-age Girls With a Family History of Breast Cancer. Pediatrics 2015;136:927-37. [PMID: 26482668 DOI: 10.1542/peds.2015-0498] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
622 Gallego CJ, Burt A, Sundaresan AS, Ye Z, Shaw C, Crosslin DR, Crane PK, Fullerton SM, Hansen K, Carrell D, Kuivaniemi H, Derr K, de Andrade M, McCarty CA, Kitchner TE, Ragon BK, Stallings SC, Papa G, Bochenek J, Smith ME, Aufox SA, Pacheco JA, Patel V, Friesema EM, Erwin AL, Gottesman O, Gerhard GS, Ritchie M, Motulsky AG, Kullo IJ, Larson EB, Tromp G, Brilliant MH, Bottinger E, Denny JC, Roden DM, Williams MS, Jarvik GP. Penetrance of Hemochromatosis in HFE Genotypes Resulting in p.Cys282Tyr and p.[Cys282Tyr];[His63Asp] in the eMERGE Network. Am J Hum Genet 2015;97:512-20. [PMID: 26365338 DOI: 10.1016/j.ajhg.2015.08.008] [Cited by in Crossref: 24] [Cited by in F6Publishing: 26] [Article Influence: 3.4] [Reference Citation Analysis]
623 Na R, Wu Y, Jiang G, Yu H, Lin X, Wang M, Conran CA, Fantus RJ, Zhang N, Liu S, Helfand BT, Zheng SL, Isaacs WB, Ding Q, Shen Z, Xu J. Germline mutations in DNA repair genes are associated with bladder cancer risk and unfavourable prognosis. BJU Int 2018;122:808-13. [DOI: 10.1111/bju.14370] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
624 Eno C, Bayrak-toydemir P, Bean L, Braxton A, Chao EC, El-khechen D, Esplin ED, Friedman B, Hagman KDF, Hambuch T, Hernandez A, Juusola J, Londre G, Machado J, Mao R, Mighion L, Rehm HL, Ward P, Deignan JL. Misattributed parentage as an unanticipated finding during exome/genome sequencing: current clinical laboratory practices and an opportunity for standardization. Genet Med 2019;21:861-6. [DOI: 10.1038/s41436-018-0265-4] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
625 Papaz T, Liston E, Zahavich L, Stavropoulos DJ, Jobling RK, Kim RH, Reuter M, Miron A, Oechslin E, Mondal T, Bergin L, Smythe JF, Altamirano-Diaz L, Lougheed J, Yao R, Akinrinade O, Breckpot J, Mital S. Return of genetic and genomic research findings: experience of a pediatric biorepository. BMC Med Genomics 2019;12:173. [PMID: 31775751 DOI: 10.1186/s12920-019-0618-0] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
626 Boardman F, Hale R. Responsibility, identity, and genomic sequencing: A comparison of published recommendations and patient perspectives on accepting or declining incidental findings. Mol Genet Genomic Med 2018;6:1079-96. [PMID: 30370638 DOI: 10.1002/mgg3.485] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
627 Sirohi D, Schmidt RL, Aisner DL, Behdad A, Betz BL, Brown N, Coleman JF, Corless CL, Deftereos G, Ewalt MD, Fernandes H, Hsiao SJ, Mansukhani MM, Murray SS, Niu N, Ritterhouse LL, Suarez CJ, Tafe LJ, Thorson JA, Segal JP, Furtado LV. Multi-Institutional Evaluation of Interrater Agreement of Variant Classification Based on the 2017 Association for Molecular Pathology, American Society of Clinical Oncology, and College of American Pathologists Standards and Guidelines for the Interpretation and Reporting of Sequence Variants in Cancer. J Mol Diagn 2020;22:284-93. [PMID: 31837433 DOI: 10.1016/j.jmoldx.2019.10.010] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
628 Blasimme A, Moret C, Hurst SA, Vayena E. Informed Consent and the Disclosure of Clinical Results to Research Participants. Am J Bioeth 2017;17:58-60. [PMID: 28661744 DOI: 10.1080/15265161.2017.1328532] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
629 Meienberg J, Bruggmann R, Oexle K, Matyas G. Clinical sequencing: is WGS the better WES? Hum Genet 2016;135:359-62. [PMID: 26742503 DOI: 10.1007/s00439-015-1631-9] [Cited by in Crossref: 163] [Cited by in F6Publishing: 125] [Article Influence: 27.2] [Reference Citation Analysis]
630 Bertier G, Hétu M, Joly Y. Unsolved challenges of clinical whole-exome sequencing: a systematic literature review of end-users' views. BMC Med Genomics 2016;9:52. [PMID: 27514372 DOI: 10.1186/s12920-016-0213-6] [Cited by in Crossref: 34] [Cited by in F6Publishing: 33] [Article Influence: 5.7] [Reference Citation Analysis]
631 Markello TC, Adams DR. Genome-scale sequencing to identify genes involved in Mendelian disorders. Curr Protoc Hum Genet 2013;79:Unit 6.13.. [PMID: 24510651 DOI: 10.1002/0471142905.hg0613s79] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
632 Poduri A, Sheidley BR, Shostak S, Ottman R. Genetic testing in the epilepsies-developments and dilemmas. Nat Rev Neurol 2014;10:293-9. [PMID: 24733164 DOI: 10.1038/nrneurol.2014.60] [Cited by in Crossref: 51] [Cited by in F6Publishing: 47] [Article Influence: 6.4] [Reference Citation Analysis]
633 Huser V, Sincan M, Cimino JJ. Developing genomic knowledge bases and databases to support clinical management: current perspectives. Pharmgenomics Pers Med 2014;7:275-83. [PMID: 25276091 DOI: 10.2147/PGPM.S49904] [Cited by in Crossref: 3] [Cited by in F6Publishing: 7] [Article Influence: 0.4] [Reference Citation Analysis]
634 Zhang S, Taylor AK, Huang X, Luo B, Spector EB, Fang P, Richards CS; on behalf of the ACMG Laboratory Quality Assurance Committee. Venous thromboembolism laboratory testing (factor V Leiden and factor II c.*97G>A), 2018 update: a technical standard of the American College of Medical Genetics and Genomics (ACMG). Genet Med 2018;20:1489-98. [DOI: 10.1038/s41436-018-0322-z] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
635 Johnston JJ, Yoo S, Biesecker LG. A commentary on actionable secondary findings in the 73 ACMG-recommended genes in 1559 Thai exomes. J Hum Genet. [DOI: 10.1038/s10038-022-01037-w] [Reference Citation Analysis]
636 Lee H, Lim J, Shin JE, Eun HS, Park MS, Park KI, Namgung R, Lee JS. Implementation of a Targeted Next-Generation Sequencing Panel for Constitutional Newborn Screening in High-Risk Neonates. Yonsei Med J 2019;60:1061-6. [PMID: 31637888 DOI: 10.3349/ymj.2019.60.11.1061] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
637 Gray SW, Martins Y, Feuerman LZ, Bernhardt BA, Biesecker BB, Christensen KD, Joffe S, Rini C, Veenstra D, McGuire AL; CSER Consortium Outcomes and Measures Working Group. Social and behavioral research in genomic sequencing: approaches from the Clinical Sequencing Exploratory Research Consortium Outcomes and Measures Working Group. Genet Med 2014;16:727-35. [PMID: 24625446 DOI: 10.1038/gim.2014.26] [Cited by in Crossref: 47] [Cited by in F6Publishing: 42] [Article Influence: 5.9] [Reference Citation Analysis]
638 Chinen J, Lawrence M, Dorsey M, Kobrynski LJ. Practical approach to genetic testing for primary immunodeficiencies. Ann Allergy Asthma Immunol 2019;123:433-9. [PMID: 31472268 DOI: 10.1016/j.anai.2019.08.016] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
639 Kalynchuk EJ, Althouse A, Parker LS, Saller DN Jr, Rajkovic A. Prenatal whole-exome sequencing: parental attitudes. Prenat Diagn 2015;35:1030-6. [PMID: 26151551 DOI: 10.1002/pd.4635] [Cited by in Crossref: 41] [Cited by in F6Publishing: 33] [Article Influence: 5.9] [Reference Citation Analysis]
640 Li Z, Liu Z, Jiang Y, Chen D, Ran X, Sun ZS, Wu J. mirVAFC: A Web Server for Prioritizations of Pathogenic Sequence Variants from Exome Sequencing Data via Classifications. Hum Mutat 2017;38:25-33. [PMID: 27676360 DOI: 10.1002/humu.23125] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
641 Veatch OJ, Butler MG, Elsea SH, Malow BA, Sutcliffe JS, Moore JH. An Automated Functional Annotation Pipeline That Rapidly Prioritizes Clinically Relevant Genes for Autism Spectrum Disorder. Int J Mol Sci 2020;21:E9029. [PMID: 33261099 DOI: 10.3390/ijms21239029] [Reference Citation Analysis]
642 Chambers C, Jansen LA, Dhamija R. Review of Commercially Available Epilepsy Genetic Panels. J Genet Couns 2016;25:213-7. [PMID: 26536886 DOI: 10.1007/s10897-015-9906-9] [Cited by in Crossref: 39] [Cited by in F6Publishing: 32] [Article Influence: 5.6] [Reference Citation Analysis]
643 Williams MS, Taylor CO, Walton NA, Goehringer SR, Aronson S, Freimuth RR, Rasmussen LV, Hall ES, Prows CA, Chung WK, Fedotov A, Nestor J, Weng C, Rowley RK, Wiesner GL, Jarvik GP, Del Fiol G. Genomic Information for Clinicians in the Electronic Health Record: Lessons Learned From the Clinical Genome Resource Project and the Electronic Medical Records and Genomics Network. Front Genet 2019;10:1059. [PMID: 31737042 DOI: 10.3389/fgene.2019.01059] [Cited by in Crossref: 16] [Cited by in F6Publishing: 11] [Article Influence: 5.3] [Reference Citation Analysis]
644 Delanne J, Nambot S, Chassagne A, Putois O, Pelissier A, Peyron C, Gautier E, Thevenon J, Cretin E, Bruel AL, Goussot V, Ghiringhelli F, Boidot R, Tran Mau-Them F, Philippe C, Vitobello A, Demougeot L, Vernin C, Lapointe AS, Bardou M, Luu M, Binquet C, Lejeune C, Joly L, Juif C, Baurand A, Sawka C, Bertolone G, Duffourd Y, Sanlaville D, Pujol P, Geneviève D, Houdayer F, Thauvin-Robinet C, Faivre L. Secondary findings from whole-exome/genome sequencing evaluating stakeholder perspectives. A review of the literature. Eur J Med Genet 2019;62:103529. [PMID: 30165243 DOI: 10.1016/j.ejmg.2018.08.010] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 4.5] [Reference Citation Analysis]
645 Klitzman R, Appelbaum PS, Fyer A, Martinez J, Buquez B, Wynn J, Waldman CR, Phelan J, Parens E, Chung WK. Researchers' views on return of incidental genomic research results: qualitative and quantitative findings. Genet Med 2013;15:888-95. [PMID: 23807616 DOI: 10.1038/gim.2013.87] [Cited by in Crossref: 82] [Cited by in F6Publishing: 80] [Article Influence: 9.1] [Reference Citation Analysis]
646 Hammer MJ. Beyond the Helix: Ethical, Legal, and Social Implications in Genomics. Semin Oncol Nurs 2019;35:93-106. [PMID: 30683550 DOI: 10.1016/j.soncn.2018.12.007] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
647 Burdon KP. The utility of genomic testing in the ophthalmology clinic: A review. Clin Exp Ophthalmol 2021;49:615-25. [PMID: 34231298 DOI: 10.1111/ceo.13970] [Reference Citation Analysis]
648 Yatsenko SA, Aarabi M, Hu J, Surti U, Ortiz D, Madan-Khetarpal S, Saller DN, Bellissimo D, Rajkovic A. Copy number alterations involving 59 ACMG-recommended secondary findings genes. Clin Genet 2020;98:577-88. [PMID: 33009833 DOI: 10.1111/cge.13852] [Reference Citation Analysis]
649 Tolusso LK, Collins K, Zhang X, Holle JR, Valencia CA, Myers MF. Pediatric Whole Exome Sequencing: an Assessment of Parents’ Perceived and Actual Understanding. J Genet Counsel 2017;26:792-805. [DOI: 10.1007/s10897-016-0052-9] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.8] [Reference Citation Analysis]
650 Lu JT, Ferber M, Hagenkord J, Levin E, South S, Kang HP, Strong KA, Bick DP. Evaluation for Genetic Disorders in the Absence of a Clinical Indication for Testing. The Journal of Molecular Diagnostics 2019;21:3-12. [DOI: 10.1016/j.jmoldx.2018.09.006] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 4.7] [Reference Citation Analysis]
651 Lázaro-Muñoz G, Conley JM, Davis AM, Van Riper M, Walker RL, Juengst ET. Looking for Trouble: Preventive Genomic Sequencing in the General Population and the Role of Patient Choice. Am J Bioeth 2015;15:3-14. [PMID: 26147254 DOI: 10.1080/15265161.2015.1039721] [Cited by in Crossref: 24] [Cited by in F6Publishing: 19] [Article Influence: 4.0] [Reference Citation Analysis]
652 Cook-Deegan R, Chandrasekharan S. Patents and genome-wide DNA sequence analysis: is it safe to go into the human genome? J Law Med Ethics 2014;42 Suppl 1:42-50. [PMID: 25298290 DOI: 10.1111/jlme.12161] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
653 Moriyama T, Metzger ML, Wu G, Nishii R, Qian M, Devidas M, Yang W, Cheng C, Cao X, Quinn E, Raimondi S, Gastier-Foster JM, Raetz E, Larsen E, Martin PL, Bowman WP, Winick N, Komada Y, Wang S, Edmonson M, Xu H, Mardis E, Fulton R, Pui CH, Mullighan C, Evans WE, Zhang J, Hunger SP, Relling MV, Nichols KE, Loh ML, Yang JJ. Germline genetic variation in ETV6 and risk of childhood acute lymphoblastic leukaemia: a systematic genetic study. Lancet Oncol 2015;16:1659-66. [PMID: 26522332 DOI: 10.1016/S1470-2045(15)00369-1] [Cited by in Crossref: 110] [Cited by in F6Publishing: 53] [Article Influence: 15.7] [Reference Citation Analysis]
654 Nielsen JB, Rom O, Surakka I, Graham SE, Zhou W, Roychowdhury T, Fritsche LG, Gagliano Taliun SA, Sidore C, Liu Y, Gabrielsen ME, Skogholt AH, Wolford B, Overton W, Zhao Y, Chen J, Zhang H, Hornsby WE, Acheampong A, Grooms A, Schaefer A, Zajac GJM, Villacorta L, Zhang J, Brumpton B, Løset M, Rai V, Lundegaard PR, Olesen MS, Taylor KD, Palmer ND, Chen YD, Choi SH, Lubitz SA, Ellinor PT, Barnes KC, Daya M, Rafaels N, Weiss ST, Lasky-Su J, Tracy RP, Vasan RS, Cupples LA, Mathias RA, Yanek LR, Becker LC, Peyser PA, Bielak LF, Smith JA, Aslibekyan S, Hidalgo BA, Arnett DK, Irvin MR, Wilson JG, Musani SK, Correa A, Rich SS, Guo X, Rotter JI, Konkle BA, Johnsen JM, Ashley-Koch AE, Telen MJ, Sheehan VA, Blangero J, Curran JE, Peralta JM, Montgomery C, Sheu WH, Chung RH, Schwander K, Nouraie SM, Gordeuk VR, Zhang Y, Kooperberg C, Reiner AP, Jackson RD, Bleecker ER, Meyers DA, Li X, Das S, Yu K, LeFaive J, Smith A, Blackwell T, Taliun D, Zollner S, Forer L, Schoenherr S, Fuchsberger C, Pandit A, Zawistowski M, Kheterpal S, Brummett CM, Natarajan P, Schlessinger D, Lee S, Kang HM, Cucca F, Holmen OL, Åsvold BO, Boehnke M, Kathiresan S, Abecasis GR, Chen YE, Willer CJ, Hveem K. Loss-of-function genomic variants highlight potential therapeutic targets for cardiovascular disease. Nat Commun 2020;11:6417. [PMID: 33339817 DOI: 10.1038/s41467-020-20086-3] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
655 Chen X, Jiang Y, Chen R, Qi Q, Zhang X, Zhao S, Liu C, Wang W, Li Y, Sun G, Song J, Huang H, Cheng C, Zhang J, Cheng L, Liu J. Clinical efficiency of simultaneous CNV-seq and whole-exome sequencing for testing fetal structural anomalies. J Transl Med 2022;20:10. [PMID: 34980134 DOI: 10.1186/s12967-021-03202-9] [Reference Citation Analysis]
656 Murray MF. Your DNA is not your diagnosis: getting diagnoses right following secondary genomic findings. Genet Med 2016;18:765-7. [PMID: 26447529 DOI: 10.1038/gim.2015.134] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
657 Johnson KJ, Gehlert S. Return of Results from Genomic Sequencing: A Policy Discussion of Secondary Findings for Cancer Predisposition. J Cancer Policy 2014;2:75-80. [PMID: 25229012 DOI: 10.1016/j.jcpo.2014.05.001] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 1.9] [Reference Citation Analysis]
658 Christenhusz GM, Devriendt K, Van Esch H, Dierickx K. Focus group discussions on secondary variants and next-generation sequencing technologies. European Journal of Medical Genetics 2015;58:249-57. [DOI: 10.1016/j.ejmg.2015.01.007] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 1.7] [Reference Citation Analysis]
659 Braverman G, Shapiro ZE, Bernstein JA. Ethical Issues in Contemporary Clinical Genetics. Mayo Clin Proc Innov Qual Outcomes 2018;2:81-90. [PMID: 30225437 DOI: 10.1016/j.mayocpiqo.2018.03.005] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
660 Shickh S, Clausen M, Mighton C, Casalino S, Joshi E, Glogowski E, Schrader KA, Scheer A, Elser C, Panchal S, Eisen A, Graham T, Aronson M, Semotiuk KM, Winter-Paquette L, Evans M, Lerner-Ellis J, Carroll JC, Hamilton JG, Offit K, Robson M, Thorpe KE, Laupacis A, Bombard Y. Evaluation of a decision aid for incidental genomic results, the Genomics ADvISER: protocol for a mixed methods randomised controlled trial. BMJ Open 2018;8:e021876. [PMID: 29700101 DOI: 10.1136/bmjopen-2018-021876] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 4.0] [Reference Citation Analysis]
661 Iglesias A, Anyane-Yeboa K, Wynn J, Wilson A, Truitt Cho M, Guzman E, Sisson R, Egan C, Chung WK. The usefulness of whole-exome sequencing in routine clinical practice. Genet Med 2014;16:922-31. [PMID: 24901346 DOI: 10.1038/gim.2014.58] [Cited by in Crossref: 142] [Cited by in F6Publishing: 124] [Article Influence: 17.8] [Reference Citation Analysis]
662 Johnston J, Lantos JD, Goldenberg A, Chen F, Parens E, Koenig BA; members of the NSIGHT Ethics and Policy Advisory Board. Sequencing Newborns: A Call for Nuanced Use of Genomic Technologies. Hastings Cent Rep 2018;48 Suppl 2:S2-6. [PMID: 30133723 DOI: 10.1002/hast.874] [Cited by in Crossref: 31] [Cited by in F6Publishing: 29] [Article Influence: 10.3] [Reference Citation Analysis]
663 Vora NL, Gilmore K, Brandt A, Gustafson C, Strande N, Ramkissoon L, Hardisty E, Foreman AKM, Wilhelmsen K, Owen P, Weck KE, Berg JS, Powell CM, Powell BC. An approach to integrating exome sequencing for fetal structural anomalies into clinical practice. Genet Med 2020;22:954-61. [PMID: 31974414 DOI: 10.1038/s41436-020-0750-4] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 7.5] [Reference Citation Analysis]
664 Carey AS, Schacht JP, Umandap C, Fasel D, Weng C, Cappell J, Chung WK, Kernie SG. Rapid exome sequencing in PICU patients with new-onset metabolic or neurological disorders. Pediatr Res 2020;88:761-8. [PMID: 32221475 DOI: 10.1038/s41390-020-0858-x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
665 Kleiderman E, Avard D, Besso A, Ali-Khan S, Sauvageau G, Hébert J. Disclosure of incidental findings in cancer genomic research: investigators' perceptions on obligations and barriers. Clin Genet 2015;88:320-6. [PMID: 25492269 DOI: 10.1111/cge.12540] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 1.6] [Reference Citation Analysis]
666 Rowsey R, Znoyko I, Wolff DJ. Whole-Genome Single Nucleotide Polymorphism Microarray for Copy Number and Loss of Heterozygosity Analysis in Tumors. In: Murray SS, editor. Tumor Profiling. New York: Springer; 2019. pp. 89-111. [DOI: 10.1007/978-1-4939-9004-7_7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
667 de Bruin C, Dauber A. Insights from exome sequencing for endocrine disorders. Nat Rev Endocrinol 2015;11:455-64. [PMID: 25963271 DOI: 10.1038/nrendo.2015.72] [Cited by in Crossref: 24] [Cited by in F6Publishing: 20] [Article Influence: 3.4] [Reference Citation Analysis]
668 Evans BJ. Minimizing liability risks under the ACMG recommendations for reporting incidental findings in clinical exome and genome sequencing. Genet Med 2013;15:915-20. [PMID: 24030435 DOI: 10.1038/gim.2013.135] [Cited by in Crossref: 26] [Cited by in F6Publishing: 23] [Article Influence: 2.9] [Reference Citation Analysis]
669 Tang CS, Dattani S, So M, Cherny SS, Tam PKH, Sham PC, Garcia-barcelo M. Actionable secondary findings from whole-genome sequencing of 954 East Asians. Hum Genet 2018;137:31-7. [DOI: 10.1007/s00439-017-1852-1] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 4.2] [Reference Citation Analysis]
670 Oberg JA, Glade Bender JL, Cohn EG, Morris M, Ruiz J, Chung WK, Appelbaum PS, Kung AL, Levine JM. Overcoming challenges to meaningful informed consent for whole genome sequencing in pediatric cancer research. Pediatr Blood Cancer 2015;62:1374-80. [PMID: 25832998 DOI: 10.1002/pbc.25520] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 2.7] [Reference Citation Analysis]
671 Prince AER, Berkman BE. Reconceptualizing harms and benefits in the genomic age. Per Med 2018;15:419-28. [PMID: 30260295 DOI: 10.2217/pme-2018-0022] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
672 Kingsmore SF. Incidental swimming with millstones. Sci Transl Med 2013;5:194ed10. [PMID: 23863830 DOI: 10.1126/scitranslmed.3006900] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
673 Naslavsky MS, Yamamoto GL, Almeida TF, Ezquina SAM, Sunaga DY, Pho N, Bozoklian D, Sandberg TOM, Brito LA, Lazar M, Bernardo DV, Amaro E, Duarte YAO, Lebrão ML, Passos‐bueno MR, Zatz M. Exomic variants of an elderly cohort of Brazilians in the ABraOM database. Human Mutation 2017;38:751-63. [DOI: 10.1002/humu.23220] [Cited by in Crossref: 110] [Cited by in F6Publishing: 105] [Article Influence: 22.0] [Reference Citation Analysis]
674 Carter HB, Helfand B, Mamawala M, Wu Y, Landis P, Yu H, Wiley K, Na R, Shi Z, Petkewicz J, Shah S, Fantus RJ, Novakovic K, Brendler CB, Zheng SL, Isaacs WB, Xu J. Germline Mutations in ATM and BRCA1/2 Are Associated with Grade Reclassification in Men on Active Surveillance for Prostate Cancer. Eur Urol 2019;75:743-9. [PMID: 30309687 DOI: 10.1016/j.eururo.2018.09.021] [Cited by in Crossref: 58] [Cited by in F6Publishing: 48] [Article Influence: 14.5] [Reference Citation Analysis]
675 Luthra R, Patel KP, Routbort MJ, Broaddus RR, Yau J, Simien C, Chen W, Hatfield DZ, Medeiros LJ, Singh RR. A Targeted High-Throughput Next-Generation Sequencing Panel for Clinical Screening of Mutations, Gene Amplifications, and Fusions in Solid Tumors.